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I) GENERAL INTRODUCTION 
 
Associations between diet and chronic disease have long been recognised through epidemiological 
studies. New genomic technologies are now enabling us to find out more about the basis of these 
associations by studying the functional interactions of food with the genome at the molecular, 
cellular and systemic levels and, moreover, the ways in which individuals respond differently to 
different diets according to their individual genetic make-up. 
These two areas, often differentiated as nutrigenomics and nutrigenetics respectively, are potentially 
of huge importance to the health care system and to the food industry, as well as to those seeking to 
understand the biology underlying normal homeostasis and disease. 
Nutrigenomics has emerged when new technologies, such as transcriptomics, proteomics, 
metabolomics, and epigenomics, have added more complex functional analysis to the basic 
sequence information provided by the Human Genome Project. Transcriptomics, for example, is a 
very valuable way of beginning understanding how cells and tissues are potentially influenced by 
diet. Three possible definitions for nutrigenomics can be used: 
“ … the application of high throughput genomics tools in nutrition research” (Müller & Kersten, 
2003) 
[nutrigenomics] “… seeks to examine ‘dietary signatures’ in cells, tissues and organisms and to 
understand how nutrition influences homeostasis” (Müller & Kersten, 2003) 
“… the interface between the nutritional environment and cellular/ genetic processes”. (Kaput & 
Rodriguez, 2004) 
There are a number of other definitions, and several authors distinguish between nutrigenomics and 
nutrigenetics (as the study of how genotype determines optimal dietary requirements for health on 
an individual basis), while others prefer to retain the use of nutrigenomics as a more generic term 
(R.M. Debusk et al, 2005). No matter how it is defined, this science investigates the interplay 
between genes, and diet. 
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To understand how nutritional exposure and environment factors influence gene expression on a 
genomic scale, it is possible to group genes of interest for particular metabolic processes and 
capture information from all of these at once, to see how the cell is functioning at any given time or 
under certain conditions. This is now possible thanks to the commercial development of chips 
dedicated to the investigation of the expression of genes involved into particular metabolic or 
functional systems. 
It’s known that some of the development work about Nutrigenomics has focused on cardiovascular 
disease or type II diabetes mellitus, where various groups have identified potential diet-gene 
interactions (Mutation Research, 2007). However what about gut health? And Gene–diet–bacteria 
interactions? 
The gastrointestinal barrier is a complex cellular structure, made up of four main components, 
which collectively act as a biological bouncer to protect the body from the entry of bacteria and 
antigens. The first are the intestinal epithelial cells that form a physical barrier and have absorptive 
functions. The second component is the mucus layer produced by goblet cells, which forms a 
chemical barrier covering the epithelium. The third component, the immunological barrier, is 
regulated by immune cells that deliver pathogens to the mucosal lymphoid tissue and dendritic cells 
that extend their arms through the tight junctions to capture luminal antigens directly. The fourth 
component, the microbiological barrier, consists of the commensal bacteria that limit the 
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colonisation of pathogens by competitively binding to the epithelium, competing for nutrients and 
producing antimicrobial compounds.  
How these components interact to maintain the gastrointestinal tract is fundamental to the delicate 
balance between health and disease. Human gastrointestinal tract is inhabited by 1013 microbes 
more than 10 times the number of cells that make up the human body with representatives from 500 
to 1,000 species. In adults, strict anaerobes outnumber facultative anaerobes by a factor of 100 to 
1,000, so these are likely to have a profound influence on the function of the gastrointestinal tract. 
The identity of almost all of these microbes and their mechanism(s) of action remains largely 
unknown. It has been illustrated in a number of germ-free mouse experiments, for example, that 
these mice require a calorific intake higher than conventional mice to maintain their weight and also 
had less developed immune systems (i.e. less circulating immunoglobulin, less T cells, etc.). 
Colonisation of these animals by the commensal bacterium Bacteroides thetaiotaomicron assisted 
with the correct development of these processes by modulating the expression of host genes 
involved in nutrient absorption, glucose and fat metabolism and immune responses (Gordon et al, 
2006). Colonisation by other commensal bacteria shaped the immunity and maturation of the 
intestinal tract, and molecules produced by the bacteria are believed to play a key role. Although the 
interactions between intestinal cells and pathogenic bacteria are only partially understood, recent 
studies have shown that pathogenic bacteria (E.coli) can modulate the cell cycle (Samba Louaka et 
al, Cell Microbiol, 2008), but in general their interactions with commensal bacteria have been 
poorly described. 
Dirk Haller (Technical University of Munich) provided evidence that intestinal epithelial cell 
signalling and host-derived regulators, along with enteric bacteria, are critical components of 
chronic intestinal inflammation. This points to a sophisticated communication network between 
commensal bacteria and intestinal cells. The gastrointestinal tract is not a passive fermentation 
vessel, but in a state of active intercommunication with its resident microbial ecosystem and our 
environment. We cannot forget that perhaps one of the most important environmental factors that 
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influences this interaction is our diet. We have only begun to understand the delicate balance 
between commensal bacteria, the gastrointestinal tract they inhabit and our health and optimal 
wellness versus disease. It becomes apparent that we need to identify both our allies and potential 
foes in order to exploit this diverse ecosystem, and to understand how our diet interacts with two 
genomes; the microbial and our own. 
In the 2 August 2005 issue of the Proceedings of the National Academy of Sciences, Ley and other 
researchers led by Jeffrey Gordon, director of the Center for Genome Sciences at Washington 
University, found that the gut microbiota of genetically obese mice contained a high percentage of 
bacteria from the phylum Firmicutes whereas their lean littermates had more bacteria from the 
phylum Bacteroides. In the 21/28 December 2006 issue of Nature, Ley reported the same 
observation in obese and lean human volunteers. She also found that the microbiota of obese people 
who lost weight through a low calorie diet shifted to look more like that of leaner people.  
It’s difficult to say which came first in some of these studies, obesity or the altered microbiota. In 
another study from the same Washington University laboratory, also published in the 21/28 
December 2006 issue of Nature, germ-free mice were colonized with the microbiota of either obese 
mice or lean mice. Mice that received the obese microbiota gained a higher percentage of body fat 
than mice receiving the lean microbiota (47.0% versus 0.86%), suggesting that microbiota shifts 
may contribute to obesity onset. The researchers also found that the obese microbiota, which 
contained more genes involved in breaking down sugars, appeared to actually harvest more energy 
from the same diet than did the lean microbiota. The transplant experiments provided functional 
evidence that this difference may be biologically relevant. It’s clear that dietary differences appear 
to influence our microbiota, consequently influence our genes and our phenotype. 
The influence of diet and of some living bacteria on health has been known for more than a hundred 
years. During recent decades, knowledge of these influences has greatly increased. A relationship 
with specific food components has also emerged. Based on this new knowledge, we are now 
increasingly able to design new and healthier foods, thereby reducing the risk of developing a 
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number of chronic or infectious diseases. These foods are often called functional foods or designer 
foods. They are traditional foods modified in such a way that they have specific health benefits 
which are absent from non-modified products. The largest groups of functional foods are probiotic 
foods, prebiotic foods and synbiotic foods. These are foods targeted to improve the gut microbiota 
and, through this, human health.  
Probiotics included in functional foods are defined as live microbial food ingredients that have a 
beneficial effect on the intestinal microbiota and on human health. The live microorganisms are 
most often bacteria from the genera Lactobacillus and Bifidobacterium. The first probiotic products 
were fermented dairy products but these now include many other types of foods, e.g. other dairy 
products, meat products, drinks and fermented foods in general. Prebiotics included in prebiotic 
foods are defined as food components, which avoid digestion by mammalian enzymes in the upper 
regions of the gastrointestinal tract, reach the colon in an intact state and stimulate the growth of 
specific, beneficial organisms of the gut microflora.  
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II) COLONIC EPITHELIUM AND MICROBIOTA 
II-1) COLONIC EPITHELIUM  
The intestinal epithelium  is considered as a succession of different compartments with a specific 
dynamic structure. The gastrointestinal epithelium is an active self renewal layer and its turnover 
time  is  gradually prolonged toward the colonic epithelium where it arrives at a maximum (Alam et 
al, 1994). This  ecosystem harbours also  a large  number of commensal micro-organisms that 
enables the gut to accomplish its physiological function (O’Keefe SJ , 2008). The important roles of 
commensal microbiota include protective effect maintained by specific bacterial species, regulation 
of epithelial cell proliferation and differentiation, production of essential mucosal nutrients, such as 
short-chain fatty acids, prevention of pathogenic bacteria colonization, and maturation and 
stimulation of intestinal immunity (Kelly et al, 2007). 
II-1-1) MORPHOLOGICAL STRUCTURE AND RENEWAL OF THE COLONIC EPITHELIAL 
CELLS. 
The colonic epithelium is organized in main structures and hierarchical compartments. The crypts 
are short invaginations of mucosal epithelium that provide protected pockets for special cellular 
functions. These finger-like invaginations into the underlying connective tissue of the lamina 
propria form the basic functional unit of the colonic epithelium. Studies based on labeling using 
tritiated thymidine have shown that the proliferation occurs in the lower part of the crypts (Falk et al 
1998) (figure 1). 
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Figure 1: Colonic crypt organization,  patterns of stem cell divisions, niche succession and clonal conversion. A 
diagrammatic representation of the colonic crypt. Stem cells are housed in the base of the crypts where they 
communicate with the niche cells — the pericryptal myofibroblasts, which are outside the crypt but communicate by 
cell signalling. Stem cells feed the transit-amplifying compartment, where most cell production occurs. This portionof 
the crypt is thought to also house the committed progenitor cells: cells committed to one or more cell lineages. 
In mouse, the number of dividing cell has been estimated to one hundred for each colonic crypt per 
day (ten cells per hour). The rate of cell renewal is quite impressive. One cell division occurs, on 
average, every 5 min in each of the approximately 106  crypt in the adult mouse small intestine (Falk 
et al 1998). In humans, the cell number in small intestine crypts is larger than in mouse, the cell 
division time is approximately twice that of mouse, and the number of amplifying transit cell 
generations is believed to be greater (Potten et al, 1992; Potten et al, 1992; wrigh et al, 1984). Cells 
emerge from colonic crypt and are incorporated into surface epithelial cuffs that surround the orifice 
of each crypt (Table 1).  
 Mouse Human 
Cells/Crypt 300-450 2250 
Cell cycle  15-36h 36-96h 
Stem cell cycle >36h >36h 
Stem cell/crypt 1-4 ? 
Transit cell generations 5-9 5-9 
Table 1: estimated values for colonic crypt cell populations. Data from Potten et al, 1992.   
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The cell migration is also remarkably well organized: several studies using chimeric mice have 
shown that crypt cells after proliferation migrate rapidly from the bottom of the crypt to the top 
(surface epithelium) where they are subsequently removed by exfoliation in the lumen or by 
apoptosis. This migration along the axis of the crypt is coupled with the  cell differentiation process, 
characterized by some changes in cell function and structure. Figure2.  
 
Figure 2: Colonic cells organization during the migration and differentiation process. 
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The surface of the epithelium is composed of sheets of epithelial cells that form the border of the 
planar region of the mucosa. During the process of differentiation cells migrate towards the surface 
of epithelium. The mature colon epithelium is mainly composed by  three  types of differentiated 
cells: the goblet cells, the colonocytes or  intestinal absorptive cells, and endocrine cells (Figure3).  
 
Figure 3: organization  of the three types of differentiated cells in the colonic epithelium.  
- The goblet cells or mucus cells, principally found in midcrypt, secret the mucus that is 
integrant part of the intestine and have a protective function against aggression. 
-  The absorptive cells or colonocytes, found in the top of the crypt, represent 80% of all the 
cells. They have a major role in the transport of electrolytes and short fatty acids produced 
by colonic fermentations. The main function of the adult colon epithelium is the absorbption 
of water and salt. The formation of colonic villi occurs in embryonic proximal intestine, in 
humans these structures are flattened at birth (Pascal et al, 2003).  
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- Endocrines cells  represent less than 3% of epithelial cells and are mainly located at the base 
of the crypt (Chang. w et all, 1971). They are specialized in the synthesis of peptides. 
Several studies have established that the differentiated cell types of the colonic epithelium derive 
from stem cells sited at the base of crypt (Potten CS et al, 1997; Marshaman E et al, 2002). All 
cellular ‘movements’ are therefore towards the lumen (P. de Sanata Barbara et al, 2003).  The 
control and balance of the different processes of proliferation, differentiation, migration and 
apoptosis is essential to normal gut morphology and function (Ruemmele FM et al,1998). Loss of 
the balance between proliferation and apoptosis leads to the development of cancer (Hanahan D et 
al, 2000). 
II-1-2) MOLECULAR MECHANISM’S CONTROLLING COLONIC EPITHELIUM 
PATTERNING.  
As previously described, the colonic epithelium is organized along the crypt axis, with stem cells in 
the bottom of crypt and terminally differentiated cells at the top of the crypt (Potten CS et al, 1990). 
Homeostasis of the colonic epithelium is maintained by molecular and cellular controls, witch 
involve different pathways (figure 4). 
Recent studies have shown that Wnt pathway play a central role in the physiology of the intestine. 
Wnt factors are secreted by epithelial cells located in the bottom of the crypt (Gregorieff et al, 
2005). Studies in vivo have indicated that proliferation of transient amplifying cells (AT) in the 
crypt is dependent on a continuous stimulation from the Wnt pathway. Van de wetering and his 
collaborators (2002) have demonstrated that the β-catenin transcription factor accumulated in the 
stem cells at crypt bottom and these cells respond to Wnt signalling. 
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Mice with removed TCF4, β-catenin, or overexpression of DKK-1 resulted in a complete loss of 
proliferation (Vakorinek et al, 1998; Pinto et al, 2003; Kuhnert et al, 2004). Whereas, mutation of 
APC gene, negative regulator of Wnt signalling, generated hyperproliferation of colonic epithelium 
and contributed to colon cancer (Harada et al, 1999; Romagnolo et al, 1999; Smits et al, 1999; 
Sanson et al, 2004; Andreu et al, 2005). 
These results indicate that genes stimulated by β-catenin/ TCF4 complex are involved in the process 
of proliferation and are located in the crypt proliferative compartment, whereas genes inhibited by 
Figure 4: 
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the same complex are involved in the differentiation process and are expressed along the walls and 
at the top of  the crypt. 
The self-renewal of the colonic epithelium requires a highly coordinated regulation of the Wnt/ -
catenin and Notch signalling pathways, to control the proliferation of multipotent stem cells. Nicolas 
Coant and collaborators have demonstrated that NADPH oxidase 1 (NOX1), highly expressed 
in colonic epithelial cells as a consequence of the presence of reactive oxygen species (ROS), is a 
pivotal determinant of cell proliferation and fate that integrates Wnt/ -catenin and Notch1 signals.  
In addition, NOX1-deficient mice reveal a massive conversion of progenitor cells into post-
mitotic goblet cells at the cost of colonocytes, due to the  repression of the PI3K/AKT/Wnt/ -catenin 
and Notch1 signalling complexes. These results indicate that NOX1 controls the balance between 
goblet and absorptive cell types in the colon by coordinately modulating PI3K/AKT/Wnt/ -catenin 
and Notch1 signaling. This finding provides the molecular basis for the role of NOX1 in cell 
proliferation and post-mitotic differentiation (Nicolas Coant et al, 2010). 
Barker et al (2008) have identified a new Wnt target gene, Lgr5, with a much more restricted 
expression within crypts. Lgr5 is expressed in the CBC cells. In mice Lgr5 knock out in the colon 
lead to 100% death. 
II-2) COLONIC MICROBIOTA  
There is growing evidence that several diseases related to the intestine and/or the immune system 
are associated with variations in the composition and consequently activity of the gut microbiota 
(Alverdy, J.C.et al, 2008; Backhed. F et al, 2005; Backhed, F.et al, 2004; Hooper, L.V et al, 2002; 
Frank, D.N. et al, 2006). Recent evidence also indicates that the bacterial conversion of foods 
produce a large number of compounds that may have beneficial (e.g. inulin); (Macfarlane, G.T.et al, 
1995; Flint. H.J. et al, 2007) or deleterious effects on the host health, (Bingham. S.A et al,1999; van 
Nuenen, M.H., 2004 ; Blaut, M et al, 2007). Understanding the effects on health of specific food-
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derived microbial metabolites is key to optimize the diet and aid re-establishment of a healthy 
homeostasis in patients, to increase the robustness of homeostatic control and to help healthy 
subjects to stay healthy and thus to properly target interventions aiming at modulating the 
microbiota. However, distinguishing the direct impact of the food component on host health from 
indirect effects through the microbial metabolites or the microbiota itself remains a major challenge. 
II-2-1) AN ANIMAL MODEL FOR STUDYING THE FUNCTIONAL IMPACT OF 
MICROBIOTA ON COLONIC EPITELIUM. 
The impact of colonic microbiota on human health and the interface role played by these microbiota 
between transiting nutrient and the host are fields that have yet to be explored. 
Studies with gnotobiotic mice have shown that the enteric microbiota is not functionally isolated 
from the mucosa; in contrast, these bacteria influence epithelial metabolism, proliferation and 
survival, and barrier function ( Hooper LV et al, 2001; Ismail AS et al, 2005). The small intestinal 
villi of the germ-free gut are relatively longer, whereas crypts are atrophic, show a slower turnover 
of the epithelial cells (Ha E.M. et al, 2005), and exhibit defective angiogenesis. Hooper et al (2001) 
reported robust transcriptional responses of gnotobiotic mice monocolonized with a single gut 
symbiont species (Bacteroides thetaiotaomicron). Jeffrey I., from Gordon’s team, have  proposed a 
simplified animal model to investigate the effect of commonly consumed live microbial strains 
varying in their ability to colonize the Intestinal Gut (Sonnenburg JL, Chen CT & Gordon JI 2006). 
The model is a Germ Free NMRI mice colonized by Bacteroides thetaiotaomicron, a prominent 
symbiotic member of human microbiota whose genome has been completely sequenced or by 
Bifidobacterium longum, is a minor member of gut microbiota commonly used  as probiotic. 
Results have shown that the presence of Bifidobacterium longum lead to an increase of degradation 
of target polysaccharides by Bacteroides thetaiotaomicron and induces host genes involved in the 
innate immunity. However, the Bifidobacterium longum induced diversification in the 
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carbohydrates accessed by Bacteroides thetaiotaomicron occurs independently of the host 
genotype. 
In conclusion, this animal model provides an excellent instrument to investigate the impact of 
probiotic species on gut health, and illustrates both the generalities and specificities of the 
relationship between a host and a component of its microbiota.  
II-2-2) COLONIC MICROBIOTA COMPOSITION   
The human normal flora, or microbiota, is vast, both in its absolute quantitative mass and its 
qualitative diversity. An estimated 1013 intestinal microorganisms are distributed along the human 
intestinal tract and reach a remarkable density in the colon. The absolute complexity of the gut 
ecosystem has required the development of modern molecular biology techniques as most of the 
microbes present have not yet been cultured and are only known as a result of their detection via 
16S ribosomal RNA (rRNA) or DNA (rDNA). 
The number of different species comprised in the human gut microbiota is controversial, with many 
authors referring to estimates of 400-500 species based on culture studies, while more recent 
estimates are reaching into the thousands (Backhed. F et al, 2005, Rajilic-Stojanovic. M et al, 
2007). A combination of sequence analysis of 16S rRNA genes and metagenomic libraries, and of 
fluorescent in situ hybridization targeting the 16S rRNA has shown that the most abundant bacterial 
groups in the human intestine belong to the phyla of the Firmicutes (including the large class of 
Clostridia and the lactic acid bacteria) and Bacteroidetes, which dominate the ecosystem, followed 
by Actinobacteria (including Collinsella and Bifidobacterium spp.), Proteobacteria, and Archaea, 
and finally bacteriophages, that out number bacteria by 10 to 1 (Table 2; Eckburg, P.B et al, 2005; 
Zoetendal, E.G et al, 2006) 
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Major Phyla Important Families *Main Fermentation Products 
  
  
Bacteroidetes 
  
Bacteroides 
Prevotellae 
Prophyromonadaceae 
Rikenellaceae 
acetate, propionate, succinate from carbohydrates 
  
  
  
 
acetate, formate, L- and D-lactate, butyrate, succinate, 
propionate from carbohydrates; 
BCFAs, indoles, sulphides, phenols, amines, NH3, 
H2, 
CO2, CH4 from proteins and amino-acids 
   
  
  
  
  
  
Firmicutes 
  
  
  
  
  
  
Clostridiaceae 
Lactobacillaceae 
Leuconostocaceae 
Bacillaceae 
Streptococcaceae 
Eubacteriaceae 
Staphylococcaceae 
Peptococcaceae 
Peptostreptococcaceae 
  
  
  
  
Actinobacteria 
  
  
Bifidobacteriaceae 
Actinomycetaceae 
Coriobacteriaceae 
Corynebacteriaceae 
Propionibacteriaceae 
Micrococcaceae 
  
  
lactate, acetate, formate from carbohydrates 
  
  
  
      
  
  
Proteobacteria 
  
  
  
Enterobacteraceae 
Oxalobacteriaceae 
Pseudomonadaceae 
Desulfovibrionaceae 
Helicobacteraceae 
  
  
lactate, acetate, succinate, formate from 
carbohydrates; 
sulphide from sulphate, H2S, mercaptans 
  
  
  
      
Euryarchaeota Methanobacteriaceae CH4 
  
acetate, butyrate, NH3, formate, lactate 
  
Fusobacteria 
  
  
Fusobacteriaceae 
  
  
Verrucomicrobia Verrucomicrobiaceae N.R 
  
Lentisphaerae 
  
  
Victivallaceae, 
e.g. Victivallis vadensis 
  
acetate, ethanol, H2 
  
 
Table 2. Main Phylogenetic Groups (Based on 16S rRNA) in the Human Gut Microbiota with Important Families and 
the Main Fermentation Products (Rajilic-Stojanovic, M et al, 2007; Louis, P. et al, 2007; Zoetendal, E.G et al, 2003] 
*The fermentation end-products are only indicative of some cultured representatives of a family as the vast majority has 
not been isolated and researched; N.R. not reported. 
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Microorganisms from the genera Bifidobacterium and Lactobacillus are the main members of the 
gut microbiota recognized as being beneficial for health (Boesten, R.J et al, 2008; Macfarlane, G.T 
et al, 2008). There is considerable circumstantial evidence that colonic bifidobacteria impact 
positively on the host via various mechanisms and consequently bifidobacteria are the target of 
prebiotic functional foods and supplements. A prebiotic is a nondigestible food ingredient that 
beneficially affects the host by selectively stimulating growth and/or modifying the metabolic 
activity of one or a limited number of bacterial species in the colon that have the potential to 
improve host health (Gibson, G.R et al, 1995). Furthermore, specific probiotic strains, often of the 
Bifidobacterium and Lactobacillus genera, may be ingested with the food or in supplements. 
Convincing evidence indicates that specific strains of these genera have a positive health effects on 
the host (Macfarlane, G.T et al, 2002). 
In human gut the composition of microbiota is specific for different intestinal tracts. Remarkable 
differences in composition are also present between populations and individuals, even if at the 
functional level a rather high uniformity is present in the vast majority of individuals, after weaning 
(Gill. S.R et al, 2006; Kurokawa. K. et al, 2007). The gut microbiota of each individual is unique 
and it is influenced by a combination of factors, including the legacy acquired during birth, the 
genotype of the individual, host physiological status, lifestyle and diet (Zoetendal E.G et al, 2006;  
Li M.et al, 2008; Turnbaugh P.J., 2008). The assembly of the gut microbiota commences at birth. In 
fact, in the neonates, this assembly starts with Escherichia coli, clostridium spp., Streptoccocus 
spp., Lactobacillus spp., Bacteroides spp., and Bifidobacterium spp. Differences in the composition 
of the fecal flora are found between children from different geographic regions, reflecting, in part, 
the impact of the environment (sanitary conditions). The mode of delivery, feeding patterns, 
hospitalization, and antibiotic treatment are other factors known to affect the composition of the gut 
flora in children. Research published by Chana Palmer et al. in the 26 June 2007 edition of PLoS 
Biology showed that, at 1 year of age, infants started to converge toward a microbiota profile that 
looked more like the adult GI tract, particularly as they begin to eat solid foods. Once fully 
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developed in adulthood, the intestinal microbiota is thought to remain quite stable over months or 
years. Dietary modulation of the gut microbiota can dramatically alter the microbiota community 
and its activity, and consequently, nutrient bioavailability and metabolism. 
II-2-3) COLONIC MICROBIOTA AND METABOLISM. 
Transit of undigested and indigestible food components through the colon is slow, allowing for the 
development of diverse microbiota in the large intestine. Microbial metabolism in the colon is 
influenced by the amount and type of dietary compounds that survive small intestinal digestion. In 
general, microbial metabolites including digested dietary compounds absorbed by the gut as well as 
non-nutrient compounds produced by the microbiota are co-metabolized by host enzymes in the 
liver (Figure 5). These modified metabolites are returned to the colon by the bile and possibly by 
other secreted fluids for further metabolism and/or excretion. The commensal bacteria derived 
metabolites can have various effects on the host immune system (Jia W. et al, 2005).  
The interaction of colonic microbial metabolites with the host is basically restricted to the 
extracellular metabolites (De Graaf A.A. et al, 2008). Whereas the microbial composition of an 
individual is unique and even varies considerably with time (Barcenilla A. et al, 2009), it is 
assumed that the microbiota as a whole performs a stable set of activities within a population, given 
the enormous functional overlap between microorganisms (De Graaf A.A. et al, 2008). In 
agreement with this, the inter-individual variation observed in faecal extracts from healthy 
volunteers has been found to originate mainly from variable metabolite concentrations rather than 
from variable metabolite compositions Jacobs et al. (Jacobs D.M. et al, 2008), suggesting that the 
core of gut microbes share general biochemical characteristics to metabolize different substrates 
through specific metabolic patterns (Mortensen P.B. et al, 1992). Nevertheless, there is substantial 
inter-individual variation between the gut microbiota of different individuals, and these global, 
regional and personal differences are likely to lead to significant differences in response to diet, that 
may impact on health (Zoetendal E.G. et al, 2006; Li M. et al, 2008).  
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In particular ‘non-digestible’ dietary carbohydrates, including polysaccharides, oligosaccharides, 
lignin and associated plant material, are the preferred energy source for colonic microbiota. They 
are metabolized to short chain fatty acids (SCFAs), primarily to acetate, propionate, and butyrate, 
which are considered to promote health (Wong J.M. et al, 2006; Elia M. et al, 2007).  
Much of the non-digestible dietary carbohydrates are fermented in the proximal colon, where they 
influence proteolytic fermentation.  
Dietary proteins can also reach the colon, and, in addition to endogenous secretions such as mucin, 
they provide other substrates for fermentation and deamination of amino-acids. These can result in a 
range of metabolites, including the branched-chain fatty acids (BCFAs) isobutyrate, isovalerate and 
isocaproate, and also indoles, sulphides, ammonium, phenols, histamine and oxaloacetate, amongst 
others. These putrefactive components are generally considered to be toxic and to cause adverse 
effects on the colonic epithelium. A strong causal relationship between proteolytic fermentation in 
the (distal) colon and the occurrence of colon cancer (Bingham S.A. et al, 1999) and inflammatory 
bowel disease (IBD) (Van Nuenen M.H. et al, 2004) is hypothesized.  
In the colon, polyphenols are deconjugated by bacterial glycosidases, glucuronidases, and sulfatases 
and further fermented to a wide range of low-molecular-weight phenolic acids (Scalbert A. et al, 
2002). Thus, the gut microbiota plays a key role in the bioavailability of polyphenols and has been 
shown to modulate the health promoting activity through transformation of diet components into 
more active derivatives (Scalbert A. et al, 2002; Fava F. et al, 2006).  
In addition to food ingredients, which influence gut homeostasis via mediating metabolic or 
biochemical factors, such as intra-colonic pH, production of bile acid metabolites, and fermentative 
production of metabolites, disturbances of the gut ecology can be caused by a variety of factors, 
including antibiotics, environmental toxins, infections, stress, and genetic predisposition. In 
particular, the use of antibiotics is speculated to be linked to several disorders such as obesity, 
insulin resistance, diabetes, irritable bowel syndrome and diarrhea (Eckburg P.B. et al, 2005; Arvola 
T. et al, 1999; Mendall M.A. et al 1998). Modern microbiota-targeted therapies envisage 
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combinations of antibiotics, probiotics, prebiotics and perhaps laxatives to restore the homeostasis 
of gut ecology in the host (Jia W. et al, 2008). 
 
 
Figure 5:  Possible links between the gut microbiota and metabolism. Continuous lines, likely pathway; dotted lines, 
putative pathway 
 
II-2-4) DEFENSE BARRIER AND MUCOSAL IMMUNE SYSTEM. 
The intestinal microbiota is an important constituent of the mucosal defense barrier. Resident 
bacteria serve as a first line of resistance to colonization by exogenous microbes and this helps in 
preventing the potential invasion of the intestinal mucosa by an incoming pathogen. This protective 
function is known as the barrier effect or colonization resistance (Geraldine et al, 2008). The 
protective function is that adherent nonpathogenic bacteria can often prevent attachment and 
subsequent entry of suspected pathogens into epithelial cells. In addition, recent studies have 
revealed further effects of butyrate on the intestinal barrier function (Peng et al, 2007). This barrier 
function,  may be classified into physical and biological barrier functions.  
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The  biological barrier includes a detoxification system formed by detoxification enzymes and 
efflux transporters (Benet L.Z. et al, 2001) which inhibits the invasion of the body by harmful 
compounds. Secretion of IgA antibodies against various pathogens (Wehkamp J. et al, 2007) can 
also be included in the biological barrier functions of IECs. 
Furthermore, in vitro or animal studies have clearly found beneficial effects of butyrate against 
oxidative stress and on various components of the intestinal barrier (including mucus, epithelial 
permeability and migration), trefoil peptides (antimicrobial peptides) and heat shock proteins 
(Wong J.M. et al, 2006; Hamer H.M. et al, 2008), which contribute to improving the colonic barrier 
defense. At the molecular level, it is known that butyrate is a histone deacetylase inhibitor (HDAC), 
leading to changes in chromatin conformation and gene expression (Siavoshian S. et al, 2000). This 
mechanism is assumed to be crucial for the ability of butyrate to modulate the expression of 
numerous genes involved in colonic health (Daly K. et al, 2006; Segain J.P. et al, 2000). Apart from 
acting on epithelial cells, butyrate is also capable of interacting with immune cells. In fact a number 
of studies have shown that butyrate has anti-inflammatory properties in IFN-γ-stimulated 
macrophages in vitro (Park J.S. et al, 2007) through the interaction with the GPR43 transmembrane 
receptor recently identified on immune cells (Brown A.J. et al, 2003; Le Poul E. et al, 2003). 
Another important trophic factor is the communication network that exists between the host and 
resident microflora at the mucosal interface, which channels the development of a competent 
immune system. Monteleone and Gordon (2005, 1997) have reported that there is a clear indication 
that microbial colonization of the gastrointestinal tract affects  the composition of the gut asociated 
lymphoid tissue (GALT). 
II-2-5) REGULATION OF COLONIC EPITHELIUM STRUCTURE  
The microflora of the gut has a direct impact on the architecture and morphology of the digestive 
system (Falk P.G. et al, 1998) For example, the villi of the small intestine are longer; crypts are 
shorter and contain fewer cells in germfree mice than in age-matched conventional animals (Alam 
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M. et al, 1994). The largest difference is in areas with the highest bacterial density. Since the 
microbiota are chiefly responsible for the degradation of mucus glycoproteins, the absence of the 
flora in germfree mice results in the accumulation of these components in the distal small bowel and 
proximal colon, with a corresponding enlargement. However, this enlargement can be easily 
reversed with monoassociation with Peptostreptococcus micros or conventionalization with flora 
from normal mice (Carlstedt-Duke B. et al, 1984). These important observations on the contribution 
of microflora to the architecture of gut have been possible primarily because of the use of animal 
models such as conventionalized or germ free mice. However, it is essential to remember that the 
pattern of colonization of the microbiota (mucosal adherent/non-adherent), epithelial cell renewal, 
cells/crypt and crypt/villus ratio in the gut of mice are different from humans (Falk P.G. et al, 
1998). Nevertheless, these animal models have been instrumental in providing us insights into the 
contributions of the microbiota to gut morphology. 
The structure and homeostasis of intestinal epithelium are the basis of the absorptive function of  
the intestine and are modulated throughout life by environmental factors. It is  
known that the surface epithelium and crypt depth increase after birth. A number of studies have 
shown  that adult humans increased colonic crypt depth reflects a morphological adaptation that 
occurs following intestinal resection (Joly F. et al, 2009). In this context,  some studies investigated 
the effect of the microbiota on the structure and homeostasis of the colonic epithelium. It has 
observed in vivo using gnotobiotic animals that the presence of microbiota leads  to an increase in 
the crypts depth of the colonic epithelium. This trophic effect of microbiota was accompanied by a 
highly orchestrated induction of proteins involved in colonic epithelial cell cycle. The presence of a 
complex of microflora in the intestinal tract is a determinant factor of its ecosystem. The 
establishment of microbiota in the host induces an early hyper-proliferation phase that is then offset 
by a late phase of proliferation arrest and differentiation (Cherbuy C. et al, 2010) (figure 6). Recent 
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studies report that cell cycle proteins that are induced by the commensal microbiota have also been 
described as cellular targets  of some pathogenic bacteria (Samba L. et al, 2008).  
 
 
Figure 6: this figure summarize the effect of microbiota on the colonic epithelium of Germ Free in comparison with 
conventional rats at 30days after 2 days and 14 days of  microbiota inoculation. At 2 days its clear that proliferation has 
a transitory pick, at 14 days there is an arrest of the proliferation and the crypt reaches the maximum development. 
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BACTERIA AS THERAPEUTIC PROBIOTIC AGENTS? 
 
III) PROBIOTIC EFFECT AND HEALT 
III-1) PROBIOTIC DEFINITION AND HISTORY 
Probiotics are living microorganisms which, upon ingestion in certain numbers, exert health 
benefits beyond inherent basic nutrition. All known probiotic bacteria belong to the group called 
lactic acid bacteria, which in this context includes the species Lactococcus, Lactobacillus, 
Streptococcus, Leuconostoc, Pediococcus, Bifidobacterium and Enterococcus. Among these, only 
some Lactobacillus-, Bifidobacterium- and Enterococcus strains are commercially available as 
probiotics in foods (Table 2), but other strains are also considered probiotics, e.g. Lactococcus, 
Pediococcus, Streptococcus and Leuconostoc. 
The term probiotic was derived from the Greek, meaning “in favour of life.” The Food and 
Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) 
have stated that there is adequate scientific evidence to indicate that there is potential for probiotic 
foods to provide health benefits and that specific strains are safe for human use (Food and 
agriculture organization of the united Nations and World Health Organization, 2001 ). An expert 
panel commissioned by FAO and WHO defined probiotics as “Live microorganisms which when 
administered in adequate amounts confer a health benefit on the host.” This is the definition that 
should be used, and probiotics should not be referred to as biotherapeutic agents (McFarland et al, 
1995). Probiotics represents an expanding research area. A Medline search of the term probiotics 
illustrates the significant increase in research undertaken in this area during the past 5 years. There 
is a relatively large volume of literature that supports the use of probiotics to prevent or treat 
intestinal disorders. 
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The principle of using harmless bacteria for conquering pathogens has been recognized for many 
years. In fact, probiotics have been used for as long as people have eaten fermented foods. 
However, it was Metchnikoff at the turn of the century who first suggested that ingested bacteria 
could have a positive influence on the normal microbial flora of the intestinal tract (Metchnikoff 
1907). He hypothesized that lactobacilli were important for human health and longevity, and 
promoted yogurt and other fermented foods as healthy. 
The belief in the beneficial effects of probiotics is based on the knowledge that the intestinal 
microbiota can protect humans against infection and that disturbance of this microbiota can increase 
susceptibility to infection. Numerous in vivo and in vitro studies have shown that the normal 
intestinal microbiota  is an extremely effective barrier against pathogenic and opportunistic 
microorganisms (Fuller 1991). 
Probiotics are usually targeted for use in intestinal disorders in which specific factors (such as 
antibiotics, medication, diet or surgery) disrupt the normal microbiota  of the gastrointestinal tract, 
making the host animal susceptible to disease. Examples of such diseases include antibiotic-induced 
diarrhea, pseudomembranous colitis and small bowel bacterial overgrowth. The goal of probiotic 
therapy is to increase the numbers and activities of those microorganisms suggested to possess 
health-promoting properties until such time that the normal flora can be reestablished. These 
diseases include traveler’s diarrhea, Helicobacter pylori gastroenteritis and rotavirus diarrhea. Many 
microorganisms have been used or considered for use as probiotics. A probiotic preparation may 
contain one or several different strains of microorganisms. Because viable and biologically active 
microorganisms are usually required at the target site in the host, it is essential that the probiotic be 
able to withstand the host’s natural barriers against ingested bacteria. 
The most widely documented effects of lactobacilli in humans are stimulation of the immune 
system, prevention and reduction of the intensity and duration of diarrhea, and reduction of lactose 
intolerance (Wolvers et al., 2010). Lactobacilli also have other potential but less documented 
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beneficial effects such as vitamin B synthesis, improvement of mineral and nutrient absorption, 
degradation of antinutritional factors, or modulation of intestinal physiology and reduction of pain 
perception. Lactobacilli may thus be of benefit to health and help protect against some diseases. The 
beneficial effects of Lactobacillus and Bifidobacterium have been discussed for decades. Bacteria in 
these two genera resist gastric acid, bile salts and pancreatic enzymes, adhere to intestinal mucosa 
and readily colonize the intestinal tract. They are considered important components of the 
gastrointestinal microbiota  and are relatively harmless.  
There are many mechanisms by which probiotics enhance intestinal health, including stimulation of 
immunity, competition for limited nutrients, inhibition of epithelial and mucosal adherence, 
inhibition of epithelial invasion and production of antimicrobial substances. Probiotics can also  
improve host growth (Figure 7) providing growth factors that  they were involved in intestinal 
maturation (Turpin et al, 2010). 
 
Figure 7: Probiotics can improve host growth by increasing biodisponibility of macronutrients (1), degradation of 
antinutrient factors (2), enhancement of mineral absorption (3), and production of growth factors (4). The other squares 
indicate the mechanism involved in host growth. 
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While this demonstrates the potential significance of this emerging field, much still remains to be 
done to standardize which strains actually fulfill the criteria of true probiotic microorganisms and  
must be undertaken additional investigations before their role in intestinal health can be delineated 
clearly . Turpin et al (2010 International Journal of Food Microbiology) have reviewed current 
knowledge of some probiotic functions including nutritional physiology, disease prevention, 
stimulation of the immune system and protection against pathogens in relation with the type of 
strain, the molecular determinants and the mechanisms involved, when the information is available. 
For the other functions. See  also a number of recent reviews (Goh and Klaenhammer, 2009; 
Kleerebezem and Vaughan, 2009; Lebeer et al., 2008).  
III-2) PROBIOTICS AND SURVIVAL OF GASTROINTESTINAL MICROFLORA 
The benefit of probiotics is based on the survival of these bacterial or yeast cultures in 
thegastrointestinal tract and the resulting effects they might generate to overall health. Having 
established that some ingested probiotics can affect the composition and behavior of intestinal 
microflora, it is important to explore what is the  factors that determine the survival of probiotics 
while in transit. Studies performed in vivo and in vitro show that about 10–30% of probiotics 
survive during gastrointestinal transient. This depends on a number of variables, including the type 
of probiotic.(Marteau P,1997 Pochart P,1992).. It was determined that the organisms most resistant 
to stomach acid were B. bifidum and Lactobacillus bulgaricus, with a half-life of _140 min. 
Streptococcus thermophilum and L.acidophilus had a half-life of _40 min.   
Several other characteristics essential for probiotics are adherence to cells, gastric acid and bile 
stability, production of antimicrobial substances, and activity against pathogenic bacteria ( Elmer 
GW et al, 1996). 
Probiotics in the gut must be able to colonise and proliferate and exert a beneficial effect on the host 
They should also possess good organoleptic properties and be phage resistant (Mattila-Sandholm et 
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al, 2002). In conclusion To be a successful probiotic, the bacteria must fulfil some  criteria for 
example :Be safe (e.g. of human origin and non-pathogenic), Be resistant to technologic processes 
and exert minimal sensory influence on the probiotic food, Be resistant to passage through the 
gastrointestinal tract (gastric acidity and bile acids), and Provide health benefits. 
The probiotic organism must reach the intestines, in particular the colon, in sufficient numbers per 
serving in order to influence the microbiota significantly; often the figure 108 is considered 
minimal. From many clinical studies, our knowledge of the health benefits of probiotic foods is 
increasing rapidly, in particular the effects on constipation, diarrhoea, colon cancer, food pathogens, 
the immune system, cardiovascular diseases (serum cholesterol), lactose malabsorption and gastric 
ulcer (Table 3). 
Reported effects                                                                   Probiotic species 
 
Modulation of immune system 
 
 
Balancing of gut microbiota 
 
 
Reduced carcinogens (enzymes) 
 
 
Antitumour 
 
 
 
 
Prevention of traveller’s diarrhoea 
 
 
 
Prevention of rotavirus diarrhoea 
 
Prevention of C. difficile diarrhoea 
 
Prevention of other diarrhoea 
 
 
L. acidophilus, L. casei, L. plantarum, 
L. delbrueckii, L. rhamnosus 
 
L. acidophilus, L. casei, Bifidobacterium 
bifidum 
 
L. acidophilus, L. casei, L. gasseri,                    
L. delbrueckii 
 
L. acidophilus, L. casei, L. gasseri,                     
L. delbrueckii, 
L. plantarum, B. infantis, B. adolescentis, 
B. bifidum, B. longum 
 
Saccharomyces spp., mixture of L. acidophilus, 
B. bifidum, Streptococcus thermophilus, 
L. bulgaricus 
 
L. rhamnosus, B. bifidum 
 
L. rhamnosus, S. spp. 
 
L. acidophilus, L. rhamnosus, B. bifidum 
 
Table 3 - Reported health effects of probiotic bacteria (reference Finn Holm, 2001) 
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III-3) IMPACT OF PROBIOTICS ON THE GUT HEALTH 
III-3-1) INFLAMMATION (IBD) 
In the search for probiotics to effectively treat certain inflammatory bowel diseases (IBD), it is 
essential to have appropriate selection tools and not rely solely on in vitro methods. The selected 
strains also need to be tested for safety, especially when the host’s intestinal mucosa is damaged. 
For these purposes, a laboratory of the Institut Pasteur in Lille (France) has developed and tested a 
mouse model of TNBS-induced colitis (Daniel C et al, 2006). 
Three species of lactobacillus (L. plantarum Lp-115, L. salivarius Ls-33 and L. acidophilus 
NCFM), previously selected in vitro for their probiotic potential and their persistence in the 
digestive tract, were administered to healthy mice and to mice presenting severe or very severe 
colitis. A non-probiotic strain of L. paracasei subsp paracasei (Lpp) isolated from the blood of a 
patient suffering from endocarditis was also used in the experiments. To evaluate inflammation, 
macroscopic scores (0 to 10) were determined using Wallace’s criteria and myeloperoxidase 
activity was measured. The safety of the strains was assessed by selectively counting the bacteria 
present in the mesenteric lymph nodes, spleen, liver and kidneys. The animals’ weights and 
mortality were also monitored. 
Whatever the degree of severity of the colitis, only the L. salivarius strain showed a significant 
reduction in the inflammation score. These results were in contrast with those for the Lpp strain, 
responsible for Osler's disease, which exacerbated the colitis and spread to the other organs. 
This result illustrates the importance of conducting in vivo tests before making any assumptions 
about the properties of a potential probiotic selected in vitro. In all cases, it is still essential to verify 
whether the strain also expresses its properties in humans. The study also shows that certain strains 
of probiotics can translocate in conditions of extreme inflammation. While these conditions 
probably cannot be transposed to human subjects, the authors nevertheless recommend choosing 
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probiotic strains whose safety profile has been assessed, especially if they are to be used for patients 
in a critical condition. 
III-3-2) PROBIOTICS AND INTESTINAL BARRIER 
ACTION OF VSL#3 STIMULATES MUCUS SECRETION IN THE RAT 
The probiotic cocktail VSL#3 was assessed for its effects on the protective mucus layer of the 
intestine of the rat (Caballero et al, 2007). After 7 days’ intragastric administration of the bacterial 
preparation, mucus secretion was measured by evaluating incorporation of tritiated glucosamine in 
the luminal glycoproteins of the animals’ colons. Expression of mucin genes (muc2 in particular) in 
colonic cells was also quantified using amplification methods (RT-qPCR). The results show that the 
animals fed with the probiotic preparation produced a 60% increase in mucin secretion compared to 
the control animals. Expression of the muc2 gene was also increased by a factor of 5. 
For more precise observation, the authors then put colonic epithelial cells(1) in culture in contact 
with the mixture of bacteria that make up VSL#3 and with each of the bacteria concerned, 
separately. Under these conditions, no mucin secretion was observed. However, both the VSL#3 
culture medium and the media from each individually cultured species caused an increase in mucin 
secretion. Thus the culture media of each of the four lactobacillus species used in the probiotic 
cocktail prove as effective as the VSL#3 medium itself, while the three bifidobacterium species and 
Streptococcus salivarius show less marked stimulation abilities. Paradoxically, in the conditions of 
the experiment mucin secretion was not accompanied by an increase in the expression of the muc2 
gene. Additional tests were conducted to try to identify the molecular factor in VSL#3 that is 
responsible for inducing mucin secretion. This factor proves to be resistant to temperature (15 mins 
boiling), to proteases and to DNase I. The authors conclude that it could be a lipoprotein or a 
polysaccharide. 
 
AN ACTION MECHANISM OF ESCHERICHIA COLI NISSLE 1917 
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 Escherichia coli Nissle 1917 (EcN) has been used as a probiotic strain for 
decades. This strain can prevent diarrhoea caused by infections due to pathogens and studies 
suggest it is effective in the treatment of certain inflammatory diseases of the digestive tract. 
However, few experimental studies have looked for the cellular and molecular mechanisms 
underlying the beneficial effects of this probiotic. 
A German team (Zyrek AA et al, 2007) investigated the molecular response of epithelial cells in 
culture with or without the presence of EcN and/or an enteropathogenic strain of E. coli (EcEP). 
They particularly focused on the expression and cellular localization of two proteins: ZO-2, which 
interacts with the membrane proteins of the tight junction and so helps to maintain the cohesion of 
the epithelial cells; and an isoform of protein kinase C (PKCz) which, by phosphorylation, 
causes ZO-2 to detach from the protein complex of the tight junction, so destabilizing the 
epithelial barrier.  When epithelial cells were incubated in the presence of EcN, the quantity of 
mRNA of ZO-2 and the protein’s level of expression increased. ZO-2 also concentrated at the points 
of contact between cells, suggesting that the protein had associated with the tight junction 
complex. Conversely, when cells were in the presence of EcEP, the expression of ZO-2 declined and 
its subcellular distribution was significantly different. At the same time, the expression, activity and 
localization of PKCz showed the opposite trends to those of ZO-2. When epithelial cells were 
incubated in the presence of both EcEP and EcN, the levels of expression and the localization of the 
proteins studied were comparable with those in the experiments with EcN alone. The experiments 
thus show that the probiotic neutralizes the deleterious effects of the pathogenic strain by preventing 
it from destabilizing the tight junction. Additional results further show that the probiotic is capable 
of restoring the integrity of the epithelial barrier in cells already infected with the bacterial 
pathogen. 
III-3-3) PROBIOTICS AND IMMUNOMODULATION 
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Current probiotics are naturally occurring indigenous microbes that are aimed to restore lost 
bacteria or metabolic activities in colonized organs, restore a balanced immune response similar to 
that induced by the usual indigenous microbiota, or to suppress pathogenic microbes (Kalliomaki 
and Isolauri 2003). The scope of probiotics being used is narrow: several intestinal species 
predominate, including Bifidobacterium and Lactobacillus species, Streptococcus thermophilus, 
Enterococcus and Bacillus species, E. coli and yeasts, including Sacharomyces boulardii. 
Preliminary studies indicate that probiotics can affect innate immunity, as evidenced by oral 
tolerance, which cannot be achieved in germ-free animals (Sudo, Sawamura et al. 1997), is reduced 
by antibiotic use (Bashir, Louie et al. 2004), and can be restored by administering probiotics (Braat, 
van der Brande et al. 2004). Probiotics also protect against pathogens  by strengthening the 
intestinal mucosal (immune) barrier (Figure8), decreasing pathogen adherence (Mack, Michail et al. 
1999), or by production of acid or antibiotics inhibitory to pathogens (Gibson, Mc Cartney et al. 
2005). More of  scientific understanding of currently used probiotics is limited; their beneficial 
effects are usually low, with strong placebo effects, and a substantial lack of robustness across 
experiments. Modern era lifestyles are impacting human  microbiome in ways we they are just 
beginning to elucidate. Its might need to have a probiotic in the future, but first, well-designed 
clinical trials are needed.  
Rather than directly inhibiting the growth or viability of the pathogen, probiotics may compete for 
an ecological niche or, otherwise, create conditions that are unfavorable for the pathogen to take 
hold in the intestinal tract. There are many possible mechanisms for how pathogen exclusion may 
take place. First, several probiotics have been demonstrated to alter the ability of pathogens to 
adhere to or invade colonic epithelial cells in vitro, for example, evidences studies reported by (K. 
C. Johnson-Henry et al, 2007, R. R. Spurbeck et al, 2008). Second, probiotics could sequester 
essential nutrients from invading pathogens and impair their colonization ability. Third, probiotics 
may alter the gene expression program of pathogens in such a way as to inhibit the expression of 
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virulence functions (M. J. Medellin-Pe˜na et al, 2007). In the last, probiotics may create an 
unfavorable environment for pathogen colonization by altering pH, the mucus layer, and other 
factors in the local environment.  
.  
Figure 8: Probiotics and Beneficial Effects in the Intestine. Depiction of the interactions between beneficial bacteria 
(left side), their secreted factors, pathogens, and the intestinal mucosa (right side). Potential beneficial effects of 
probiotics are listed. Only two host cell types are shown, intestinal epithelial cells and macrophages although other cell 
types including dendritic cells, lymphocytes, myofibroblasts, and neutrophils comprise the intestinal mucosa. The 
arrows indicate the release and possible distribution of secreted factors derived from probiotics. demonstrated. 
 (Figure reference, R. A. Britton and J. Versalovic; Hindawi Publishing Corporation Interdisciplinary Perspectives on 
Infectious Diseases Volume 2008, Article ID 290769, 10 pages doi:10.1155/2008/290769) 
 
III-3-4) PROBIOTICS AND CANCER 
Probiotics have been found by several researchers to decrease fecal concentrations of enzymes 
and secondary bile salts, and reduce absorption of harmful mutagens that may contribute to 
colon carcinogenesis (Rafter JJ et al, 1995) 
Certain probiotics may protect the host from carcinogenesis activity: exemple: L. acidophilus and L. 
casei supplementation in humans helped to decrease levels of the enzymes involved in the 
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carcinogenesis, as shown (Hayatsu H et al, 1993;Lidbeck A et al,1992) In animal studies , 
administration of Lactobacillus GG.45, the suppressed  the activity of enzymes involved in the 
tumurogenesis. Burns and Rowland(2000) suggested that increasing the amount of lactic acid 
bacteria in the colon decreases the ability of microbiota  to produce carcinogens. A randomized, 
controlled study by Aso and Akazan57 of 48 Japanese patients demonstrated that the recurrence of 
bladder tumors was delayed with daily intake of L. casei.. In an animal model with 
dimethylhydrazine (DMH)-induced colon cancer, it was shown that Lactobacillus GG significantly 
reduced the incidence of colon tumors (Goldin BR et al, 1996) A review article by Vanderhoof 
(2001) describes a study using two carcinogens to test the effects of probiotics on the prevention of 
DNA damage in an animal model. Several probiotic strains were tested in this study, including L. 
gasseri, L. confusus, S.thermophilus, B. breve, B. longum, and L. acidophilus. All of the strains 
showed an antigenotoxic effect after MNNG administration (Vanderhoof JA et al, 2001). Similar 
studies have shown that pretreatment with L. acidophilus, L. confusus, L. gasseri, B. longum, and B. 
breve inhibited DNA damage from DMH, but that only one of four S. thermophilus strains and only 
one of three L. delbrueckeii strains were protective (Rafter JJ et al, 1995). In vitro data suggest that 
some lactobacilli may have a protective effect against the multi-step process leading to 
carcinogenesis (Figure 9) but they can also have adverse effects. Some lactobacilli can modulate 
enzymes involved in the xenobiotic pathway. Lb. fermentum I5007 has been shown to be able to 
increase the level of detoxifying glutathione S transferase (GST) in Caco-2 cells (Yang et al., 2007). 
Several mechanisms have been proposed as to how lactic acid bacteria may inhibit colon cancer; 
these include: enhancing the host’s immune response, altering the metabolic activity of the 
intestinal microflora, binding and degrading carcinogens, producing antimutagenic compounds, and 
altering the physiochemical conditions in the colon (Hirayama K et al, 2000).  
The result was a decrease in fecal pH and cell proliferative activity in the upper colon( Biasco G et 
al, 1991). The mechanisms of the links of probiotics to antitumor activity are not completely clear, 
but offer useful potential material for future cancer studies. 
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Figure 9: Carcinogenesis and action of probiotics: inhibition of enzymatic activities of colonic bacteria (1), modulation 
of xenobiotic metabolizing enzymes (XME) (2), enhancement of carcinogen elimination (3), prevention of mutation 
through antioxidant production (4), augmentation of apoptosis of abnormal cells (5) (Turpin et al, 2010). 
 
III-3-5) OTHER EFFECTS OF PROBIOTICS 
A LACTOBACILLUS STRAIN TO MAKE UP VITAMIN B DEFICIENCIES  
 
A clinical study was performed by Mohammad MA et al ( 2006 ) to investigate the impact of a milk 
fermented by Lactobacillus acidophilus on the vitamin status of Egyptian children.  
Two groups were formed, each with 12 subjects. For 6 weeks, one group (test group) received the 
probiotic fermented milk while the second group (control group) consumed an equivalent quantity 
of commercial yoghurt. Various measure of vitamin B12 and vitamin B9 in the start and in the end 
of experiment were performed.  The results show that consuming the probiotic for 6 weeks, 1 child 
in 12 presented a vitamin B12 deficiency and only 1 was deficient in vitamin B9. Measurements of 
methylmalonic acid(biomarker for deficiency of vitamine B12 and B9) and total homocysteine 
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(biomarker for difecency of vitamine B12) in the blood or urine of group by Lactobacillus 
acidophilus also indicated a significant reduction in these two metabolites at the end of the protocol. 
Results indicate an improvement in the vitamin status of subjects consuming probiotic fermented 
milk. 
The results of this study contrast with those of two earlier clinical trials which did not show any 
significant effects of probiotic products on vitamin status (Donaldson MS (2000); Elmadfa I, 2001). 
While the new results are encouraging, they need to be confirmed. The authors suggest several 
other parameters it seems to be important to take into account in this type of study, including the 
quantity and viability of the probiotic and the initial nutritional status of the subjects. 
 
CHOLESTEROL 
 
Forty-four adults with total serum cholesterol ≥ 4 mmol.L-1 were subjects in a 10-week clinical trial 
designed to assess the impact of capsules of Lactobacillus fermentum on their levels of low-density 
lipoproteins (LDL) (Simons LA et al, 2006). A non-significant reduction in LDL levels was 
observed in the patients treated with L. fermentum, but also in the placebo group. 
Moreover, no variation was observed in total cholesterol, high-density lipoproteins (HDL) or 
triglycerides. Contrary to preliminary observations in animals, this study did not reveal any 
anticholesterolemic action by this strain of L. fermentum in humans. 
Animal studies have demonstrated the efficacy of a range of LAB to be able to lower serum 
cholesterol levels, presumably by breaking down bile in the gut, thus inhibiting its reabsorption 
(which enters the blood as cholesterol). Some, but not all human trials have shown that dairy foods 
fermented with specific LAB can produce modest reductions in total and LDL cholesterol levels in 
those with normal levels to begin with, however trials in hyperlipidemic subjects are needed.( 
Sanders ME, 2000) 
IV) YOGHURT AS FUNCTIONAL FOOD 
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Immunologist lie Metchnikoff, spoke highly about the possible health benefits of the lactic acid-
bacteria (LAB). He wrote in his book,”The Prolongation of Life”,that consumption of live bacteria, 
such as Lactobacillus bulgaricus and Streptococcus thermophilus, in the form of yogurt was 
beneficial for gastrointestinal health, as well as for health in general, and for longevity. 
According to current scientific concepts, yoghurt cultures are probiotics if a beneficial physiological 
effect can be obtained by consumption of the live cultures and the benefit has been substantiated 
appropriately in human studies. All S. thermophilus and most L. bulgaricus strains have a high 
lactase activity (Sanders et al. 1996). It is well recognized that yoghurt consumption improves 
lactose digestion and eliminates symptoms of lactose intolerance. The physiological effects have 
been clearly demonstrated in a large number of human studies in which consumption of yoghurt 
(with live cultures) has been compared with consumption of a pasteurized product (with heat-killed 
bacteria) (Gilliland & Kim, 1984; Savaiano et al.1984; McDonough et al. 1987; Dewit et al. 1988; 
Lerebours et al. 1989; Pochart et al. 1989; Marteau et al. 1990; Varela-Moreiras et al. 1992; 
Rizkalla et al. 2000; Labayen et al. 2001; Pelletier et al. 2001).  
All studies have shown better lactose digestion and absorption in subjects who consumed yoghurt 
with live cultures, as well as reduction of gastrointestinal symptoms. The benefit on lactose 
absorption was also demonstrated in healthy subjects without lactose mal digestion (Rizkalla et al. 
2000). All these studies highlight the essentiality of live bacteria for the beneficial effect on lactose 
digestion (not excluding that other beneficial effects can be due to non-viable bacteria). There are 
no major scientific discrepancies on this issue fully established by human intervention studies. 
The functional properties of yoghurt are consistent with further evidence obtained in important 
ancillary studies that confirmed viability and metabolic activity of yoghurt bacteria in the human 
intestine (Martini et al. 1987; Pochart et al. 1989; Marteau et al. 1990), as well as in in vivo animal 
models (Lick et al. 2001; Drouault et al. 2002). Yoghurt bacteria can also be detected in faeces of 
human subjects consuming yoghurt (Brigidi et al. 2003; Callegari et al. 2004). 
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Yoghurt is also being used in the management of acute diarrhea disorders, as recommended by 
World Health Organization (1995). This recommendation is based on the traditional approach in 
many countries all over the world, as well as on evidence gained in human intervention studies 
(Boudraa et al. 1990, 2001). Yoghurt feeding in children with acute watery diarrhoea decreased 
stool frequency and shortened the duration of diarrhea episodes (Boudraa et al. 2001). Other studies 
have addressed the role of yoghurt on the immune system. Yoghurt consumption may enhance the 
immune response particularly in immunocompromised populations, such as the elderly (Meydani & 
Ha, 2000). The role of yoghurt in the modulation of the immune system was further demonstrated 
by Van de Water et al. (1999) in a randomized controlled trial with human subjects. Long-term 
consumption of yoghurt, as compared with either the same product heat-treated after fermentation 
or exclusion of yoghurt products from the diet during the length of the study (1 year),was associated 
with a significant decrease in allergic symptoms. 
V) GENERAL CHARACTERISTICS OF STREPTOCCOCUS THERMOPHILUS 
Streptococcus thermophilus is a major dairy starter used  in the manufacture of yoghurt and sheese. 
For cheese-making, S. thermophilus is used alone or in combination with several lactobacilli or 
mesophilic starters while in yoghurt it is always cocultured with Lactobacillus delbrueckii ssp. 
Bulgaricus (L. bulgaricus) (Tamime et al, 1999). S. thermophilus is closely related to L. lactis, but 
it is even more closely related to other streptococcal species including several pathogens (Mitchell, 
T. J.et al, 2003). Recently, the complete genome sequence of three strains became available 
(Bolotin, A. et al, 2004; Hols P. et al,2005; Makarova, K. et al, 2006). Comparison of S. 
thermophilus genome sequences with published genomes of streptococcal pathogens reveals that 
the most important determinants for pathogenicity are either absent or present as pseudogenes and 
that S. thermophilus has followed an evolutionary path divergent to that of pathogenic species due 
to its adaptation to milk (Bolotin, A. et al, 2004) S. thermophilus is highly adapted to grow on 
lactose, the main carbon source in milk and rapidly converts it into lactate during growth. Lactose is 
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transported into the cell by a lactose permease (Foucaud, C. et al, 1992). Lactose is efficiently 
transported into the cell and subsequently hydrolyzed by an intracellular βgalactosidase..  The milk 
is poor in free amino acids (AA) and short peptides (Desmazeaud, M. J. et al, 1990), therefore for 
optimal growth, S. thermophilus requires either hydrolysis of caseins followed by the internalization 
and the degradation of the resulting peptides (Hols, P. et al,2005). For many LAB including S. 
thermophilus, the hydrolysis of milk caseins (i.e. the amino acid supply) mostly depends on the 
activity of a cell-wall-anchored proteinase. Few strains of S. thermophilus possess this proteinase 
(Shahbal, S. et al, 1991); they grow rapidly in milk and reach up to 109 cell/mL, when they are 
proteinase-minus, they only reach a cell density of about 108 cell/mL (Letort, C. et al, 2002). For 
the internalization and degradation of peptides, S. thermophilus posses an efficient oligopeptide 
transport system (Garault, P. et al, 2002) and a set of intracellular peptidases (Rul, F. et al, 1997). 
Although, some strains of S. thermophilus are prototroph for amino acids, others are auxotrophs for 
given amino acids. The importance of amino acids biosynthesis for the growth in milk was 
established (Hols, P. et al, 2005) and the branched-chain amino acids biosynthesis pathway was 
identified as a key pathway for optimal growth of S. thermophilus in milk (Garault, P. et al, 2000). 
Whitford, E.J. et al (2009) study has shown very positive results when Streptococcus thermophilus 
TH-4 was used to treat rats with mucositis caused by chemotherapy drugs. Rats responded to the 
treatment by showing a normalization of healthy cell function in the affected areas and a significant 
reduction of distress to the tissue of the intestines.As research continues to produce varied strains of 
Streptococcus thermophilus, the usefulness of this probiotic seems limitless. Its effects on digestive 
and overall health have already been widely documented. Its benefits to cancer patients undergoing 
chemotherapy are beginning to be understood. Streptococcus thermophilus is one of the many 
reasons probiotics are changing the health industry ( U.S. Department of Energy Office of Science, 
2009). Recent data indicate that strains related to S.thermophilus LMD-9 (Strain used in this study) 
are among the 57 bacteria species found in 90% of 124 European individuals (Qin J. et al, 2010). In 
comparison with the overall human intestinal microbiota, S.thermophilus is numerically non 
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dominant species with high variable levels (Qin J. et al, 2010; Mater D. et al, 2005). At birth, 
Streptococcus genus -with in some studies a precision at the level of S. thermophilus species- is 
among the first coloniser of the GIT, since it has been detected in infant faeces and breast milk 
(Moreau M. et al, 1986- Perez .P. F. et al, 2007). Thus, Streptococcus, as pioneer bacteria 
colonising a yet immature GIT, may impact the maturation and homeostasis of intestinal epithelium 
after birth. In order to understand the interplay between lactic acid bacteria and host, recent study ( 
Françoise Rul et al, 2010;submitted) on the gnotobiotic rats colonized by Streptococcus 
thermophilus have shown that: - after progressive adaptation in GIT rat the main response 
Streptococcus thermophilus was the massive induction of the glycolysis pathway leading to formation of 
lactate in the caecum while in the colonic epithelium of the host there’s  an abundance of p27kip1 Protein 
that is protein  involved in the cell cycle arrest. 
VI) AIM OF THESIS  
The prospects of these work is to understand molecular mechanisms by which the microbiota 
influence homeostasis of the colonic epithelium using bacterial populations and simplified using 
strains probiotic lactic acid bacteria as streptococcus thermophilus strain LMD9.  
The strategies that we have adopted to answer at this goal :  
1) Generation of  mono-associated rats with Streptococcus thermophilus by oral administration 
and the integrative study of the crosstalk established between the bacterium and the host. 
“Impact of the metabolic activity of Streptococcus Thermophilus on the colon epithelium of 
gnotobiotic rats”. (paper submitted /JBC). 
2) Transcriptomic study using Supressive subtractive hybridization (SSH) technology to 
investigate genes differentially expressed in colonic epithelium rat  in the presence of  
Streptococcus thermophilus.  
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“Genes induced in vivo by Streptococcus Thermophilus using supressive subtractive 
hybridization (SSH) thecnology” 
3) Large-scale molecular analysis of colonic epithelium in mono-associated vs. germ free rats 
using a microarray technology. Therefore, microarrays may be used to link molecular events 
with physiological response and identify critical genes and biological pathways. 
“Microaerray based indentification of colonic epithelium genes differentially expressed in 
the presence of Streptococcus Thermophilus bacteria” 
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ABSTRACT 
 
The thermophilic lactic acid bacterium Streptococcus thermophilus is widely and traditionally used 
in dairy industry. Despite the vast level of consumption of S. thermophilus through yoghurt or 
probiotic functional food, very few data are available about its physiology in the gastro-intestinal 
tract (GIT). The objective of the present work was to explore both S. thermophilus’ metabolic 
activity and host response in vivo. Our study profiles the protein expression of S. thermophilus after 
its adaptation to the GIT of gnotobiotic rats and describes the impact of S. thermophilus 
colonization on the colonic epithelium. S. thermophilus colonized progressively the GIT of germ-
free (GF) rats to reach a stable population in 30 days (108 CFU/g faeces). This progressive 
colonisation suggested that S. thermophilus undergoes an adaptation process within GIT. Indeed, 
we showed that the main response of S. thermophilus in the rat’s GIT was the massive induction of 
the glycolysis pathway leading to formation of lactate in the caecum. In the colonic epithelium, the 
abundance of p27kip1 protein involved in the cell cycle arrest increased in the presence of S. 
thermophilus compared to GF rats. Based on different mono-associated rats harbouring two 
different strains of S. thermophilus (LMD-9 or LMG18311) or weak lactate producing commensal 
bacteria (Bacteroides thetaiotaomicron and Ruminococcus gnavus), we propose that lactate could 
be a signal produced by S. thermophilus  inducing p27kip1 in the colon.  
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I) INTRODUCTION 
Streptoccocus thermophilus (S. thermophilus) belongs to the group of the thermophilic lactic acid 
bacteria and is traditionally and widely used as a starter in manufacturing dairy products 
(Emmental, Gruyere, Parmigiano, Mozarella, Yoghurt etc). Yoghurt, which results from the 
fermentation of milk by S. thermophilus and Lactobacillus delbrueckii sp. bulgaricus (L. 
bulgaricus), fulfils the current specifications required to be recognized as a probiotic product ( 
Guarner, F. et al, 2005). The health beneficial effect of yoghurt consumption is linked to the 
metabolic properties of S. thermophilus and L. bulgaricus.  As such, it improves lactose digestion in 
the gastro-intestinal tract (GIT) through their lactose hydrolysing activity present in yoghurt and in 
the GIT, thus reducing symptoms of lactose intolerance ( Lomer, M. C. et al,2008;  Rabot, S. et al, 
2010). 
Yoghurt cultures were shown to induce other health benefits such as reduction of diarrhoea or 
allergic disorders as well as modulation of the immune system (Guarner, F. et al, 2005; 
Higashikawa, F. et al, 2010). S. thermophilus is also present at high concentration in VSL#3, a 
probiotic mixture of eight different bacterial strains, that possesses beneficial effects in several 
intestinal conditions (Pagnini, C et al, 2010; Preidis, GA. et al, 2009).  
Recent data indicate that strains related to S. thermophilus LMD-9 are among the 57 bacteria 
species found in 90% of 124 European individuals ( Qin, J. et al, 2010). In comparison with the 
overall human intestinal microbiota, S. thermophilus is numerically non dominant species with high 
variable levels ( Qin, J. et al, 2010; Mater, D. D. et al, 2005 ). At birth, Streptococcus genus -with in 
some studies a precision at the level of S. thermophilus species- is among the first coloniser of the 
GIT, since it has been detected in infant faeces and breast milk ( Moreau, M. C. et al, 1986; Perez, 
P. F. et al, 2007). Thus, Streptococcus, as pioneer bacteria colonising a yet immature GIT, may 
impact the maturation and homeostasis of intestinal epithelium after birth.  
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Convergent data show that intestinal bacteria modulates proliferation and differentiation processes 
of the intestinal epithelium ( Alam, M. et al, 1994; Willing, B. P. et al, 2007), which is one of the 
most dynamic tissues of the whole organism. Moreover, we have recently demonstrated that 
microbiota increases colonic epithelium crypt depth in concordance with a well orchestrated 
modulation of the level of proteins involved in cycle life steps like PCNA, Bcl2, and p21cip1, p27kip1 
(markers of proliferation, anti-apoptotic pathway and cell cycle arrest, respectively) ( Cherbuy, C. et 
al, 2010). Despite its large utilisation and consumption, its probiotic-associated traits and its 
presence in the intestinal microbiota, the role of S. thermophilus in the gut is still largely unknown. 
A previous study ( Drouault, S. et al, 2002) showed that, in mono-associated animals, S. 
thermophilus produced an active β-galactosidase in the gut which is responsible for lactose 
hydrolysis. Therefore, the aim of the present study was to expand our view of S. thermophilus’ 
metabolic activity in the intestinal environment and to investigate its relationship with the host. To 
do this, we assessed the behaviour of 2 sequenced strains of S. thermophilus, LMD-9 and 
LMG18311, in gnotobiotic rats. We established the first global protein profile of S. thermophilus 
after its survival in GIT in mono-associated rats. We also described how S. thermophilus influences 
crypt depths and cell cycle-related proteins of the colonic epithelium. In view of our findings using 
different mono-associated models, we propose that lactate resulting from the adaptive metabolic 
activity of S. thermophilus may serve as a biological signal to communicate with host epithelium. 
II) EXPERIMENTAL  PROCEDURES 
II-1) BACTERIAL STRAINS, MEDIA, AND CULTURE CONDITIONS.  
The strains S. thermophilus LMD-9 (ATCC BAA-491, USA), S. thermophilus LMG18311 (BCCM 
collection, Belgium), L. bulgaricus ATCC11842 (USA), Bacteroides thetaiotaomicron (BtII8) and 
Ruminococcus gnavus (FRE1) were used. Stock cultures of S. thermophilus LMD-9, S.  
thermophilus LMG18311 and L. bulgaricus ATCC11842 were prepared in reconstituted 10% 
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(wt/vol) Nilac skim milk (NIZO, Ede, the Netherlands) as previously described ( Herve-Jimenez, L. 
et al, 2002). S. thermophilus monocultures and S. thermophilus/L. bulgaricus co-cultures were 
obtained by inoculating Nilac milk with 106 CFU/ml of stock cultures of each species and incubated 
at 42°C until pH 5.4-5.5. One ml of culture was used for rat gavage and the remaining was N-liquid 
frozen and stored at -20°C until protein extraction. The cultures were enumerated a posteriori by 
plating appropriate dilutions on M17 agar lactose (10g/L) for S. thermophilus or on acidified MRS 
agar lactose (20g/L) (pH 5.2) for L. bulgaricus. After 16 h (S. thermophilus) or 24 h (L. bulgaricus) 
incubation at 42°C under anaerobiosis (Anaerocult A, Merck, Darmstadt, Germany), colonies were 
counted.  
II-2) ANIMALS AND EXPERIMENTAL DESIGN.  
All procedures were carried out according to European and French guidelines for the care and use 
of laboratory animals (permission 78-123, dedicated to MT). 
A the age of 2 months, germ-free (GF) rats (male, Fisher 344) were inoculated either with S. 
thermophilus LMD-9 (Ino-LMD9, n=11), S. thermophilus LMG18311 (Ino-LMG18311, n=4), or 
with a mix of S. thermophilus and L. bulgaricus (Ino-LMD9+Lb, n=5) according to the following 
protocol: 1 ml of a culture of S. thermophilus in Nilac milk (5x108 S. thermophilus/ml) or 1 ml of a 
co-culture with S. thermophilus (2x109 S. thermophilus/ml) and L. bulgaricus (8x107 L. 
bulgaricus/ml) were transferred to GF rat by oral gavage. As a control, GF rats were also inoculated 
with 1 ml of sterile Nilac milk (without bacteria). GF, mono-and di-associated rats were housed in 
sterile Plexiglas isolators (Ingénia, Vitry-sur-Seine, France). Rats mono-associated with either 
Bacteroides thetaiotaomicron (Ino-Bt), or Ruminococcus gnavus (Ino-Rg) were described in ( 
Cherbuy, C. et al, 2010). All groups of rats received the same standard diet (UAR), which was 
sterilized by gamma irradiation. Throughout the experiment, and two times a week, S. thermophilus 
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(and L. bulgaricus in the case of Ino-LMD9+Lb) was enumerated by plating serial dilutions of the 
faeces. All rats were euthanized at three months old, i.e, 30 days after inoculation.  
At 9:00h, rats were anesthetized with isoflurane, and tissues were removed. The colon was 
immediately used either for cell isolation or for histological procedures. The luminal content of 
jejunum, ileum, caecum and faeces were diluted in 10 volume of M17, vigorously vortexed with 
sterile glass beads (3.5 mm diameter) and bacteria were enumerated. All results were expressed as 
log10 (CFU/gram or ml).  
II-3) SCANNING ELECTRON MICROSCOPY.  
Scanning electron microscopy (20) analyses were performed on the MIMA2 plateform 
(http://mima2.jouy.inra.fr/mima2) with 0.2g of caecal samples being suspended in 1 ml 0.1 M Tris 
buffer (pH 7.5) and mixed. Debris were removed by centrifugation at 1000g for 5 min at 4°C. 
Supernatant of caecal samples were centrifuge to recover bacteria, the pellets were suspended in 0.1 
M Tris buffer (pH 7.5) and 2-time washed in the same buffer by centrifugation at 5000 g for 5 min 
at 4°C. The bacterial pellets were suspended and fixed in 200 µl glutaraldehyde 3% ruthenium red 
and stored at 4°C. Scanning electron microscopy was performed as previously reported ( Joly, F. et 
al, 2010). 
II-4) PROTEIN EXTRACTION.  
Bacteria were isolated as follows. 500 ml of frozen milk cultures (3 replicates) were homogenized 
with an Ultra-turrax (Bioblock, Paris, France). The suspension was centrifuged at 8000 g for 10 min 
at 4°C and 3-time washed  in Na phosphate buffer (5 mM) containing 1 mM EDTA, pH 7; bacteria 
were suspended in 2 mL Na phosphate buffer (20 mM, pH 7). Frozen faeces from 3 Ino-LMD9 rats 
were pooled and 12g of faeces were suspended in 25 ml Na phosphate buffer (20 mM, pH 6.4), 
homogenized with an Ultra-turrax and faecal debris were removed by 2 successive centrifugations 
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at 400g for 5 min at 4°C. The bacteria were then collected by centrifugation at 5000 g for 10 min at 
4°C, 3-time washed with Na phosphate buffer (20 mM, pH 6.4) and the pellets were suspended in 2 
mL of this buffer. Bacterial pellets from milk cultures and faeces were then submitted to a high-
speed centrifugation on a Nycodenz density gradient as previously described ( Roy, K. et al, 2008). 
After ultracentrifugation, the bacterial suspensions were washed with 14 ml Na phosphate buffer 
(20 mM, pH 6.4) and the bacteria were recovered by centrifugation at 5000 g for 10 min at 4°C.  
The bacterial pellets were suspended in 0.5 mL of Na phosphate buffer (20 mM, pH6.4) containing 
protease inhibitor cocktail (Sigma-Aldrich, St Louis, Mo), 40 U/ml catalase and 10 mM 
tributylphosphine (Applied Biosystems). Cells were mechanically disrupted with a FP120 FastPrep 
cell disruptor (Bio 101 Systems, Qbiogen, Irvine, Canada) by two 30s cycles of homogenization at 
maximum speed (6.5) at 1 min interval at 4°C. Supernatants were collected by centrifugation at 
5000 g, 15 min at 4°C and centrifuged (200000 g, 30 min, 4°C); they correspond to cytoplasmic 
proteins whereas the pellet was a fraction enriched with envelope-associated proteins. The protein 
concentrations were determined by the Coomassie protein assay reagent (Pierce, Rockford, Ill) 
using bovine serum albumin as a standard.  
II-5) 1-DE COUPLED TO LIQUID CHROMATOGRAPHY-TANDEM MASS 
SPECTROMETRY (LC-MS/MS) ANALYSIS. 
Proteins of the cell-envelope enriched fraction (4.7 µg) from faecal sample were separated and 
identified by one-dimensional (1D) electrophoresis (SDS-PAGE) coupled with liquid 
chromatography-tandem mass spectrometry as previously described ( Gardan, R. et al, 2009).  
Comparative bi-dimensional (2-DE) protein analysis and image analysis. A volume of cytosolic 
fraction corresponding to 250 µg of proteins was treated as previously described ( Derzelle, S. et al, 
2005). Fractions of three independent cultures in milk were analyzed. Fractions of two faecal 
batches were used, each batch resulting from the pool of faeces of three rats. Isoelectric focusing 
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was performed with 24cm 4-7 pH IPG strip and 12% SDS-PAGE was used for the second 
dimension. The gels were stained with BioSafe colloidal Coomassie blue (Biorad) for 1h and rinsed 
out with three successive washes in deionised water. Gels were digitized using an Epson Expression 
1640XL scanner set (at 256 grey levels) controlled by the Silver Fast software and analyzed using 
the Progenesis SameSpot software (Nonlinear Dynamics). The relative volume of each spot was 
obtained from its intensity and normalized with the intensity of all spots. Only spot volume 
differences of at least twofold between the milk and fecal samples were further analyzed. 276 
different protein spots on pH4-7 2-DE gels were detected.  
MS analyses were performed using a Voyager-DE-STR (Applied Biosystems, Framingham, USA) 
on the PAPSSO proteomic plateform (http://pappso.inra.fr). The proteins were identified using MS-
FIT (http://prospector.ucsf.edu). 
II-6) WESTERN BLOT ANALYSIS.  
Colonic epithelial cells were isolated from the whole colon according to the method described by 
Cherbuy et al. ( Cherbuy, C. et al, 1995). Cell pellet was immediately used for protein extraction. 
Western blot analysis was performed as previously described (17) by using a denaturing (SDS)–
polyacrylamide gel. Proteins were analysed using anti-PCNA (GeneTex; diluted 1/1000), anti-
p21cip1
 (Oncogene; 1/200 or Santa Cruz Biotechnology; 1/200), anti- p27kip1
 
(Santa Cruz 
Biotechnology; 1/500). Several loading controls were used, either GAPDH, Skp1 or cullin1 ( 
Cherbuy, C. et al, 2010). Signals imprinted on autoradiography films were quantified by scanning 
densitometry of the autoradiograph using Biovision 1000 and logiciel bio1D (Vilber Lourmat, 
France).  
II-7) DOSAGE OF D- AND L-LACTATES.  
D- and L-lactates were measured in caecal contents and faeces of GF and mono-associated rats by 
2X- diluting of 50-100 mg samples in 0.1 M triethanolamine buffer (pH 9.15). Samples were 
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centrifuged at 13 000 g for 5 min at 4°C, the supernatant were precipitated with trichloroacetic acid 
(10%) and centrifuged at 4500 g for 20 min at 4°C. The lactates were measured in the supernatants 
with the Biosentec D/L lactic acid enzymatic kits according to the manufacturer instructions 
(Biosentec, Toulouse, France). 
II-8) HISTOLOGY AND IMMUNOHISTOCHEMISTRY.  
Colon samples were cut into 2 cm sections, fixed in 4% paraformaldehyde (4 hours, room 
temperature), dehydrated and embedded in paraffin according to standard histological protocols. 
Five micrometer sections were mounted on SuperFrost
® 
Plus slides. Slides were stained with 
hematoxylin and eosin for histological analysis. Crypt depths were analyzed with ImageJ. Only U 
shaped longitudinally cut crypts with open lumina along the crypt axis were evaluated. Results were 
the mean obtained by analysis at least 30 crypts per rat (n=2).  
II-9) RNA ISOLATION AND QUANTITATIVE RT-PCR ANALYSIS.  
Total RNAs were extracted from colon epithelial cells of 6 rats (2 GF and 4 mono-associated with  
S. thermophilus LMD-9 strain)  by the guanidinium thiocyanate method ( Chomczynski, P. et al, 
1987). The RNA yield was quantified by spectrophotometer analysis and the RNA purity was 
determined by Agilent 2100 Bioanalyzer analysis using the RNA 6000 Nano Assay Kit. Reverse 
transcription was performed with 1 µg of total rat RNA using iScript™cDNA Synthesis Kit 
(BioRad). Quantitative RT-PCR (RT-qPCR) was performed on the Opticon Monitor 3 (BioRad) 
using specific primers and Master Mix (2X) Universal (KAPA SYBR® FAST qPCR Kits) KAPA 
BIOSYSTEMS. Primers were 5’GGCGGCAAGATGTCAAACGTG3’ and 
5’GGGCCGAAGAGGTTTCTG3’ . Primers were validated to ensure efficient amplification of a 
single product at 60°C (annealing temperature). Relative mRNA levels were calculated using the 
comparative 2-∆∆Ct method. Comparisons were made with samples from epithelial cells harvested 
from GF and mono-associated colon rats (2 GF animals and 4 Ino-LMD9) using GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) as the reference gene and p27kip1 gene as target gene.  
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II-10) STATISTICAL ANALYSIS.  
Results are presented as means ± SE for the number of animals indicated. Comparisons of group 
data between different batches of rats were performed using one–way analysis of variance 
(ANOVA) followed by Tuckey’s student range test where appropriate. Significance was a P value 
lower than 0.05. Statistical analysis was performed using the JMP® software (version 7, SAS 
institute INC). 
III) RESULTS 
III-1) PROGRESSIVE ADAPTATION OF S. THERMOPHILUS TO THE GIT. 
After a single gavage, S. thermophilus LMD-9 progressively colonized the GIT of germ-free rats 
leading to Ino-LMD9 mono-associated rats (Figure 1A). The implantation of S. thermophilus LMD-
9 occurred in a 3-way step: i) initiation phase with implantation of 105 CFU/g; ii) growth period 
between weeks 2 and 3 where it reached a population of 108 and iii) maintenance phase (post third 
week). Thus, four weeks were necessary to reach a level of 108 CFU/g faeces. At day 30, the 
population of S. thermophilus LMD-9 was higher in the distal digestive compartment with an 
increasing gradient of population from jejunum (1.6x103CFU/ml) to colon (9.3x108 CFU/ml) 
(Figure 1B). The progressive implantation curve was also observed with another strain of S. 
thermophilus, LMG18311 (Ino-LMG18311 rats). In Ino-LMG18311 rats, the final implantation of 
LGM18311 was similar to that obtained with LMD-9, with 2x108 CFU/g (n=4). To mimic the levels 
present in yogurt, GF rats were inoculated with a co-culture containing S. thermophilus LMD-9 109 
CFU/ml and L. bulgaricus 107 CFU/ml, which is similar to the relative proportion of both strains in 
yoghurt. 24 hours after gavage, L. bulgaricus was undetectable in faeces whereas the implantation 
curve of S. thermophilus LMD-9 was similar to that observed with Ino-LMD9 (data not shown). 
The progressive implantation of S. thermophilus suggested that an adaptation of S. thermophilus 
occurred in the GIT. 
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It has been previously shown that the morphology of Lactobacillus sakei changed after its survival 
through the GIT ( Chiaramonte, F. et al, 2009 ). Thus, the global morphology of S. thermophilus 
recovered from caecum of Ino-LMD9 rats was observed by scanning electron microscopy (Figure 
1C). In caecum, S. thermophilus exhibited the expected ovococcus-shape chains and was present as 
dividing cells with visible septa.  
 
III-2) PROTEOMIC PROFILES OF S. THERMOPHILUS IN THE DIGESTIVE TRACT.  
In the faeces of Ino-LMD9 rats, proteins of S. thermophilus were analysed by LC-MS/MS, listed 
(Supplemental data) and classified into different functional categories (Figure 2). This result 
showed that the main S. thermophilus LMD-9 proteins expressed in the GIT are involved in staple 
cellular functions as translation, carbon metabolism, nitrogen metabolism or nucleic base 
metabolism. This indicated that S. thermophilus LMD-9 was metabolically active in the rat GIT 30 
days after inoculation. 
Using a comparative  proteomic analysis, we then identified the proteins that were differentially 
produced when S. thermophilus LMD-9 was grown in milk (inoculum) or when it was recovered 
from faeces of Ino-LMD9 rats (day 30). In both conditions, bacterial populations were similar, i.e., 
1 to 5x108 CFU/ml (Figure 1). 52 proteins displayed different abundances between the 2 conditions: 
11 were up-regulated (induction from 2 to 11 fold) and 41 were down-regulated (repression from 3 
to 25 fold) in faeces compared to milk (Table 1).  
Of the 11 up-regulated proteins, 3 are related to environmental signal responses: SodA (superoxide 
dismutase) and GroEL which are stress proteins and EF-Tu (Elongation Factor Tuf), which is a 
translation/adhesion-related protein. The remaining up-regulated 8 proteins in the gut played a role 
in carbon metabolism, specifically in the glycolytic pathway. We have also verified whether these 
proteins involved in glycolysis were more abundant in faeces of Ino-LMG18311 than in milk (data 
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not shown). Thus, proteins involved in glycolysis that are already expressed at high level in milk  
(24) were over-expressed after a survival in GIT.  
The proteins down-regulated in faeces compared to milk were involved in protein synthesis, cell 
division (FtsZ), nucleotide biosynthesis and salvage (PyrG, PurC, PurL, GuaB), energy providing 
(F0-F1 ATP synthase AtpD) and iron metabolism (Dpr bacterioferritin). Overall, the proteins of the 
2 strains of S. thermophilus that were over-expressed in the GIT compared to milk are devoted to 
glycolytic pathway.  
III-3) PRODUCTION OF LACTATE BY S. THERMOPHILUS IN THE DIGESTIVE TRACT  
Considering the preponderant abundance of enzymes involved in glycolysis, L-lactate concentration 
was measured in caecum of gnotobiotic rats. Although no lactate (either D- or L-) was found in GF 
rats, 13.6 mM±0.9 and 9.8 mM±2.5 L-lactate was detected respectively in caecum and faeces of 
Ino-LMD9 rats. Note that only the L -form was detected in caecum of Ino-LMD9 rats as expected 
due to the well known capacity of S. thermophilus to produce this isoform. This production of L-
lactate did not induce any acidification of the caecal content of Ino-LMD9 rats (mean pH 7.7±0.08, 
n=11; versus pH: 7.7±0.2, n=6 GF). Acetate, propionate and butyrate levels in Ino-LMD9 
(respectively 1.8 mM±0.7, <0.1 mM, <0.1 mM) were not statistically different from that obtained 
with GF rats (1.7 mM±1, <0.1 mM, <0.1 mM). Similar caecal concentration of lactate was 
measured in Ino-LMG18311 rats (10.02±3.0 mM) and in Ino-LMD9+Lb rats (9.91±0.99 mM); thus 
lactate was found in GIT of mono-associated rats with two different S. thermophilus strains. 
III-4) CROSSTALK BETWEEN S. THERMOPHILUS AND THE COLONIC EPITHELIUM.  
The colonic tissue of Ino-LMD9 rats was structured in crypts (Figure 4A); with 201±13 µm crypt 
depth mean and the detection of bifurcating crypts (noted with arrows in figure 3A). Considering 
these two parameters, the global histological trait of colonic epithelium in Ino-LMD9 rats was 
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similar to that we have previously observed in GF rats ( Cherbuy, C. et al, 2010). When comparing 
the amount of colon proteins involved in cell cycle between Ino-LMD9 and GF rats, we noticed that 
PCNA, Bcl2, p21cip were similar between GF and Ino-LMD9 rats (Figure 3B) whereas p27kip1 
abundance was significantly higher (1.8 fold induction) in the presence of S. thermophilus LMD-9. 
The induction of p27kip1 was also observed in Ino-LMG18311 (2 fold) and Ino-LMD9+Lb (1.5 fold) 
(Figure 4). In contrast to the protein level, the p27kip1 mRNA amount was not statistically different 
between GF (mean ∆Ct: 4.8±0.3, n=3) and Ino-LMD9 rats (∆Ct: 4.7 ±0.1, n=4). Thus, the induction 
of protein p27kip1 was observed in vivo with 2 different strains of S. thermophilus and did not result 
from a parallel induction at mRNA level. It has been previously shown in epithelial keratinocyte 
cell line that p27kip1 is induced by lactate in vitro ( Hsiao, Y. P. et al, 2009). This suggests that 
lactate accumulates in GIT of mono-associated rats leading to the induction of p27kip1 protein. In 
order to demonstrate the preponderant role of lactate we have tried to inactivate the ldh gene 
encoding the lactate deshydrogenase responsible for lactate production. We  have failed to generate 
this mutant (data not shown), confirming previous unsuccessful attempts to obtain this probably 
lethal mutant (Hols, P. et al, 2009). However, in rats mono-associated with Bacteroides 
tethaiotaomicron (Ino-Bt) or Ruminococcus gnavus (Ino-Rg) ( Cherbuy, C. et al, 2010) containing 0 
and 3.2±0.7mM of caecal lactate, respectively, no p27kip1 induction was observed in comparison 
with GF (Figure 4). 
IV) DISCUSSION 
In order to gain a better understanding of the behaviour of lactic acid bacteria within the intestinal 
environment and the complex bacterium/host crosstalk system, here we combined in vivo 
characterization of S. thermophilus metabolism and the resulting host response. This study led to 
novel insights of the interplay between S. thermophilus and the host through its major metabolite 
product, lactate.  
  
77
The implantation of S. thermophilus in GF rats occurred progressively and this trend was observed 
with both strains studied, LMD-9 and LMG18311. These 2 strains differ in particular by the 
presence of a cell-wall protease PrtS and a sortase A1 present in LMD-9 strain. This suggests that 
the latter proteins were probably not essential for the kinetic of implantation of this bacterium. In 
contrast to S. thermophilus, the implantation was maximal in few days for E. coli ( Alpert, C. et al, 
2009), R. gnavus and B. thetaiotaomicron ( Cherbuy, C. et al, 2010), Lactobacillus casei and 
Bifidobacterium breve ( Shima, T. et al, 2008) and Lactococcus lactis ( Roy, K. et al, 2008). This 
adaptive response of S. thermophilus was not accompanied by significant morphological changes 
contrarily to what was observed  with L. sakei or E. coli ( Chiaramonte, F. et al, 2009; Giraud, A. et 
al, 2008). The proteomic analysis of S. thermophilus before- (milk inoculum) and after GIT transit 
(faeces) shed light on its adaptive metabolic profile. Indeed, we showed that the main response to 
the passage of S. thermophilus through the rat GIT was the massive induction, at the maintenance 
phase, of the glycolysis pathway leading to formation of lactate in caecum. Here, we propose that S. 
thermophilus modulates p27kip1 through production of lactate. This hypothesis stems from four 
observations: 1) the main S. thermophilus metabolic pathway enhanced in GIT compared to a milk 
culture was the glycolysis leading to production of lactate; 2) the increase of p27kip1 level in colon 
was observed in the presence of two S. thermophilus strains producing equivalent amount of lactate; 
3) the increase of p27kip1 level in colon did not appear in the presence of non- or low lactate-
producing bacteria (B. thetaiotaomicron and R. gnavus) and 4) p27kip1 was induced in vitro by the 
presence of lactate ( Hsiao, Y. P. et al, 2009). Obviously, our hypothesis does not exclude other 
underlying mechanisms involved in the interplay between S. thermophilus and the host. Thus, using 
other lactic acid bacteria it would be of interest to test if the induction of p27kip1 systematically 
correlates with the high level of lactate production.  
The increase in proteins abundance belonging to glycolysis in GIT compared to milk was 
unexpected for S. thermophilus as these proteins are already present at  high levels in the milk ( 
Derzelle, S. et al, 2005). The capacity for a bacterium to diversify its carbon sources seems to be 
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essential for the colonization in GF rodents ( Roy, K. et al, 2008; Alpert, C. et al, 2009; Bron, P. A. 
et al, 2004; Marco, M. L. et al, 2009). S. thermophilus is particularly-well adapted to milk, in 
particular via the assimilation of lactose which is its preferential sugar and is present at high and 
non-limiting concentration in milk (4.5g L-1). However, we showed here that S. thermophilus may 
develop an efficient ability to use other sources of saccharides present in GF rat ( Sonnenburg, J. L. 
et al, 2005) since the  rat diet did not contain lactose. This flexibility is rather unexpected since S. 
thermophilus has a small genome with a large proportion of non functional genes (10% of pseudo-
genes), in particular genes involved in carbon utilization in line with the paucity of carbon sources 
in milk (Bolotin, A. et al, 2004). Therefore, it would be of interest to determine whether the 
implantation level and the adaptive responses of S. thermophilus may be improved by using mono-
associated rats receiving a diet enriched with lactose, as previously suggested ( Mater, D. D. et al, 
2006). The use of mono-associated rats is an efficient tool to reveal the activity of bacterial proteins, 
especially those with dual functions. For example, EF-Tu is an elongation factor playing a key role 
in protein synthesis but also in the maintenance in the GIT. The up-regulation of EF-Tu was 
observed in vivo for L. lactis (Beganovic, J. et al, 2010), Bifidobacterium ( Yuan, J. et al, 2008) and 
in vitro for L. plantarum (Ramiah, K. et al, 2007). While S. thermophilus reduced most of its 
translation and protein synthesis machinery, EF-Tu was the sole protein belonging to protein 
synthesis pathway that was increased at high level in digestive tract compared to milk (induction 
factor 12). We thus propose that in Ino-LMD9 rats, EF-Tu -that displays the characteristics of an 
adhesion factor  (Dallo, S. F. et al, 2002)- is mainly involved in the maintenance of S. thermophilus 
rather than in the protein synthesis.  
We have recently demonstrated that the colonisation of GF rats with a complex microbiota leads to 
increase in the absorptive surface by deepening crypts and splitting bifurcated crypts by crypt 
fission process (Cherbuy, C. et al, 2010). This trophic effect of microbiota is associated with a 
modulation of several cell-cycle related proteins. Along the colonisation with a complex microbiota, 
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we have previously described a precocious hyper-proliferative phase at the level of colonic 
epithelium which is counter-balanced by an induction of proteins restraining the proliferation and a 
decrease of anti-apoptotic proteins ( Cherbuy, C. et al, 2010). In contrast to what was observed with 
a complex microbial population, the presence of S. thermophilus did not trigger deeper crypts and 
the division of bifurcating crypts. Thus, as we reported previously ( Cherbuy, C. et al, 2010), a 
single strain is not sufficient to switch on proliferation and the associated greater absorptive surface. 
In contrast, the induction of cell cycle arrest proteins could be triggered by a single bacterium. 
Indeed B. thetaiotaomicron and  R. gnavus increased p21cip1 ( Cherbuy, C. et al, 2010) while S. 
thermophilus increased p27kip1. p21cip1 and p27kip1 are cyclin-dependent-kinases (CDKs) inhibitors 
and are preponderant cell cycle regulators in GIT  ( Besson, A. et al, 2008). In particular, p27kip1 is 
involved in the capacity of epithelium and host to attenuate deleterious effects of environmental 
stimuli ( Zheng, Y. et al, 2008). Thus we have shown that p27kip1 is stabilized in vivo by a complex 
microbial population ( Cherbuy, C. et al, 2010) and by lactate produced by S. thermophilus (Figures 
3 and 4). In human healthy adults, no or low (0 to 2 mM) lactate is detected in fecal samples (Hove, 
H. et al,1995; Hove, H. et al, 1993), since the luminal lactate is absorbed by host and is also used as 
an energy source by other commensal bacteria ( He, T. et al, 2008; Marquet, P. et al, 2009). 
However, increased fecal lactate has been associated with intestinal mal-absorption and colitis ( 
Hove, H. et al, 1995). It could also be of interest to measure fecal lactate in humans with short 
bowel syndrome, since we have shown that their microbiota is deeply enriched in lactobacilli at the 
expense of others bacterial members (Joly, F. et al, 2010). Thus, the effect of lactate that we 
evidenced here by using a model of lactic acid bacteria in an experimental model may have 
significance in human digestive diseases. Since S. thermophilus is able to adapt its global 
metabolism to gut environment and to induce p27kip1, this work provides new insights into the 
functional “panoply“ of one of the two yoghurt bacteria. Finally, the fact that S. thermophilus 
emphasizes its carbohydrate metabolism in the digestive tract is in accord with the beneficial role of 
fermented milk consumption in improving lactose intolerance. 
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Table 1:  Fold changes in protein abundance (2-DE) of S. thermophilus LMD-9 between 
faeces and late growth phase in milk. 
 
Gene/locus  pItha MWthb Peptide          Sequence       Fold       Protein   
 (kDa) numberc       coverage (%)     change           identification 
 
Higher level in TD 
         Carbohydrate metabolism 
      eno  4.67 47       22  63              3.06  Phosphoenolpyruvate carboxylase  
      gapA1 5.76 37.2       18  60           4.69  Glyceraldehyde-3-phosphate  
         dehydrogenase 
      hdhL 5.09 34.4       11  41           2.97  Putative L-2-hydroxy 
                          isocaproate/malate/lactate  
         dehydrogenase 
      malQ 5.2 57.6       13  28           2.39  4-alpha-glucanotransferase 
      pgk 4.86 42.2       17  54           3.02  3-phosphoglycerate kinase 
      pfkA 5.09 36.0       13  38           7.67  6-phosphofructokinase  
      pyk 5.21 56.6       17  49           3.01  Pyruvate kinase 
      ster_1876 4.81 31.5         9  47           6.05  Fructose/tagatose bisphosphate  
         aldolase 
         Stress 
      sodA 5.1 24.7         6  48           2.44  Superoxide dismutase (Mn) 
      groEL 4.7 56.9       35  69           2.46  Chaperonin GroEL (HSP60 family) 
 
         Translation 
      tuf  4.9 43.9       15  45          11.76 GTPase - translation elongation factor 
 
Lower level in TD 
         Transcription, translation 
      alaS 5.03 96.7       25  31            0.12 Alanyl-tRNA synthetase 
      asnS 4.93 51.1       27  51            0.1  Asparaginyl-tRNA synthetase 
      aspS 4.81 65.9       21  37            0.19 Aspartyl-tRNA synthetase  
      fus 4.88 76.6       37  62            0.25 Translation elongation factor  
         (GTPase) 
      gltX 4.97 55.3       26  47            0.29 Glutamyl- and glutaminyl-tRNA  
         synthetase 
      glyQ 4.91 34.9        9  33            0.33 Glycyl-tRNA synthetase, alpha  
         subunit 
      glyS 5.05 78.5       22  38            0.09 Glycyl-tRNA synthetase, beta subunit 
      hisS 5.44 48.4       18  49            0.23 Histidyl-tRNA synthetase 
      leuS 4.99 94.4       13  17            0.11 Leucyl-tRNA synthetase 
      rplJ 5.36 17.5        7  43            0.33 Ribosomal protein L10  
      rplL 4.42 12.4        9  81            0.1  Ribosomal protein L7/L12 
      rpoB 5.02 29.2       13  50            0.33 DNA-directed RNA polymerase, beta  
         subunit/140 kD subunit  
      rpsA 4.88 43.9       21  55            0.1  Ribosomal protein S1 
      rpsB 5.3 28.4       12  43            0.12 30S ribosomal protein S2 
      ster_1166 5.02 29.2       13  50            0.33 Putative translation factor 
      thrS 5.39 74.8       36  45            0.06 Threonyl-tRNA synthetase 
      tig 4.41 46.7       22  53            0.16 FKBP-type peptidyl-prolyl cis-trans  
         isomerase (trigger factor)  
      tsf 4.75 37.4       15  60            0.04 Translation elongation factor Ts 
          
         Nitrogen metabolism 
         Amino acids biosynthesis 
      asnA 5.1 37.5       13  31           0.14  asparagine synthetase A 
      bcaT 4.9 37.5        9  30           0.22  branched chain amino acid  
         aminotransferase 
      cysM1 5.2 32.3       15  51           0.31  cysteine synthase 
      lysA 4.81 46.4       10  38           0.17  diaminopimelate decarboxylase 
      metK 4.93 44.7       15  44           0.33  S-adenosylmethionine synthetase 
      ster_1751 4.87 50.1       11  32           0.16  glutamine synthetase  
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         Peptidases 
      pepC 4.85 50.4        9  17           0.16  aminopeptidase C 
      pepN 4.59 96.3       15  19           0.18  aminopeptidase N  
 
         Nucleotide biosynthesis and  
         salvage 
      pyrG 5.51 59.1       12  28           0.26  CTP synthase (UTP-ammonia lyase) 
      purC 5.00 27       22  80           0.25  phosphoribosylaminoimidazole –  
         succinocarboxamide synthase  
      purL 4.93 136       19  19           0.05  phosphoribosylformylglycinamidine  
         synthase II (FGAM synthetase) 
      guaB 5.31 52.9       13  29           0.07  IMP dehydrogenase/GMP reductase 
 
         Cell division protein 
      ftsZ 4.6 46.5       17  43          0.38 Cell division GTPase 
 
         Carbohydrate metabolism 
      gdhA 5.21 48.9       19  56           0.13  Glutamate dehydrogenase/leucine  
         dehydrogenase 
 
         Miscellaneous 
      atpD 4.73 50.9       11  32           0.14  F0F1-type ATP synthase, beta subunit  
      dpr 4.59 19.2        5  29           0.18  DNA-binding ferritin-like protein 
      murC 5.23 49.6       15  44           0.17  UDP-N-acetylmuramate-alanine   
         ligase 
      panE 5.6 36.1       13  42           0.40  ketopantoate reductase 
      secA 5.22 96.4       28  41           0.09  Preprotein translocase subunit SecA 
      ster_0157 4.77 46.4       15  38           0.22  hypothetical protein  
      ster_1854 4.41 59.5       17  32           0.21  Predicted kinase related to  
         dihydroxyacetone kinase 
      ster_1995 4.74 60.9       23  49           0.18  ATPase component of ABC  
         transporter with duplicated  
         ATPase domain 
      typA 4.9 68.7       21  38           0.09  Predicted membrane GTPase involved  
         in stress response 
  
a: theorical isoelectric point 
b: theorical molecular weight 
c: number of peptides identified 
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Figure 1. S. thermophilus in the digestive tract. 
Enumeration of viable S. thermophilus isolated from faeces (A) and different rat digestive tract sections (B) of Ino-
LMD9 rats. Faecal or luminal sample were diluted and immediately plated on culture medium M17+lactose. Colonies 
were numbered after 24h-anaerobic culture. Results are expressed on a log scale. n: number of rats used. (C) Snaps shot 
of S. thermophilus isolated from caecum of Ino-LMD9 rats obtained by scanning electron microscopy. 
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Figure 2. Functional distribution of the proteins of S. thermophilus LMD-9 isolated from rat faeces. Proteins from the 
envelope-enriched fraction were separated and identified by liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS). Transport, regulation: transporters and regulators, respectively, other than those involved in 
carbon metabolism, nitrogen metabolism, nucleic base metabolism. In brackets: number of proteins.  
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Figure 3: Histological and molecular analysis of the colonic epithelium of Ino-LMD9 rats.             
 A) Representative photomicrograph of colonic sections obtained from Ino-LMD9 rats stained with hematoxylin and 
eosin. Arrows indicated a bifurcating crypt in colonic epithelium. Crypt depth mean (µm) of Ino-LMD9 (2 rats, 30 
measures/rat) was indicated. B) Western blot analysis and quantification of p27kip1, PCNA, p21cip1 and Bcl2 from 
colonic epithelial cells of GF and Ino-LMD9 rats. Autoradiography represents representative blots with Ino-LMD9 
(n=3) and GF (n=1) rats. Densitometric analysis was means (± SE) obtained with 8 rats per group and values are 
expressed in fold induction considering the GF as 1. Statistical significantly differences (p < 0.05) between groups. 
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Figure 4: p27kip1 detection in different mono-associated groups. Ino-LMD9+Lb rats have been inoculated 
with a mixture of S. thermophilus and L. bulgaricus. At the end of the experiment (30 days after the gavage), 
rats were only mono-associated with S. thermophilus, since L. bulgaricus did not efficiently implanted. Ino-
LMG18311 (n=4), Ino-Bt (n=3) and Ino-Rg (n=3) were respectively harbouring S. thermophilus strain 
LMG18311, B. thetaiotaomicron and R. gnavus. Western blots were from colon cells. 
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ABSTRACT 
Streptococcus thermophilus is a lactic acid bacteria largely used by the food industry for production 
of yoghurt and cheese, among other products. In spite of its wide consumption, insufficient 
information is presently available on the molecular effects of its consumption at the level of 
intestinal cells. The present research aimed at studying the impact of S. thermophilus on colonic 
epithelial cells gene expression. In this study we have used  Differential screening (Suppressive 
Subtractive Hybridization or SSH) methods to identify and study genes induced by S. thermophilus 
in colonic epithelial cells. The subtraction library was prepared subtracting mRNA between 
epithelial cells isolated from colonic mono-associated rats (inoculated with LMD9 strain of S. 
thermophilus) and germ-free rats (without bacteria). Eighty clones were sequenced after SSH. 
These clones correspond to genes whose expression in colonic epithelial cells is potentially 
activated in the presence of S. thermophilus. These "candidate" genes can be grouped into four 
Functional groups: 1) genes that play a role in cell-cycle arrest and induction of differentiation; 2) 
genes involved in  cell-communication; 3) genes involved in calcium binding; 4) genes encoding 
growth factors. Tow candidate genes involved inthe regulation of cell cycle, Kruppel like factore 
and 14-3-3 σ, were selected and tested by RT-PCR , qRT-PCR to quantify mRNA and Western blot 
to analyze the related protein. The results of various tests confirmed that selected candidate genes 
involved in cell cycle and differentiation increase their expression in the presence of 
S.thermophilus.These results indicate that S.thermophilus modifies the expression of genes involved 
in essential intestinal functions. They, combined with the observation that this bacterial genus  is 
present in women breast milk and in the bowel of infants (> 108/g faeces), suggest that S. 
thermophylus may play a role in the early on-setting of colon correct structure and function. 
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I)  INTRODUCTION 
The gastrointestinal tract contains within it a microenvironment of bacteria that influences the host 
Human/animal in many ways. This microbial ecosystem serves for a  numerous important functions 
for its human and animal host, including education of  the immune system ( Gordon et al, 2005), 
regulation of  angiogenesis (Stappenbeck et al, 2002), modification of the activity of the enteric 
nervous system, extraction and processing nutrients consumed in the diet ( Ley RE et al, 2005, 
Bckhed F et al, 2004, Hooper et al, 2002), integrity of the intestinal mucosal barrier and modulation 
of proliferation and differentiation  of its epithelial lineages (Alam et al, 1994, Thomas et al, 2009). 
It is clear that this list is not yet complete; as this field  of study expands, we can discovering a new 
functions and relationships. In contrast the structure and homeostasis of intestinal epithelium are the 
basis of the absorptive function of  the intestine and are modulated throughout life by environmental 
factors. At birth, it is known that the surface epithelium and crypt depth increase. Recent studies 
have  shown that adult humans increased colonic crypt depth reflects a morphological adaptation 
that occurs following intestinal resection (Joly et al, Am J. Physiol, 2009). In this context, studies 
were concentrated to provide evidences of the effect of the microbiota on the structure and 
homeostasis of the colonic epithelium. Experimentally work  in vivo using gnotobiotic animals that 
the presence of microbiota leads an increase in the depth of the crypts of the colonic epithelium. 
This trophic effect of microbiota accompanied by a highly orchestrated induction of proteins 
involved in cell cycle colonic epithelial cells. The establishment of microbiota in the host induces 
an early phase hyper-proliferation that is then offset by a late phase of proliferation arrest and 
differentiation (Cherbuy et al, 2010). the . Some cell cycle proteins that are induced by the 
commensal microbiota have also been described as cellular targets some pathogenic bacteria 
(Samba Louaka et al, Cell Microbiol, 2008). Studies of Germ free(GF) and colonized mice have 
revealed an important relationship between the gut and microbiota and have been particularly 
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illustrating the essential role of the gastrointestinal microbiota in normal gut development (Palmer 
et al, 2007). The prospects of these work is to understand molecular mechanisms by which the 
microbiota influence homeostasis intestinal epithelium using bacterial populations and simplified 
using strains probiotic lactic acid bacteria as streptococcus thermophilus. We have used for this 
study S.thermophilus bacteria first one because we have find a several papers which haves been 
reported that S.thermophilus among the first to colonise the intestinal tract in the birth (>108 /g 
faces), (Moreau et al, 1986) (Palmer et al, 2007) and her presence in the faces and in breast milk is 
recently described (Perez et al, 2007). So, S.thermophilus can have an impact on the maturation and 
homeostasis of intestinal epithelium after birth. The second one is to the importance and the use of 
S.thermophilus as probiotics in the manufacturing of some industrials product in particularly 
yoghurt and milk fermentation. This bacterium belongs to the group of the thermophilic lactic acid 
bacteria and is traditionally used in combination with others Lactobacillus for the manufacture of 
yogurt and so-called hard ‘‘cooked’’ cheeses (e.g., emmental, gruye`re, grana), at a relatively high 
process temperature (45°C) (Fox et al, 1993, Tamime et al, 1980). S. thermophilus is a ‘‘generally 
recognised as safe species and over 1021 live cells are ingested annually by the human population. 
Recently, the complete genome sequence of certain  yogurt strains (LMG 18311,  CNRZ1066 and 
LMD9), (Bolotin et al, 2004).  
For this study we have choice a Supressive Subtractive Hybridization (SSH) method  as a 
differential screening to studies the impact of S.thermophilus on gene expression profile of the host 
( rat animal). Suppression subtractive hybridization (SSH) is a widely used method for separating 
DNA molecules that distinguish two closely related DNA samples. Two of the main SSH 
applications are cDNA subtraction and genomic DNA subtraction. To our knowledge, SSH is one 
of the most powerful and popular methods for generating subtracted cDNA or genomic DNA 
libraries. It is based primarily on a suppression polymerase chain reaction (PCR) technique and 
combines normalization and subtraction in a single procedure (Diatchenko et al, 1996). The 
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normalization step equalizes the abundance of DNA fragments within the target population, and the 
subtraction step excludes sequences that are common to the populations being compared. This 
dramatically increases the probability of obtaining low-abundance differentially expressed cDNAs 
or genomic DNA fragments and simplifies analysis of the subtracted library. SSH technique is 
applicable to many comparative and functional genetic studies for the identification of disease, 
developmental, tissue specific, or other differentially expressed genes, as well as for the recovery of 
genomic DNA fragments distinguishing the samples under comparison. The results have been 
validated using the quantitative RT-PCR and western blot analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 
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II) MATERIAL AND METHOD. 
II-1) ANIMALS 
All procedures were carried out according to the European and French guidelines for the care and 
use of laboratory animals (permission 78-123, dedicated to MT). At the age of  two months, three 
germ-free (GF) rats (male, Fisher 344) were inoculated by oral administration with one ml of 
S.thermophilus LMD9 (Ino-LMD9) in Nilac milk (5x108 S.thermophilus/ml) . As a control, three 
GF rats  were also inoculated with one ml of sterile Nilac milk (without bacteria). GF, and mono-
associated  rats were housed in sterile Plexiglas isolators (Ingénia, Vitry-sur-Seine, France). All 
groups of rats received the same standard diet (UAR), which was sterilized by gamma irradiation. 
In addition, germfree rats received supplemental vitamin K in their drinking water. Twice a week 
during the experiment, S. thermophilus (Ino-LMD9) was enumerated by plating serial dilutions of 
the faeces. The  feces of germfree rats were also checked weekly for the absence of 
microorganisms. All rats were scarified at three months of age, i.e, 30 days after inoculation. Rats 
were anesthetized with isoflurane aspiration, and the colons were removed rapidly and  immediately 
used for cell isolation procedure.  
II-2) CELL ISOLATION 
Colonic cells originating from both groups of rats were isolated using a protocol previously 
described  by Cherbuy et al (Cherbuy C et al, 1995&2004). Briefly: the colons removed were 
flushed clean, first with NaCI (9 g/L) and then with a Ca2+- and Mg2+-free Krebs'-Henseleit 
bicarbonate buffer (pH 7.4) containing 10 mmol/L HEPES, 5 mmol/L dithiothreitol, and 2.5 glL 
albumin and equilibrated against a mixture of O2/CO2 (19:1, vol/vol). Thereafter, the colons were 
perfused for 20 minutes (30 mL/min at 37°C) with the same buffer containing 10 mmol/L EDTA. 
Then, the colons were gently squeezed and the luminal fluid collected and centrifuged (150xg for 3 
minutes) to harvest the cell fraction. An additional 15 minutes incubation was performed in a 
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shaking water bath (100 oscillations/min at 37°C) using the same buffer without EDTA and in the 
presence of hyaluronidase (4 g/L). The isolated cells were washed twice and resuspended in the 
same bicarbonate buffer medium (pH 7.4) without dithiothreitol and containing CaC12 (1.3 
mmol/L), MgCl2 (2 mmol/L), and 10 g/L albumin (incubation buffer). After two washes and 
centrifugations, the  colonic cell pellet was immediately used for RNA and proteins extraction. 
II-3) GENE EXPRESSION 
II-3-1) RNA PURIFICATION  
Total RNA was extracted from epithelial cells by the guanidinium thiocyanate method 
(Chomczynski P et al, 1987). The RNA yielded was quantified by spectrophotometric “Nanodrop “ 
analysis and the RNA purity was determined based on the A260-A280 ratio. All RNA samples were 
analysed by agarose gel electrophoresis to check for integrity of 18S and 28S rRNA. Finally, the 
quality of the RNA was verified by Agilent 2100 Bioanalyzer analysis using the RNA 6000 Nano 
Assay Kit. 
II-3-2) ASSESSMENT OF RNA QUALITY AND QUANTITY USING THE NANODROP 
Total RNA was quantified by an ND-1000 Spectrophotometer (ND-1000 spectrophotometer; 
Nanodrop Technologies, Wilmington, DE) using the nucleic acid function which uses the 
absorbance at 260 nm to calculate concentration using Beer’s law. The ratio of absorbance at 260 
nm and 280 nm was used to assess purity of the RNA with a ratio of ~2 indicating sample purity. 
The 260/280 ratios for RNA samples were all in the acceptable range of 1.8-2.1. 
II-3-3) ASSESSMENT OF RNA QUALITY USING GEL ELECTROPHORESIS. 
When yields of RNA were adequate, gel electrophoresis was used to assess RNA quality.  
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5 ug of total RNA  was loaded onto TAE agarose gel with ethidium bromide. Gels were 
electrophoresed for 20-30 minutes in Sub Cell-GT electrophoresis tanks (Biorad) at 40-120 volts at 
room temperature using power packs (PowerPAC-300, Biorad). Agarose gels were visualized under 
UV light (260 nm) using the UVP Dual Density transilluminator and photographed with the UVP 
Image Store 7500 system . Figure 2 showed total RNA gel for RNA extracted from animals used for 
this study . 
 
 
Figure 2:RNA gel with total RNA extracted from colonic epithelium cells of 3 mono-associated rats with Streptococcus 
thermophilus and 4 germ free rat : well presents the total RNA extracted of each sample. 
 
II-3-4) ASSESSMENT OF RNA QUALITY USING THE BIOANALYZER 
Quality of total RNA for microarray analysis was assessed using the Agilent 2100 Bioanalyzer 
(Agilent Technologies). Total RNA was used to generate an electropherogram (Figure 1) that 
allowed an estimate of RNA concentration and ribosomal ratio to be obtained. High quality RNA 
showed the following features on a electropherogram: 
- clear 18S and 28S rRNA peaks 
- A low small RNAs (5S, transfer RNA and miRNA) presence relative to the rRNA peaks 
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- A flat base line in the fast-migrating region 
- A flat inter-rRNA peak regions 
- A return to the baseline after the ribosomal RNA peaks 
In addition to visual inspection of the electropherogram, integrated software generated an RNA 
integrity number (RIN) by analysis of the entire electrophoretic trace. This number provides a de 
facto standard for RNA integrity with an RIN >7 indicating a sample of sufficient quality for 
successive analysis.  
 
 
Figure 3: Features of a total RNA bioanalyzer electropherogram. 
 
II-4) CONSTRUCTION OF SUBSTRACTED cDNA LIBRAIRIE USING SSH TECHNIQUE 
II-4-1) DRIVER AND TESTER cDNA SYNTHESIS 
mRNA purified from the total RNA, using commercial Kit ( Pharmacia, Biotech ), extractable from 
colonocytes of colonic epithelium was reverse transcribed and the cDNA was subjected to PCR 
using the  PCR-Select cDNA Subtraction kit (Clontech Laboratories Inc., Palo Alto, CA). Protocols 
were followed according to the manufacturer’s instructions. Briefly, about 100 ng of mRNA from 
both mono-associated LMD9 (driver) And Germ Free  (tester) was denatured at 70°C for 2 min, 
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then reverse transcribed in the presence of, 10 µM of cDNA synthesis primer, 5X First-Strand 
Buffer, 10 mM each dNTPs, and 20 units/µl of AMV reverse transcriptase and incubated  at 42°C 
for 1.5 h in an air incubator. The samples were placed on ice to terminate first-strand cDNA 
synthesis and immediately proceeded  to Second-Strand cDNA Synthesis. First strand cDNA was 
incubated at 16°C thermal cycler  for 2 h in the presence of  5X Second-Strand Buffer, 10 mM 
dNTP Mix and 20X Second-Strand Enzyme Cocktail. Additional incubation at 16°C thermal cycler 
for 30 min after added of 6 u of T4 DNA Polymerase. the reaction was stopped by adding 20X 
EDTA/Glycogen and the product was conserved at -20°C. The product was  purified once with 100 
ul of phenol:chloroform:isoamyl alcohol (25:24:1). After centrifugation,  total of aqueous phase was 
removed and collected in a fresh 0.5-ml microcentrifuge tube with 100 ul chloroform:isoamyl 
alcohol (24:1). The mix was centrifuged and the top aqueous layer was collected and transfered in a 
fresh 0.5-ml microcentrifuge. Precipitation step was immediately preceded by adding 40 µl of 4 M 
NH4OAc and 300 µl of 95% ethanol after pellet recuperation a step of wash was computed using 
500 ul of 80% ethanol.  Finally the precipitate was  Dissolved in 50 µl of sterile H2O.  Both driver 
and tester cDNAs were then digested with 50 units of RsaI in a 50 µl reaction mixture at 37°C for 3 
h, and the reaction was stopped by adding 2.5 ul of 20X EDTA/Glycogen Mix. RsaI digested driver 
and tester cDNA were extracted once with phenol:chloroform:isoamyl alcohol. The aqueous phase 
was removed, precipitated with ethanol, and the pellet was redissolved in 5.5 ul of of H2O. One 
microliter of RsaI digested tester cDNA was diluted in 5 ul of sterile water, and 2 ul of the diluted 
tester was then ligated with 2 ul of adapter 1 and adapter 2R (10 uM) according to the guidelines 
provided in the PCR-Select cDNA subtraction kit (Clontech) in separate ligation reactions in a total 
volume of 10 ul at 16°C overnight using 400 units of T4 DNA ligase in 2 ul of 5X ligation buffer. 
The ligation was stopped by adding EDTA/glycogen and heated at 72°C for 5 min to inactivate the 
ligase. Samples were stored at - 20°C. A PCR-based ligation efficiency analysis to verify that at 
least 25% of the cDNAs had adaptors on both ends was performed according to the instructions 
detailed in the Clontech PCR-Select cDNA subtraction kit user manual. 
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II-4-2) SUPPRESSION SUBTRACTIVE HYBRIDIZATION (SSH) 
SSH was performed using the Clontech PCR-Select cDNA subtraction kit. Briefly, 1.5 ul of driver 
cDNA was added to each of two tubes containing 1.5 ul of adapter 1 and adapter 2R-ligated tester 
cDNA  in 1 ul of 4X hybridization buffer. The samples were denatured at 98°C for 1.5 min, and 
then allowed to anneal at 68°C for 8h. Following first hybridization, the two samples were 
combined in the presence of fresh excess denatured driver cDNA  in 1 ul of 4X hybridization 
buffer. The samples were allowed to hybridize overnight at 68°C. The hybridized samples were 
diluted in 200 ul of dilution buffer (20 mM Hepes pH 8.3, 50 mM NaCl, and 0.2 mM EDTA), 
heated at 68°C for 7 min, and stored at -20°C. 
II-4-3) PCR AMPLIFICATION OF SUBTRACTED PRODUCTS 
Two PCR amplifications of the subtracted cDNAs were performed. The primary PCR contained 1 
ul of diluted, subtracted cDNA, and 24 ul of the PCR master mixture prepared using the reagents 
provided in the kit. PCR was performed at 75°C for 5 min to extend the adaptors; 94°C for 25 sec; 
and 27 cycles at 94°C for 10 sec, 66°C for 30 sec, and 72°C for 1.5 min. The amplified products 
were diluted 10-fold in sterile deionized water. The diluted primary PCR product was used as 
template in a secondary nested PCR for 10 cycles at 94°C for 10 sec, 68°C for 30 sec, and 
72°C for 1.5 min using two nested primers, 1 and 2R, provided in the kit. Primary and secondary 
PCR products were analyzed on a 2% agarose gel. A second PCR-based analysis was performed 
according to the instructions detailed in the Clontech PCR-Select cDNA subtraction kit user manual 
to test for the efficiency of subtraction. 
II-4-4) CLONING AND ANALYSIS OF SUBTRACTED cDNA 
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Following PCR subtraction, the amplified products were cloned into the pCR II vector of the TA 
cloning kit (Invitrogen) and used to transform competent DH5a Escherichia coli cells. Colonies 
were grown for 16–18h at 37°C on Luria broth (LB) agar plates containing ampicillin, X-gal (5- 
bromo 4-chloro 3-indoyl-b-D-galactopyranoside) and ampiciline antibiotic for blue/white colony 
selection. Plasmids were extracted and the inserts were subjected to DNA sequencing using a Big 
Dye terminator Cycle Sequencing Ready Reaction Kit and an automated DNA sequencer ABI 
PRISM 310. Basic Local Alignment Search Tool (BLAST) analysis from the National Center for 
Biotechnology Information was used to search GenBank for homologous nucleotide and protein 
sequences. 
II-5)  QUANTITATIVE RT-PCR ANALYSIS  
Total RNA extracted from  colon epithelial cells of 5 rats (2 germ free and 3 mon-associated with  
streptococcus thermophilus LMD strain ) was used to cDNA synthesis. 
Reverse transcription was performed with 1 µg of rat total RNA using iScript™cDNA Synthesis Kit 
( Bio-rad). Quantitative RT-PCR (RT_qPCR) was performed on the Opticon Monitor 3 ( Bio-rad) 
using specific  primers (table1), which  were designated to have a PCR product that incorporates at 
least one exon-exon splice junction to allow a product obtained from the cDNA to be distinguished 
on electrophoresis from genomic DNA contamination, and  Master Mix (2X) Universal (KAPA 
SYBR®FASTqPCR Kits) KAPA BIOSYSTEMS. 
All primers sets were validated to ensure efficient amplification of a single product before use in 
assays. Relative mRNA levels were calculated using the comparative 2-∆∆Ct method. Comparisons 
were made with samples from epithelial cells harvested from Germ Free and mono-associated 
colonic epithelium cells of  rats ( 2 germ free animals and 3 mono-associated ) using GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) as the reference genes. Expression levels were shown 
in the results. 
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Primer Name Primer sequences Product size 
GAPDHL1 ATACTTGGCAGGTTTCTCCA 116pb 
GAPDHR1 ATGGCCTTCCGTGTTCCTAC  
SNFL1 CCAGTAGAGCCGGAAAGGGT 151pb 
SNFR1 CCTTGAGACCAATGCTGGAT  
KLF4L1 TTAAAAGTGCCTCCTGTGT 126pb 
KLF4R1 GCCACCCACACTTGTGACTA  
Table 1: Gene specific primer sequences shown were used for real-time RT-PCR validation of the changes in gene 
expression in mono-associated rats with Streptococcus thermophilus  revealed by SSH analyses. Real-time PCR based 
on SYBR green (Biorad) mediated detection was run on an Biorad Mini-Opticon. Primer sequences are named as L1and 
R1 representing forward and reverse primer sequences, respectively. 
 
II-6) WESTERN BLOT ANALYSIS 
Total proteins were extracted from colonocytes with RIPA buffer. and quantified by Lowry method 
using spectrophotometer (Spectra Fluor Plus; XFLUOR4 V4.11). Different amount of  these 
proteins were loaded in a 10% SDS-polyacrylamide gel, after denaturation at 100°C for 5 min and 
migration at room temperature for 2h, and then electro-transferred to a PVDF membrane 
(Amersham Pharmacia Biotech; Saclay, France). Membrane transferred  was   pre-hybridized  
with5% milk/PBST 1X  Overnight . Proteins were analysed using anti- p27kip1 (Santa Cruz 
Biotechnology; 1/500), anti  14-3-3 sigma (chemicon AB9742 ; 200X) and anti KLF4 (IMGENEX, 
IMG-6081A; 500X) Several loading controls were used, either GAPDH, Skp1 or cullin1 (Cherbuy 
C. et al, 2010). To check homogeneity of loading, all membranes were stripped and re-hybridized 
with an antibody against -tubulin (1:20000) (Sigma; L’Isle d’Abeau Chesnes, France). An anti-
mouse antibody (Jackson Immuno Research Laboratories; West Grove, PA) conjugated with 
peroxydase was used at 1:12000 to detect immune complexes by chemiluminescence using the 
ECL+ detection system (Amersham Pharmacia Biotech; Orsay, France). Systematically, a protein 
ladder was loaded and the weight of the band was checked. Signals imprinted on autoradiography 
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films were quantified by scanning densitometry of the autoradiograph using Biovision 1000 and 
logiciel bio1D (Vilber Lourmat, France). 
II-7)  STATISTICAL ANALYSIS 
II-7-1) GENE ONTOLOGY  
Gene Ontology analysis of the 46 unique sequences was carried out using the BLAST2GO 
program(Conesa et al, 2005), a universal gene ontology annotation, visualization and analysis tool 
for functional genomics research http://www.blast2go.org/start_blast2go. This program is a Java 
application enabling gene ontology (GO) assignment, based on data mining of sequences for wich 
no GO annotation is currently available. FASTA-formatted sequences representing all the 
sequences generated by SSH were uploaded to the program and BlASTX carried out against the 
Swiss-Prot database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). GO terms associated with the hits ( e-
value
 < 1X10e-5) were retrieved by the program, and queries were annotated based on hit similarity 
and GO evidence codes 
II-7-2) QRT-PCR 
Statistical analysis for qRT-PCR was computed using REST 2009 Software  jointly developed by 
Dr. Michael W. Pfaffl (Chair of Physiology, Technical University Munich) and Qiagn. 
REST 2009 Software applies a mathematic model that takes into account the different PCR 
efficiencies of the gene of interest and reference genes (Relative Expression Software Tool 
http://rest.gene-quantification.info). Compared to using a single reference gene, using multiple 
reference genes for normalization can improve the reliability of results (Randomization Tests 
http://ordination.okstate.edu/permute.htm). 
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III) RESULTS 
III-1) GENERAL LIBRARY ANALYSIS 
In order to find genes expressed in monoassociated rats after 30 days of colonization we constructed 
a SSH library. The tester library was prepared with germ free rats mono-associated with 
Streptococcus termophilus  from 3 months old. whereas the driver library was prepared with germ 
free rats 3 months old. cDNA sequencing from the SSH library resulted in Sequences obtained were 
filtered as low quality reads or as ribosomal RNA, polyA+ tails or vector sequences and 56 
sequences were selected and analyzed .To identify unique sequences from all transcripts, the dataset 
was filtered in order to reduce redundancy of all mammalians, as well as of Rattus Norvegicus  in 
particular. Identical or highly similar sequences (E-value > e-100) where identified  with a custom 
script employing Blast (Altschul et al. 1997; Gish 1996-2009) and the longest sequence among two 
or more similar sequences was selecte. After the filtering  46 unique sequences were considered for 
the successive analysis. We carried out direct nucleotide comparison (blastn),  and only matches 
with high  similarity were considered significant for labeling them as known genes. In summary, we 
found that 31 sequences had  counterpart genes known in Rattus Norvegicus, whereas 15 were 
described as ESTs with no hit.  
III-2) GENE ONTOLOGY ANALYSIS 
Sequences resulted after filtering, blasting, mapping and annotation using Blast2GO program, were 
classified into the three ontology categories: "Molecular function", "Biological process" and 
"Cellular component" (Figure4:A, B and C, respectively). In the category "Biological process"  , the 
most frequent activity was  cellular process with 22 sequences, biological regulation with 18 
sequences, response to stimulus with 17 sequences, signaling with 12 sequences and cell growth 
and development process with 11 sequences. "Molecular function" the most frequent was Binding 
with 29 sequences followed by catalytic activity with 6 sequences and transcription regulator with 2 
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sequences. Concerning the category "Cellular component", cellular and membrane enclosed lumen 
were the most frequent activities. Of all categories unknown sequences were not represented. 
III-3) STRATIFIN (14-3-3Σ) AND KRUPPEL LIKE FACTOR 4 (KLF4)  TOW PRIVILEGED 
GENES  CANDIDATES. 
A total of 46 transcripts differentially expressed were identified as unique sequences, 9 sequences 
have determinate functions. Tow genes of all transcripts were  privileged. These gene have a main  
role in the cell cycle control  and were involved in some different functions (Stier S. et al ,2005; 
G.Suske et al, 2005; J.Kaczynski et al, 2003; L.A Garrett-Sinha et al , 2003 ). 
 III-3-1) EXPRESSION OF KRUPPEL LIKE FACTOR 4 IN COLONIC EPITHELIUM IN GERM 
FREE RATS ASSOCIATED WITH STREPRTOCOCCUS THERMOPHILUS STRAIN 
BACTERIA (LMD9). 
Klf4 gene was identified after analysis using SSH represented with 2 clones relatively to all of 
genes generated. To extend these data, we verified the expression of klf4 using conventional PCR at 
different cycles and we have noticed that  klf4 expression were increased in the in colonic 
epithelium cells of mono-associated LMD9 rat at 30 cycles (figure 5) relatively to germ free and 
was quasi similar to Conventional rats (animals with complex flora). In order to give an evidence of 
our finding we have quantified relatively  the expression of klf4 using the qRT-PCR (Figure 6). 
Klf4 resulted up regulated in sample group LMD9 in comparaison to control group by a mean factor 
of 1,26 ( S.E. range is 1,008-1,524) and with pvalue =0,031. This results combined to the semi-
quantitative data suggests  that Streptococcus thermophilus influenced klf4 expression in the 
colonic epithelium cells. Additionally, and in order to give more evidence of our results we 
extended these data using western blot approach to analyze the related protein. Consistent with data 
generated of previous analysis the expression of klf4 protein was higher in the colonic epithelium 
cells of mono-associated LMD9 rats to the colonic epithelium cells of germ free (figure 7). 
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III-3-2) EXPRESSION OF STRATIFIN OR 14-3-3Σ IN COLONIC EPITHELIUM INGREM 
FREE RATS ASSOCIATED WITH STREPRTOCOCCUS THERMOPHILUS STRAIN 
BACTERIA (LMD9). 
One of the most important genes that we have identified of the total sequences generated by SSH 
analysis was a stratifin gene called also 14-3-3σ. 14-3-3 σ protein is one of 14-3-3 family proteins 
that have many divers functions in a board range of organisms, including critical roles in signal 
transduction pathways and cell cycle regulation (Aitken A. et al, 1999; Fu H. et al, 2000; Wang W. 
et al, 1996). And  the 14-3-3σ gene is one of seven isoform members of the 14-3-3 family (Aitken 
A. et al, 1995). 
To validated the influence of Streptococcus thermophilus on 14-3-3σ expression we have quantified 
the mono-associated LMD9  mRNA using conventional RT-PCR (figure 5). Here we have noticed 
that 14-3-3σ expression was increased in mono-associated LMD9 in comparaison to Germ Free rats 
and this expression was quasi similar to the conventional rats at 30 cycles PCR. To have a robust 
confirmation we have tested the relative mRNA expression of 14-3-3σ using qRT-PCR (Figure 8) . 
significantly, the expression level of 14-3-3σ was increased in rats associated with Streptococcus 
thermophilus in comparaison to germ free rats by a mean factor of 1,96 (S.E. range is 0,951 - 4,317) 
and with pvalue =0,038. To further confirm  the previous results we have quantified the expression 
of related protein using western blot analysis. We showed that 14-3-3σ protein was higher in the 
colonic epithelium cells of mono-associated LMD9 rats to germ free rats (figure 9). 
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A)biological_process Level 2 
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B) molecular_function Level 2 
 
  
 C) cellular_component Level 2 
 
Figure 4:A-Distribution by biological processes, B-Molecular Functions, and C-Cellular Components involved of 
differentially expressed transcripts  generated by SSH in the rat mono-associated with Streptococcus thermophilus  
LMD9 strain compared to Germ Free rat. Distribution was by Biological Processes, Molecular Functional, and Cellular 
Components  among those sequences with associated GO terms according to the Blast2-GO software (level 2). 
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Figure 5: RT-PCR using specific primer to detect abundance of tow privilege genes 14-3-3σ and KLF 4 between 3 
group of rat: Germ Free (GF), mono-associated (S.th) and conventional (CV). GAPDH is the endogenous control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Boxes represents the interquartile range, or the middle 50% of observations. The dotted line represents the 
median gene expression. Whiskers represent the minimum and maximum observations. KLF4 is UP-regulated in 
sample group (in comparison to control group) by a mean factor of 1,265 (S.E. range is 1,008 - 1,524). KLF4 sample 
group is different to control group. P(H1)=0,031 
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Figure 7: KLF4 detection in different mono-associated samples. Mono-associated LMD9 rats have been inoculated 
with S. thermophilus. Western blots were from colon cells. 
 
 
Figure 8: Boxes represents the interquartile range, or the middle 50% of observations. The dotted line represents the 
median gene expression. Whiskers represent the minimum and maximum observations. 14-3-3sigma is UP-regulated in 
sample group (in comparison to control group) by a mean factor of 1,963 (S.E. range is 0,951 - 4,317). 14-3-3sigma 
sample group is different to control group. P(H1)=0,038 
 
 
                
Figure 9:14-3-3σ detection in different mono-associated LMD9 samples. Western blots were from colon cells. 
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IV) DISCUSSION 
Streptococcus thermophilus is a lactic acid bacteria largely used by the food industry for production 
of yoghurt and cheese, among other products. In spite of its wide consumption, insufficient 
information is presently available on the molecular effects of its consumption at the level of 
intestinal cells. The research we discuss in this work aimed at studying the impact of 
S. thermophilus on colonic epithelial cells gene expression. In this study we have used a  
suppression subtractive hybridization to identify and study genes induced by S. thermophilus in 
colonic epithelial cells. The subtraction library was prepared subtracting mRNA between epithelial 
cells isolated from colonic mono-associated rats (inoculated with LMD9 strain of S. thermophilus) 
and germ-free rats (without bacteria).46 clones were sequenced after SSH. Thirty of these clones 
correspond to genes whose expression in colonic epithelial cells is potentially activated in the 
presence of S.thermophilus. Candidate genes were grouped into essential  Functional groups: genes 
that play a role in cell-cycle arrest and regulation of proliferation and differentiation, genes involved 
in the pathway of cell-communication, genes involved in binding and genes involved in regulation 
of biological process. We have focused our interest on two candidatesthat were kruppel like factor 4 
and 14-3-3σ involved in cell cycle. These two  candidates genes were tested by RT-PCR to quantify 
mRNA and Western blot to analyze the related proteins in mono-associated animals versus  germ-
free animals and conventional animals. The results confirmed that selected candidate genes increase 
their expression in the presence of S.thermophilus. 
Krupel like factore 4( klf4) was identified initially as a gene whose expression accompanies growth 
arrest (Shields JM et al, 1996). Further, it’s in vivo pattern of expression mirrors that seen in vitro 
(Chen X. et al, 2003). Thus klf4 mRNA is found primarily in terminally differentiated and 
mitotically  inert epithelial cells of the intestine (Shields JM et al, 1996, Chen et al, 2003) and 
epidermis (Garrett-Shinha LA. et al, 1996; Segre JA. et al, 1999). Chen et al,(Chen et al, 2001), 
have reported in a recent work using inducible RKO cell line that the inducible expression of klf4 
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result in an arrest in the cell cycle at the transition phase between G1 and S, and that this arrest is 
accompagnied by the activation of p21WAF1/Cip1  a potent suppressor of cell proliferation (El-Deiry 
WS. et al, 1993). The  role of klf4 in regulating differentiation of epithelial tissues was 
demonstrated by gene targeting experiments that confirmed the effect of klf4 on terminal 
differentiation of two epithelial cell types, epidermal keratinocytes (Segre JA. et all, 1999) and 
colonic goblet cells (Katz JP. et al, 2002) . Increased expression in vivo of klf4 in differentiated cell 
compartments, of the villi of the small intestine and near the surface of the mouse colonic crypts, 
was demonstrated by M. Flandez (Flandez M. et al, 2008).Recent study computed by  Rull et al, 
untitled impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of 
gnotobiotic rats (Rull et al, 2010 submetted), have demonstrated that S.thermophilus increased 
p27kip1 p27kip1 is cyclin-dependent-kinases (CDKs) inhibitor and is preponderant cell cycle 
regulators in gut intestinal tract (Besson A. et al,2008). Our present study give in part  an evidence 
to the previous observations and confirmed  that Streptococcus thermophilus has a beneficially role 
to enhance  and maintain colonic homeostasis. The present study has demonstrated that 14-3-3σ 
was another important gene differentially expressed. 14-3-3σ called also stratifin, an inhibitor of 
G2/M progression of the cell cycle following DNA damage (Hermeking H. et al, 1997; Chan TA. et 
al, 1999). Expression of the 14-3-3σ was activated by klf4 (Chen X. et al, 2003). However, our 
results of all experiments (Semi-quantitative RT-PCR, quantification of mRNA expression by 
quantitative PCR, and western blot analysis) demonstrated that it was a coordination between 
induction of klf4 and 14-3-3σ. Additionally, recent study reported by Yang et al, (Yang H. et al, 
2006), demonstrated that 14-3-3σ mediated cell cycle arrest concurred with  p27Kip1 up-regulation  
and Akt inactivation.  
In summary, using differential gene expression, we identified groups of genes that are differentially 
expressed upon the presence of Streptococcus thermophilus in a colonic epithelium cells. 
Functional analysis of all of transcripts generated by SSH reveal that they may mediate some and 
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most of the previously reported functions of klf4 and 14-3-3σ  that were arrest of cell proliferation 
and promotion of  differentiation process consequently maturation of colonic epithelium cells. Gene 
ontology has provide other most  process involved by  all of the generated  transcripts, including 
transport, binding and trafficking,  that were involved to maintain the right function of colonic 
epithelium.  
These results indicate that S. thermophilus modifies the expression of genes involved in essential 
intestinal functions. They, combined with the observation that this bacterial genus is present in 
women breast milk and in the bowel of infants suggest that S. thermophylus may play a role in the 
early on-setting of colon correct structure and function. 
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ABSTRACT 
Probiotics are deliberately ingested preparations of live bacterial species that confer health benefits 
on the host. However, the scientific evidence is still scarce and the mechanisms by which probiotics 
influence the host organism are only beginning to be explored. The initial step in the 
characterization of mechanism of action for functional food products is the identification of a 
specific interaction between the active component of this food and an effect in the host organism 
that is potentially beneficial for health. One approach to investigate these interactions is to map the 
changes in transcription profile of the host organism caused by nutrient intake. Recent development 
of expression profiling by the use of microarray technology has made it possible to monitor the 
expression of thousands of genes simultaneously, allowing systematic analysis of complex 
biological processes and offering an advantage of reducing bias in data collection, compared with 
the candidate gene-based approaches. In the present study , we have studied regulation of intestinal 
gene expression of the host organism after colonization for 30 days by probiotic bacteria strain. 
Oligonucleotide microarrays, using the advanced Combimatrix technology, were applied to 
compare global transcriptional profiles in the colonic epithelium  rats receiving streptococcus 
thermophilus LMD9 with the control group of rat receiving a placebo product. The effect of 
Streptococcus Thermophilus on the colonic epithelium gene expression has been analyzed by the 
context of networks of interacting proteins to convert a complex dataset to biological understanding. 
We showed  that Streptococcus thermophilus  caused important changes on the transcriptional. 
profile of the host. This bacteria evoked a complex response in the gut, reflected by differential 
regulation of a number of genes involved in essential biological functions such as metabolic 
activity, transport activity, development and cell growth, which are essential of a healthy colonic 
functionality. In conclusion differential expression of an array of genes described in this report 
evokes novel hypothesis of possible interactions between the Streptococcus thermophilus  bacteria 
and the host organism and warrants further studies to evaluate the functional significance of these 
transcriptional changes on the functionality of the host. 
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I) INTRODUCTION  
Progress in molecular biology has provided methods to rapidly and comprehensively analyse genes 
and their products in a massively paralleled manner. The first high-throughput techniques 
developed were gene-sequencing methods, resulting in a great number of available genome 
sequences of different organisms. The comprehensive studies of active and regulated genes through 
transcriptomic techniques, such as microarrays, have promoted the study of molecular disease 
mechanisms. The understanding of the molecular basis of health is an even greater challenge, as a 
health status is less defined than a disease state. Nevertheless, global gene expression analysis 
begins to contribute also in this field. The analysis of gene expression deepens the understanding of 
regulatory networks, helps identifying diagnostic and prognostic biomarkers as well as potential 
targets for medical and nutritional intervention. Moreover, transcriptomic studies have improved the 
understanding of the complex interaction between genetic and environmental factors, such as 
lifestyle and nutrition (Hocquette, 2005) and have enabled the assessment of nutritional 
interventions at global gene expression level. 
I-1) MICROARRAY TECHNOLOGY, ANALYSES AND INTERPRETATION OF DATA 
Microarray experiments are, in principle and practice, extensions of hybridization-based methods 
that have been used for decades to identify and quantify nucleic acids in biological samples (E.M. 
Southern et al, 1975; F.C. Kafatos et al, 1979). Microarray technology utilizes gene-specific probes 
that represent individual genes which are arrayed on an inert substrate. Several types of microarray 
plat- forms are available (G. Hardiman et al,2004; F.E. Ahmed et al, 2006), but currently the most 
commonly used arrays are manufactured by companies such as Agilent (P.K. Wolber et al, 2006) or 
Affymetrix (D.D. Dalma-Weiszhausz et al, 2006).  More recently, other arraying technologies have 
emerged, which offer the design of custom arrays at a lower cost, such as Combimatrix (modified 
semiconductor technology), MetriGenix (flow-through chip four-dimensional microarrays), 
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SuperArray (printed oligonucleotides or cDNAs on nylon matrix), or Illumina (probe-coated small 
beads deposited on the array surface). With this choice of custom arrays at hand, scientists can now 
design high-density arrays for virtually any gene set of any organism, provided sequence data are 
available. Studies conducted with customized array have already shown the benefit of 
complementing whole genome experiments by expression analysis of gene subsets (Comelli et al., 
2002; Dougherty and Geschwind, 2002; Morris et al., 2005). The experimental procedure involves 
extraction of RNA from biological samples, followed by labeling with a detectable marker 
(typically a fluorescent dye). After hybridization to the array and subsequent washing, an image of 
the array is acquired by determining the extent of hybridization to each gene-specific probe (J. 
Quackenbush et al, 2006; M.B. Eisen et al, 1999). The data are then normalized to facilitate the 
comparison between the experimental samples. Next, a set of objective criteria is applied, for 
example the elimination of genes with minimal variance between the samples. The most common 
aim of transcriptome analysis is to find genes that are differentially expressed between the various 
experimental samples. Although early microarray papers used a simple ‘fold change’ approach to 
generate lists of differentially expressed genes, most analyses now rely on more sound statistical 
tests to identify differences in expression between groups (D.B. Allison et al, 2006). Unfortunately, 
there are no standards at the level of data filtering, which is often done according to personal 
preference and experience. This leads to discrepancies and prevents a high degree of 
reproducibility. It should also be emphasized that statistical significance is not the same as 
biological significance. Moreover, the classical approach of treating genes as independent entities is 
increasingly being criticized. The main reasons are first the arbitrariness of the chosen cut-off (e.g. 
false discovery rate, fold change) and second the disregards of the broader context in which gene 
products function. Although by design this approach will enable the identification of genes that 
show large changes in gene expression, it might not reveal small yet coordinated changes in gene 
expression in a set of related genes, which is often the case in nutrigenomics research. In response, 
testing for gene classes is becoming increasingly popular. Gene classes are traditionally based on 
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Gene Ontology categories (M. Ashburner et al, 2000), but recently also relationships based on e.g. 
metabolic pathways or signal transduction routes are taken into account (A. Subramanian et al, 
2005). Gene class testing thus improves the identification of affected biological processes in 
microarray data sets, promoting greater understanding of the underlying mechanisms driving the 
observed differences between samples. 
I-1-1) COMBIMATRIX MICROARRAY TECHNOLOGY  
Application of oligonucleotide microarrays in different areas of molecular biology, bio-defense, and 
infectious disease monitoring has been rapidly growing during the last decade (Burton et al., 2005; 
Dobbin et al., 2005; Irizarry et al., 2005; Larkin et al., 2005). Commonly, microarray manufacturing 
is based on spotting of pre-synthesized oligonucleotides, inkjet depositing technologies (Hughes et 
al., 2001), and light-directed synthesis processes (Tan et al., 2003). Measurements of signal 
intensities of bio-components bound to the manufactured arrays are performed using fluorescent 
detection (laser scanning or imaging with a CCD camera) (Shi et al., 2005). CombiMatrix core 
technology is based on a specially modified semiconductor adapted for biological applications, 
which contains arrays of platinum microelectrodes. The semiconductor logic circuitry directs 
digitally controlled simultaneous synthesis of different oligonucleotides at thousands of electrodes 
in response to a computer software program. To perform a synthetic step, a microelectrode is 
activated to selectively generate acid by means of an electrochemical reaction. The generated acid 
in turned protects the growing oligonucleotide chain activating it for binding of the next nucleotide. 
Since a different oligonucleotide can be synthesized at each microelectrode, this technology enables 
one to design a microarray of any desired configuration. CombiMatrix has previously demonstrated 
feasibility of the Combi Matrix Custom Array 90 microarray platform for electrochemical detection 
in oligonucleotide hybridization assays and multiplexed immunoassays (Dill et al., 2004).  
I-2) STATISTICS FOR MICROARRAY DATA ANALYSIS 
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Microarray technology takes advantage of hybridization properties of nucleic acid and uses 
complementary molecules attached to a solid surface, referred to as probes, to measure the quantity 
of specific nucleic acid transcripts of interest that are present in a sample, referred to as the target. 
The molecules in the target are labeled, and a specialized scanner is used to measure the amount of 
hybridized target at each probe, which is reported as an intensity. Various manufacturers provide a 
large assortment of different platforms. Most manufacturers, realizing the effects of optical noise 
and non-specific binding, include features in their arrays to directly measure these effects. The raw 
or probe-level data are the intensities read for each of these components. In practice, various 
sources of variation need to be accounted for, and these data are heavily manipulated before one 
obtains the genomic-level measurements that most biologists and clinicians use in their research. 
This procedure is commonly referred to as preprocessing. The different platforms can be divided 
into two main classes that are differentiated by the type of data they produce. The high-density 
oligonucleotide array platforms produce one set of probe-level data per microarray with some 
probes designed to measure specific binding and others to measure non-specific binding. The two-
color spotted platforms produce two sets of probe-level data per microarray (the red and green 
channels), and local background noise levels are measured from areas in the glass slide not 
containing probe. Despite the differences among the different platforms, there are some tasks that 
are common to all microarray technology. 
I-2-1) PREPROCESSING OF MICROARRAY DATA 
Preprocessing can be divided into 6 tasks: image analysis, data import, background adjustment, 
normalization, summarization, and quality assessment.  
Image analysis:  permits us to convert the pixel intensities in the scanned images into probe-level 
data. Flexible data import methods are needed because data come in different formats and are often 
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scattered across a number of files or database tables from which they need to be extracted and 
organized.  
Background adjustment:  is essential because part of the measured probe intensities are due to non-
specific hybridization and the noise in the optical detection system. Observed intensities need to be 
adjusted to give accurate measurements of specific hybridization.  
Normalization: Without proper normalization, it is impossible to compare measurements from 
different array hybridizations due to many obscuring sources of variation. These include different 
efficiencies of reverse transcription, labeling, or hybridization reactions, physical problems with the 
arrays, reagent batch effects, and laboratory conditions. For each gene, the background adjusted and 
normalized intensities need to be summarized into one quantity that estimates an amount 
proportional to the amount of RNA transcript.  
Quality assessment: is an important procedure that detects divergent measurements beyond the 
acceptable level of random fluctuations. These data are usually flagged and not used, or down 
weighted, in subsequent statistical analyses. The complex nature of microarray data and data 
formats makes it necessary to have flexible and efficient statistical methodology and software.  
I-2-2) DIFFERENTIAL GENE EXPRESSION 
Differential expression analysis of microarray data is fraught with many classical statistical issues, 
such as appropriate test statistics, replicate structure, sample size, outlier detection and statistical 
significance of results. The original and simplest approach to identifying differentially expressed 
genes was to use a fold change criteria; selecting cutoff was something of an ad-hoc procedure; a 2-
fold change was however thought as being a suitable cutoff. This selection process is however, 
completely biased towards individual genes with large fold changes and completely disregards the 
fact that groups of related genes showing smaller deviations could be just as important and also 
does not allow for assessment of significance of expression differences in the presence of biological 
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and experimental Biological experiments are continuously generating more and more data. It has 
become nearly impossible to analyze a biological experiment without statistics and bioinformatics. 
Bioconductor is an open-source / open-development set of tools which can be widely employed in a 
number of genetic and biomedical settings. Bioconductor was started in the Fall of 2001. The core 
maintainers and hosts of the Bioconductor websites are located at Fred Hutchinson Cancer Research 
Center. A new version of Bioconductor is released twice-anually and is linked to the release of R 
(http://cran.at.r-project.org). R is a comprehensive statistical environment and programming 
language for professional data analysis and graphical display. The associated BioConductor project 
provides many additional R packages for statistical data analysis in different life science areas, such 
as tools for microarray, sequence and genome analysis.  
There are a number of statistical tests available that can be applied to assess differential expression 
between populations of microarray data, such as the t-test, which can be used to assess the statistical 
probability that, given the number of samples available, the true expression levels for a given gene 
differ in the overall populations. In such an analysis, the number of samples is invariably far less 
than the number of genes which are being investigated. The number of genes could run into tens of 
thousands, but the number of arrays used will, due to overall cost or rarity of tissue samples, rarely 
exceed thirty, thus creating a multiple testing problem. For example, on an array of 25,000 genes, if 
even 5% are misinterpreted as being differentially expressed, or “false positives”, then »1,250 genes 
will be construed as being differentially expressed when they are in fact not. There are a number of 
solutions available to the problem of false positives which result from the large number of variables 
in a statistical test; they include False Discovery Rate (FDR) developed by Benjamini and 
Hochberg (1995) , or the more stringent Bonferroni Method which controls the family-wise error 
rate. These and other methods can be applied to address the problem of false positives in microarray 
gene expression analysis. One of most functions available in Bioconductors  was LIMMA package 
to calculate differential expression of GeneChip, dual dye and single dye data, as the same 
principals can be applied to all of these data types.  
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Limma “Linear model” 
Limma uses linear models to analyze designed microarray experiments (Yang and Speed, 2003; 
Smyth, 2004). This approach allows very general experiments to be analyzed nearly as easily as a 
simple replicated. Limma provides functions topTable and decideTests, which summarize the 
results of the linear model, perform hypothesis tests and adjust the p-values for multiple testing. 
Results include (log) fold changes, standard errors, t-statistics, and p-values. The basic statistic used 
for significance analysis is the moderated t-statistic, which is computed for each probe and for each 
contrast. This has the same interpretation as an ordinary t-statistic except that the standard errors 
have been moderated across genes, i.e., shrunk toward a common value, using a simple Bayesian 
model. This has the effect of borrowing information from the ensemble of genes to aid with 
inference about each individual gene (Smyth, 2004). Moderated t-statistics lead to p-values in the 
same way that ordinary t-statistics do except that the degrees of freedom are increased, reflecting 
the greater reliability associated with the smoothed standard errors. A number of summary statistics 
are presented by topTable for the top genes and the selected contrast. The most popular form of 
adjustment is "fdr", which is Benjamini and Hochberg’s method to control the false discovery rate 
(Benjamini and Hochberg, 1995). The meaning of "fdr" adjusted p-values is as follows. If all genes 
with p-value below a threshold, say 0.05, are selected as differentially expressed, then the expected 
proportion of false discoveries in the selected group is controlled to be less than the threshold value, 
in this case 5%. The B-statistic (lods or B) is the log-odds that the gene is differentially expressed 
(Smyth, 2004). A B-statistic of zero corresponds to a 50-50 chance that the gene is differentially 
expressed. The B-statistic is automatically adjusted for multiple testing by assuming that 1% of the 
genes, or some other percentage specified by the user in the call to eBayes, are expected to be 
differentially expressed. The p-values and B-statistics will normally rank genes in the same order.  
The eBayes function computes one more useful statistic. The moderated F-statistic (F) combines the 
t-statistics for all the contrasts into an overall test of significance for that gene. The F-statistic tests 
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whether any of the contrasts are non-zero for that gene, i.e., whether that gene is differentially 
expressed on any contrast.  
I-3) FUNCTIONAL ANALYSIS 
The relationships between genes and their involvement in specific cellular functions can be better 
characterized. However, owing to large number of gens and to the small number of samples, there 
are many many statistical problems associated with microarray data(Audic S. et al, 1997; Eisen 
MB. et al, 1998), which mackes the detection of differential gene expression a challenging task. 
One of the main problems is the huge amount of data generated by microarray technology. 
Consequently , algorithms such as Ingenuity Pathway Analysis, LSGraph, Cognia Molecular, 
Metacore, ecct…, were developed to analyse and understand complex biological systems, 
distinguishing functional categories of genes and association and interaction between genes. 
Ingenuity Pathway Analysis. 
Ingenuity Systems is a leading provider of information solutions for the exploration, interpretation, 
and analysis of life science information. Ingenuity’s products and services have one common goal 
to help life science researchers generate maximum value from all types of biological and chemical 
knowledge. Ingenuity offers a broad range of flexible solutions that can be tailored to the needs of 
its clients, including academic and therapeutic area researchers, computational biologists and 
informatics departments, and suppliers in the life sciences industry. All Ingenuity products leverage 
the Ingenuity knowledge base, the largest database of its kind, which houses biological and 
chemical relationships extracted from the scientific literature. Today, Ingenuity’s solutions are used 
by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic 
research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood 
City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and 
Japan. 
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 IPA is an all-in-one, web-based application that enables people to analyze data derived from gene 
expression and SNP microarrays, metabolomics and proteomics experiments, and smaller-scale 
experiments that generate gene lists. With IPA  researchers can search for targeted information on 
genes, proteins, chemicals, and drugs, and build interactive models of the experimental systems. 
IPA’s data analysis and search capabilities help to understand the significance the data, specific 
target, or candidate biomarker in the context of larger biological or chemical systems, backed by the 
Ingenuity knowledge base of highly structured, detail-rich biological and chemical findings. 
II) AIM OF MICROARRAY STUDY 
During the last decades the role of the diet in development, as well as in prevention and 
management, of many diseases has been subjected to intense research. The term ‘functional food’ 
has been adapted to denote foods that may provide a health benefit beyond basic nutrition (Saris et 
al. 1998). The oldest and probably best-known functional food products are health-promoting 
bacteria or probiotics, defined as live microbial dietary supplements that beneficially affect 
consumers through their effects in the intestinal tract (Roberfroid,2000). At present, probiotics, 
most often belonging to the species  Streptococcus thermophilus , are almost exclusively consumed 
as fermented dairy products, such as yoghurt or cheese . Several health-related effects associated 
with the intake of probiotics have been reported in different animal models as well as in human 
studies (Roberfroid,2000; Turpin et al, 2010). However, the scientific evidence is still scarce and 
the mechanisms by which probiotics influence the host organism are only beginning to be explored. 
The initial step in the characterization of mechanism of action for functional food products is the 
identification of a specific interaction between the active component of this food and an effect in the 
host organism that is potentially beneficial for health. One approach to investigate these interactions 
is to map the changes in transcription profile of the host organism caused by nutrient intake. Recent 
development of expression profiling by the use of microarray technology has made it possible to 
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monitor the expression of thousands of genes simultaneously, allowing systematic analysis of 
complex biological processes and offering an advantage of reducing bias in data collection, 
compared with the candidate gene-based approaches. In the present section , we have studied 
regulation of intestinal gene expression of the host organism after colonization for 30 days by 
probiotic bacteria strain. Oligonucleotide microarrays were applied to compare global 
transcriptional profiles in the colonic epithelium  rats receiving streptococcus thermophilus LMD9 
with the control group of rat receiving a placebo product.  
III) MATERIAL AND METHODS 
III-1) ANIMALS AND EXPERIMENTAL DESIGN.  
All procedures were carried out according to the European and French guidelines for the care and 
use of laboratory animals (permission 78-123, dedicated to MT). At the age of  two months, three 
germ-free (GF) rats (male, Fisher 344) were inoculated by oral administration with one ml of 
S.thermophilus LMD9 (Ino-LMD9) in Nilac milk (5x108 S.thermophilus/ml) . As a control, three 
GF rats  were also inoculated with one ml of sterile Nilac milk (without bacteria). GF, and mono-
associated  rats were housed in sterile Plexiglas isolators (Ingénia, Vitry-sur-Seine, France). All 
groups of rats received the same standard diet (UAR), which was sterilized by gamma irradiation. 
In addition, germfree rats received supplemental vitamin K in their drinking water. Twice a week 
during the experiment, S. thermophilus (Ino-LMD9) was enumerated by plating serial dilutions of 
the faeces. The feces of germfree rats were also checked weekly for the absence of microorganisms. 
All rats were euthanized at three months of age, i.e, 30 days after inoculation. At 9:00h, rats were 
anesthetized with isoflurane, and the colons were removed rapidly and  immediately used for cell 
isolation procedure. 
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Experimental Plan 
        
All animals were euthanized at 3 months old 
Figure 1: Schematic diagram summarizing the number of animal and groups used for the experiment.  
III-2) CELL ISOLATION PROCEDURES 
Colonic cells originating from both groups of rats were isolated using a protocol previously 
described  by Cherbuy et al (Cherbuy C et al, 1995&2004). Briefly: the colons removed were 
flushed clean, first with NaCI (9 g/L) and then with a Ca2+- and Mg2+-free Krebs'-Henseleit 
bicarbonate buffer (pH 7.4) containing 10 mmol/L HEPES, 5 mmol/L dithiothreitol, and 2.5 glL 
albumin and equilibrated against a mixture of O2/CO2 (19:1, vol/vol). Thereafter, the colons were 
perfused for 20 minutes (30 mL/min at 37°C) with the same buffer containing 10 mmol/L EDTA. 
Then, the colons were gently squeezed and the luminal fluid collected and centrifuged (150xg for 3 
minutes) to harvest the cell fraction. An additional 15 minutes incubation was performed in a 
shaking water bath (100 oscillations/min at 37°C) using the same buffer without EDTA and in the 
presence of hyaluronidase (4 g/L). The isolated cells were washed twice and resuspended in the 
same bicarbonate buffer medium (pH 7.4) without dithiothreitol and containing CaC12 (1.3 
mmol/L), MgCl2 (2 mmol/L), and 10 g/L albumin (incubation buffer). After two washes and 
centrifugations, the  colonic cell pellet was immediately used for RNA extraction. 
 
Germ Free n=6  at 2 months old  
  
Germ Free control Group  n=3 
 
Mono-associated S.th LMD9 strain  n=3 
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III-3) GENE EXPRESSION ANALYSIS  
III-3-1) TARGET PREPARATION AND HYBRIDIZATION TO MICROARRAYS 
Total RNA was extracted from epithelial cells by the guanidinium thiocyanate method 
(Chomczynski P et al, 1987). The RNA yield was quantified by Biophotometer (Eppendorf AG 
Hamburg, Germany)  and the RNA purity was determined with the A260-A280 ratio. Further, the 
quality and integrity  of the RNA were assessed with an RNA 6000 Nano LabChip Kit using the 
Agilent 2100 Bioanalyzer  (Agilent Technologies, Santa Clara, CA, USA) . After the quality 
controls, the total RNA extracted, from controls (GF) and treated ( LMD9) rats  was amplified using 
the RNA ampULSe  Amplification and Labeling Kit (KREATECH’s ULS™ RNA ampULSe with 
cy5 for combimatrix arrays: Amplification and Labeling Kit; KREATECH BIOTECHNOLOGY, 
Amsterdam) to generate antisense RNA (aRNA) which was Labeled and prepared for 
Hybridization. Steps of amplification were performed according to the standard manufacturer’s 
protocol ( KREATECH BIOTECHNOLOGY ). Briefly: 1000 ng of total RNA was transcribed to 
synthesize First Strand cDNA using T7 Oligo(dT) primer and incubation 10minutes at 70 °C using 
thermal cycler a second incubation for 2 hours at 42 was performed, using an air incubator 
(GRANT BOIKEL, MOD: KIR10M ), after added the following reagents: 10X First Strand Buffer, 
dNTP Mix, RNase Inhibitor, and ArrayScript. 
To synthesize the second strand cDNA, the following reagent were added directly to the first –
strand reaction mixture: Nuclease-free Water, 10X Second Strand Buffer, dNTP Mix, DNA 
Polymerase, and RNase H. and all mixture was Incubated for 2 hr in a16°C thermal cycler.  
After incubation the product was subjected to a direct purification step. This step is designed to 
prevent carryover of unincorporated dNTPs, Primers, and inactivated enzymes into the subsequent 
in vitro transcription reaction. The purified double stranded cDNA was subjected to a linear 
amplification by in vitro transcription to generate aRNA.  At room temp, an in vitro transcription( 
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IVT) Master Mix was prepared by adding the following reagents to a nuclease-free microfuge tube: 
Double-stranded cDNA in Nuclease-free Water, T7 rNTP mix (75mM), T7 10X Reaction Buffer, 
and T7 Enzyme Mix. Once assembled, the samples were incubated using an in air incubator 
(GRANT BOIKEL, MOD: KIR10M) at 37°C for 14 hours. After Stop the reaction by adding 
Nuclease-free Water to each aRNA, a purification step was recommended to removes enzymes, 
salts and unincorporated nucleotides from the aRNA. At the end of the purification, the aRNA is 
eluted from the filter with Nuclease-free Water. Concentration of  aRNA  was determined by 
measuring the absorbance at 260nm. aRNA products were conserver at - 80°C or directly labelled 
using ULS aRNA Fluorescent Labelling kit KREATECH’s ULS™ RNA ampULSe with cy5 for 
combimatrix arrays: Amplification and Labeling Kit; KREATECH BIOTECHNOLOGY, 
Amsterdam). 5 ugs of each  purified aRNA were added to 5 ul of cy5, a 1/10 volume of 10x 
Labeling solution was added and the final volume was adjusted with RNase-free water for each 
sample. Samples were Labeled by incubation for 30 min at 85ºC and finally purified using the 
KREApure columns.  The product were assessed by measuring A260 and A650 for determining the 
DOL of Cy5-ULS labeled aRNA and  the  degree of labeling (DOL) using the following formula:   
- ng / µL =A260 *dilution factor* 40/cuvet length (in cm) 
Degree of labeling (amount of dyes per 100 nucleotides) 
- Labeling % = ( 340 * pmoldye /ng nucleic acid *1000 )  x 100% 
Gene expression experiments were performed according to the standard CombiMatrix protocol 
described in detail at http://www.combimatrix.com/docs/CustomArray 90K Protocol.pdf. according 
to manufacturer’s protocol. Briefly: before hybridization step the microarray was Filled with 
nuclease-free water and incubated at 65
o
C for 10 minutes to hydrate it.  A pre-hybridization solution 
was introduced into hybridization chamber and incubated at 42 °C for 30 min using Rotisserie oven 
(GRANT BOIKEL; KIR10M).  5X RNA fragmentation solution were prepared  and a defined 
volume ( see: CustomArray™ 90K Microarray: Hybridization and Imaging Protocol (PTL020) ) 
was added to 4 ug of labeled aRNA of each sample. Samples were incubated for 20min at 95°C 
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thermo cycler and the entire Fragmentation Reaction volume was added to the Hybridization 
Solution. the product was Denatured at 95
o
C for 3 minutes and Filled into  the hybridization 
chamber. The microarrays were placed onto the rotisserie in the hybridization oven and incubate at 
42 °C for 16 hours with gentle rotation. Figure 2 summarize  the Hybridization and Imaging of 
CustomArray™ 90K Workflow Fluorochrome.  After hybridization the arrays were then washed 
and conserved in PBS solution for imagining.  
Slides were then scanned using a Gene Pix Professional 4200A scanner (Molecular Devices, 
Sunnyvale, CA, USA) ,that operate using sequential scanning, at variable photomultiplier tube to 
obtain optimized signal intensities, the PMT was optimized to obtain  2-6  level of saturation. The 
image was saved as a tiff image file. Spot identification, intensity quantification, and data filtered 
and extracted was performed using GenePix Pro software 6.0 (Molecular Devices, Sunnyvale, CA, 
USA) . 
Target Preparation: RNA (user chooses kit): 
Fluorochrome Labeling Targets:  1-3 days 
 
 
Pre-hybridization/ RNA Fragmentation 
(RNA targets only): 40 min (10-15 min 
 
 
 
Hybridization 4 – 16 hours  (10 min hands on) 
 
Hybridization Washing  (30 min) 
 
 
Fluorochrome-labeled Targets1 (30min 
 
Final Washing and imagining (30min) 
Figure 2: Hybridization and Imaging of CustomArray™ 90K Workflow Fluorochrome. 
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III-3-2) MICROARRAY RE-USE (MICROARRAY STRIPPING) 
The microarray stripping procedure was performed using the CombiMatrix CustomArrayTM 
Stripping Kit according to the standard protocol: http://www.combimatrix.com/docs/ 
StrippingProtocol CustomArray90K.pdf (Stripping and Preparation of 90K Microarrays  
for Re-hybridization Protocol) . The stripped microarrays were stored then store wet in Imaging 
Solution or 1X PBS at 4
o
C for a maximum of 2 weeks. The CombiMatrix platform is the first and 
only commercially available microarray that can be stripped from hybridized targets and re-used 
three times resulting in four uses for a single microarray. Figure 3 summarize the workflow of the 
stripping and re-hybridization of microarray. 
 
CombiMatrix Microarrayafter Hybridization and Imaging 
Store the microarray wet, do not let it dry out. Proceed to the Stripping 
Protocol as soon as possible after imaging. 
 
 
 
 
Stripping1 hour (10-15 min hands on) 
 
 
 
 
 
Washing 30 min hands on 
 
 
 
 
Imaging10 –15 min 
 
 
 
 
Re-hybridization As required by the Hybridization Protocol 
 
 
Figure 3: Stripping and Preparation of 90K Microarrays for Re-hybridization  Protocol Workflow 
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III-3-3) MICROARRAY SYNTHESIS  
Transcriptomic analysis was performed on a 90K Rattus 1.1 microarray synthesized using the 
CombiMatrix platform at the Plant Functional Genomics Center of the University of Verona 
http://ddlab.sci.univr.it/Functional_ Genomics/.  The 90K Rattus 1.1 array contains 90,000 silicon 
electrodes  including 30,082 unique 35-40 mer DNA oligonucleotide probes synthesized in situ 
with three replications. The  target sequences for designing probes to be included on the microarray 
were selected from the RefSeq (http://www.ncbi.nlm.nih.gov/projects/RefSeq/) and UniGene 
(http://www.ncbi.nlm.nih.gov/unigene/) databases. The Reference Sequence (RefSeq) collection 
aims to provide a comprehensive, integrated, non-redundant, well-annotated set of sequences and 
the UniGene collection represents an organized view of the transciptome where each entry is a set 
of transcript sequences that appear to come from the same transcription locus. The full dataset of rat 
RefSeq transcript sequences (35033 entries on April, 8th 2009) where selected from the mammalian 
dataset downloaded from ftp://ftp.ncbi.nih.gov/refseq/release/vertebrate_mammalian/. The unique 
UniGene sequences (63440 entries on March, 29th 2009) where downloaded from   
ftp://ftp.ncbi.nih.gov/repository/UniGene/Rattus_norvegicus/Rn.seq.uniq.gz. In total 98473 rat 
sequences were available. Since part of the UniGene entries are represented in the RefSeq database  
the dataset was filtered in order to reduce redundancy. Identical or highly similar sequences (E-
value > e-100) where identified  with a custom script employing Blast (Altschul et al. 1997; Gish 
1996-2009) and the longest sequence among two or more similar sequences was selected giving 
priority to RefSeq entries. After the filtering 59815 unique sequences, including 55 sequences from 
SSH experiments, constituted the final dataset used to design the probes  with the OligoArray 2.1. 
software (http://berry.engin.umich.edu/oligoarray2_1/utilization.html) . From the output of the 
software, about 30000 unique probes were selected, matching 25198 RefSeq, 4721 UniGene and 46 
SSH targets. The selection was performed by giving priority to RefSeq targets, longer sequences 
and available annotation derivedretrieved from NCBI database or by similarity with known protein 
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in other species. The limited selection of 30000 probes was necessary in order to allow the 
representation of three replicates for each target on the chip. Only the sequences with the necessary 
thermodynamics allowing the design of specific probes  were  represented on the chip . These three 
replicates of each probe were distributed randomly across the array to control for internal 
variability. The Table 1 presents the number and descriptions hows the composition  of the final 
layout of the microarray. Besides the probes for the  target genes, the array carries 31 different 
housekeeping genes (replicated three time ), selected from the commercial arrays for rat prepared 
by Combimatrix, and used as positive controls to evaluate labeling and sample hybridization. This 
is based on the assumption that these genes show a constant expression between samples. However, 
no set of housekeeping genes has proven to be universally stable. In addition, these housekeeping 
genes are often highly expressed and therefore possibly influenced by saturation effects. Moreover, 
probes targeting phage, bacterial and plant DNA used as negative control and probes for quality and 
factory controls were included in the layout. These last probes were used of quality control of data 
by indentified outlier samples, contamination samples and or decide whether a sample needs to be 
repeated or removed from data set.  
Probe Number  Probe discriptions 
25198 Refseq 
4721 Unigene 
46 Transcripts generated by supressive subtractive hybridization (SSH) 
31 Housekeeping 
32 
negative controls (lambda phage, Agrobacterium tumefaciens, Alteromonas  
phage,  Arabidopsis thaliana) 
19 Quality Controls ( controls of microarray hybridization quality) 
35 factory negative  (controls 
Table1: number and description of probe 90K Rattus microarray synthesized using the CombiMatrix platform. 
The Oligoarray 2.1. software (Rouillard et al, 2003). computes oligonucleotide specificity by 
searching for similar sequences in a database containing all the transcribed sequence derived from 
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the genome. When the genome sequence is not known, the Blast database that is used to compute 
oligo's specificity is represented by the set of transcribed sequences often derived from the 
expressed sequence tags (EST) available.  
III-3-4) MICROARRAY DATA ANALYSIS 
Before any kind of microarray data  analyzed for differential expression we have taken several 
preprocessing steps to assesses raw data quality and to ensure its integrity. The most appropriate 
method that we have used to preprocess the raw data before differential expression analysis were 
linked at least. 
III-3-4-1) Background Correction 
The first step is to background correct the intensity reading for each spot. Background fluorescence 
can arise from many sources, such as non-specific binding of labeled sample to the array surface, 
processing effects such as deposits left after the wash stage or optical noise from the scanner. There 
is always some level of background noise, even if nothing but sterile water is labeled and 
hybridized to the array, some fluorescence will still be picked up by the scanner. For our analysis 
we have used  “normexp”  (Matthew E et al, 2007) a new method has been implemented from 
Bioconductor’s limma package. This method offers  a very important advantage over other 
background corrections: It dosen’t produce negative values. This means that we don’t loose any 
spot, even if very high background signal was measured. 
III-3-4-2) Normalization between arrays 
Oligonucleotide microarrays often suffer substantial scale differences because of technical 
variation, which could be down to any number of factors. Performing normalization between arrays 
will compensate for such effects and thus yield more reliable results. The purpose of this step is to 
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adjust data for technical variation, as opposed to biological differences between the samples. There 
will always be slight discrepancy between the hybridization processes for each array and these 
variations tend to lead to scaling differences between the overall fluorescence intensity levels of 
various arrays.The  Quantile normalization method was implemented through the Affy module of 
the bioconductor microarray analysis. The goal of the Quantile method is to make the distribution of 
probe intensities for each array in a set of arrays the same.  
III-3-4-3) Data Quality Assessment Methods 
Quality assessment is an important phase that applies to analysis of all types of microarrays. Quality 
assessment of data ensures that the best use is made of the information available and ensures 
meaningful results at the end of an analysis. Boxplot is  is a convenient means by which to compare 
the probe intensity levels between the arrays of a dataset. For microarray data, these graphs are 
always constructed using log2 transformed probe intensity values, as the graph would be virtually 
unreadable using raw values. 
III-3-4-4)  Identification of differentially expressed genes  
To assess inter-animal variation, colonic epithelium samples were not pooled in this experiment. 
Therefore, each animal was analyzed as an individual experimental unit. Differential expression of 
the microarray data was evaluated using the limma (Smyth GK, 2004) a R library which is part of 
the bioconductor  project . This procedure first fit a linear model to the expression data for each 
probe. Differences between groups were then extracted from the model as contrasts ( LMD9 versus 
Germ Free). An empirical Bayes ‘‘shrinkage’’ method was employed on the standard errors to 
improve power for small sample sizes (Smyth GK, 2004). Lastly, multiple test correction of p-
values was done using the false discovery rate (FDR) method (Benjamini Y et al, 1995). Gene 
transcripts having ≥1 log-fold change and FDR ≥
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III-3-5) NETWORKING ANALYSIS  
The analysis was performed using Gene Ontology (Ensembl; http:/ www.ensembl.org ) to identify 
the functional categories of our list of genes differentially expressed, and  Ingenuity Pathway  
Analysis (IPA; http://www.ingenuity.com , Redwood City, CA). IPA is a web –based application 
that enables the discovery, visualization , and exploration of functions, canonical pathway, and 
interaction networks, the software relies on currently known relationships ( i.e., published 
manuscripts) among  human, mouse, and rat genes/proteins. The IPA Functional Analysis identifies 
the biological functions, canonical pathway, and networks that are most significant to the data set. 
Genes from the dataset that meet the cutoff of p 0.05 and are associated with biological functions in 
the ingenuity knowledge base are considered for the analysis. 
III-3-5-1) Network Generation 
A data set of genes (differentially expressed in the mono-associated rats models relative to control) 
containing gene identifiers differentially expressed were uploaded into the application. Each gene 
identifier was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base. 
These genes, called focus genes, were overlaid onto a global molecular network developed from 
information contained in the Ingenuity Pathways Knowledge Base. Networks of these focus genes 
were then algorithmically generated based on their connectivity. 
III-3-5-2)  Functional analysis 
Functional Analysis identified the biological functions that were most significant to the data set. 
Genes from the dataset were associated with biological functions in the Ingenuity Pathways 
Knowledge Base were considered for the analysis. Fischer’s exact test was used to calculate a p-
value determining the probability that each biological function assigned to that data set is due to 
chance alone. 
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 Pooled data of all test Samples                         VS.              Pooled data of all control samples  
 
                                                       
Gene expression genes 
 
 
Figure 4: Schematic diagram illustrating the design of the pilot microarray experiment that investigated gene changes 
in the colonic epithelium of mono-associated rat versus Germ free rats .   
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IV) RESULTS 
II-1) Association of Germ-Free rats with Streptococcus thermophilus 
Two groups of three 3-weeks-old, germ-free male rats  belonging to the Ficher  inbred strain 344 
and maintained on a standard diet,one of the two group was colonized with a single gavage of 109 
colony forming units (CFU) of Streptococcus thermophilus in fermented milk (Rul  F.et al, 2010 
submetted) And the second group was maintained as a control. The rats were sacrificed 30 days 
later, a period of time sufficient for S. thermophilus to colonize the colonic epithelium. The number 
of viable bacteria was determined in the faeces of each rat during 4 week and  at the time of their 
sacrifice (Figure1). Furthermore, the colonization experiment revealed that the S.thermophilus 
strain LMD9 can implanted after one time of 
adaptation.
 
Figure 5: level of implantation during 4 weeks after inoculation of the Germ Free rats with Streptococcus thermophilus 
strain LMD9 by single gavage . Control of viable bacteria determined in the faeces during 4 weeks. At the moment of 
the animals sacrifice, S.thermophilus population was similar in feaces  to the inoculum 
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II-2) GLOBAL ALTERATIONS IN GENE EXPRESSION DUE TO THE  PRESENCE OF 
STREPTOCOCCUS THERMOPHILUS IN HOST COLONIC EPITHELIUM. 
 
We have used oligonucleotide microarray to analyse the host transcriptional responses caused by 
oral delivery of Streptococcus thermophilus bacteria (strain LMD9). Rats from the test group  
received LMD9 strain of Streptococcus thermophilus in  milk, while those from the Germ Free (GF) 
control group  received  only milk. Experiments were performed using age-matched rats  raised 
under Germ Free and mono-associated conditions. After the period of colonization (30 days), the 
presence of the corresponding Streptococcus thermophilus LMD9 strains in the intestinal content of 
the test group, and the lack of these bacteria in the control, were confirmed. Importantly, from the 
colon of the rats from test group, only the administrated strain could be re-isolated, while the 
corresponding control group remained Germ Free during the whole study period. 
RNA was isolated from the colonocytes cells  of each animal in each Treated  and control group. 
The resulting RNAs were subjected to microarray analysis ( combimatrix technology). 
II-2-1) MICROARRAY QUALITY ASSESSMENT 
After hybridization and scanning steps, we obtained spots of good quality, with high intensity, 
homogeneous size, and very low background. After we have performed the normalization step to 
eliminate variations between biological replicates, results were presented by box plot graph 
(Figure6a). The mean correlation coefficient for microarray values, obtained by scatter plot was 
0.90 for biological replicates (Figure 6b)    
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                                   a        b  
Figure 6: a – boxplot of the M-values from 6 arrays after  Quantile normalization to equalize the median absolute 
deviation for each array. b-  heatmap representig correlation between different biological samples after normalization  
II-2-2) IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES 
Gene that were up- or down-regulated by log -1 ≤ fold-change ≤ 1 genes altered by administration 
of Streptococcus thermophilus are presented in table 2 (“Top table”). Top table is a function 
provided by limma package (described in Material and Method section). In the mono-associated rats 
LMD9 in comparaison to Germ Free rats , A total of 95 genes were designated as differentially 
expressed using selections criteria (adj.P≤ 0.1), and maintained just the unique genes (NB: we have 
eliminated all probe none and predicted genes). A number of summary statistics are presented by 
topTable for the top genes and the selected contrast (Table2).  
ID description 
          
logF
C t 
               
P.Value 
                
Adj.P. 
Value 
NM_175838.1   eukaryotic translation elongation factor 1 alpha 1 (Eef1a1), mRNA 2,63 5,54 0,0010 0,1042 
NM_199498.1   keratin 19 (Krt19), mRNA 2,39 6,63 0,0003 0,0873 
NM_138827.1   solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1), mRNA 2,30 5,64 0,0009 0,1015 
NM_001011918.1   annexin A11 (Anxa11), mRNA 2,17 7,54 0,0002 0,0736 
NM_139257.1   lymphocyte antigen 6 complex, locus B (Ly6b), mRNA 2,06 6,23 0,0005 0,0958 
NM_134409.2   zymogen granule protein 16 (Zg16), mRNA 1,97 7,85 0,0001 0,0736 
NM_182738.1   calcineurin B homologous protein 2 (Chp2), mRNA 1,90 8,86 0,0001 0,0665 
NM_053586.1   cytochrome c oxidase subunit Vb (Cox5b), nuclear gene encoding mitochondrial protein, mRNA 1,88 12,1 0,0000 0,0365 
NM_001107660.1   carbonic anhydrase 1 (Car1), mRNA 1,86 6,27 0,0005 0,0958 
NM_001034151.1  transmembrane protein 54 (Tmem54), mRNA 1,85 8,60 0,0001 0,0665 
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NM_021740.1  prothymosin alpha (Ptma), mRNA 1,77 13,1 0,0000 0,0365 
NM_199207.1   family with sequence similarity 21, member C (Fam21c), mRNA 1,76 10,1 0,0000 0,0566 
NM_153469.4   protein kinase inhibitor, gamma (Pkig), mRNA 1,66 5,68 0,0008 0,1015 
NM_001007701.1   translocation associated membrane protein 1 (Tram1), mRNA 1,64 8,55 0,0001 0,0665 
NM_001126120.1   alcohol dehydrogenase 5 (Adh5), mRNA 1,63 7,55 0,0002 0,0736 
NM_001004209.1   hydroxysteroid (17-beta) dehydrogenase 11 (Hsd17b11), mRNA 1,58 6,47 0,0004 0,0898 
NM_017231.1   phosphatidylinositol transfer protein, alpha (Pitpna), mRNA 1,56 7,69 0,0001 0,0736 
NM_001025418.1 
  protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), 
mRNA 1,55 7,15 0,0002 0,0845 
NM_053299.1   ubiquitin D (Ubd), mRNA 1,55 6,17 0,0005 0,0958 
NM_053475.1   protein tyrosine phosphatase 4a2 (Ptp4a2), mRNA 1,52 5,50 0,0010 0,1060 
NM_031614.2   thioredoxin reductase 1 (Txnrd1), mRNA 1,52 6,24 0,0005 0,0958 
NM_199370.1   keratin 8 (Krt8), mRNA 1,51 6,66 0,0003 0,0873 
NM_017320.1   cathepsin S (Ctss), mRNA 1,49 5,59 0,0009 0,1026 
NM_001108826.1   TNFAIP3 interacting protein 1 (Tnip1), mRNA 1,48 5,39 0,0011 0,1097 
NM_001106957.1   glyoxalase domain containing 5 (Glod5), mRNA 1,48 5,40 0,0011 0,1097 
NM_001106557.1   endothelial differentiation-related factor 1 (Edf1), mRNA 1,47 7,36 0,0002 0,0781 
NM_019299.1   clathrin, heavy chain (Hc) (Cltc), mRNA 1,45 6,60 0,0003 0,0873 
NM_001034104.1   transmembrane channel-like 4 (Tmc4), mRNA 1,45 8,75 0,0001 0,0665 
NM_001108624.2   NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (Ndufb2),  mRNA 1,45 6,74 0,0003 0,0865 
NM_001106029.2   cornichon homolog (Drosophila) (Cnih), mRNA 1,42 9,32 0,0000 0,0577 
NM_031000.3   aldo-keto reductase family 1, member A1 (aldehyde reductase) (Akr1a1), mRNA 1,40 6,44 0,0004 0,0898 
NM_001100995.1   similar to 4930438D12Rik protein (RGD1563224), mRNA 1,39 10,6 0,0000 0,0566 
NM_031026.1   dynein, cytoplasmic 1 light intermediate chain 2 (Dync1li2), mRNA 1,37 12,5 0,0000 0,0365 
NM_001013919.1   galactokinase 2 (Galk2), mRNA 1,35 6,04 0,0006 0,0975 
NM_031603.1   tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, (Ywhae), mRNA 1,35 6,46 0,0004 0,0898 
NM_139099.1   ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (Atp5e), mRNA 1,35 5,93 0,0006 0,1009 
NM_001108442.1   NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (Ndufb7), mRNA 1,34 6,09 0,0006 0,0962 
NM_012653.2 
  solute carrier family 9 (sodium/hydrogen exchanger), member 2 (Slc9a2), transcript variant 2, 
mRNA 1,33 13,4 0,0000 0,0365 
NM_001106289.1   TMEM9 domain family, member B (Tmem9b), mRNA 1,32 5,67 0,0008 0,1015 
NM_054002.1   zinc finger and BTB domain containing 7a (Zbtb7a), mRNA 1,32 9,01 0,0001 0,0653 
NM_175757.2   crystallin, lambda 1 (Cryl1), mRNA 1,31 9,48 0,0000 0,0566 
NM_001025419.1   Tax1 (human T-cell leukemia virus type I) binding protein 3 (Tax1bp3), mRNA 1,31 6,14 0,0005 0,0961 
NM_053755.1   solute carrier family 26, member 3 (Slc26a3), mRNA 1,31 8,52 0,0001 0,0665 
NM_001008319.1   macrophage erythroblast attacher (Maea), mRNA 1,29 7,50 0,0002 0,0736 
NM_012975.1   lectin, galactoside-binding, soluble, 4 (Lgals4), mRNA 1,29 10,4 0,0000 0,0566 
NM_031731.2   aldehyde dehydrogenase 3 family, member A2 (Aldh3a2), mRNA 1,28 8,55 0,0001 0,0665 
NM_001100756.1   tetratricopeptide repeat domain 7 (Ttc7), mRNA 1,28 7,43 0,0002 0,0769 
NM_031132.3   transforming growth factor, beta receptor II (Tgfbr2), mRNA 1,27 9,52 0,0000 0,0566 
NM_001107449.1   chloride channel calcium activated 3 (Clca3), mRNA 1,26 6,50 0,0004 0,0898 
NM_001014119.1   dehydrogenase/reductase (SDR family) member 11 (Dhrs11), mRNA 1,26 6,04 0,0006 0,0975 
NM_001130559.1   NIPA-like domain containing 2 (Npal2), mRNA 1,26 5,71 0,0008 0,1015 
NM_001007600.1   ribosomal protein S4, X-linked (Rps4x), mRNA 1,25 7,71 0,0001 0,0736 
NM_017318.2   PTK2B protein tyrosine kinase 2 beta (Ptk2b), mRNA 1,25 5,94 0,0006 0,1009 
NM_001134687.1   solute carrier family 35, member E3 (Slc35e3), mRNA 1,23 8,43 0,0001 0,0691 
NM_001031654.1   annexin A8 (Anxa8), mRNA 1,22 5,99 0,0006 0,0996 
NM_001007662.1   archain 1 (Arcn1), mRNA 1,19 6,94 0,0003 0,0859 
NM_001134701.1   MHC class I RT1.Aa alpha-chain (Rt1.aa), mRNA 1,19 6,49 0,0004 0,0898 
NM_198748.1   scinderin (Scin), mRNA 1,18 8,54 0,0001 0,0665 
NM_001109678.1   NAD kinase (Nadk), mRNA 1,18 6,27 0,0005 0,0958 
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NM_001039031.1   dihydroxyacetone kinase 2 homolog (S. cerevisiae) (Dak), mRNA 1,18 5,45 0,0010 0,1075 
NM_001108330.1   similar to CG14977-PA (RGD1309735), mRNA 1,17 6,97 0,0002 0,0859 
NM_019376.2   tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, (Ywhag), mRNA 1,16 6,56 0,0004 0,0888 
NM_001106066.1   6-phosphogluconolactonase (Pgls), mRNA 1,14 6,61 0,0003 0,0873 
NM_182671.2   NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10-like 1 (Ndufa10l1), mRNA 1,14 9,56 0,0000 0,0566 
NM_012762.2   caspase 1 (Casp1), mRNA 1,12 5,64 0,0009 0,1015 
NM_001008348.1   FERM domain containing 8 (Frmd8), mRNA 1,11 6,76 0,0003 0,0859 
NM_001077670.1   eukaryotic translation initiation factor 3, subunit J (Eif3j), mRNA 1,10 6,19 0,0005 0,0958 
NM_133526.1   tetraspanin 8 (Tspan8), mRNA 1,10 6,16 0,0005 0,0958 
NM_001079887.1   inhibitor of growth family, member 4 (Ing4), mRNA 1,08 6,87 0,0003 0,0859 
NM_001025773.1   tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9), mRNA 1,07 5,90 0,0007 0,1015 
NM_001013150.1   mitogen-activated protein kinase kinase kinase 11 (Map3k11), mRNA 1,07 5,75 0,0008 0,1015 
NM_001014253.2   selenoprotein T (Selt), mRNA 1,06 5,54 0,0010 0,1042 
NM_134365.1   ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 (Atp5f1),  mRNA 1,06 5,83 0,0007 0,1015 
NM_001033706.1   aldehyde dehydrogenase 16 family, member A1 (Aldh16a1), mRNA 1,05 6,43 0,0004 0,0898 
NM_207595.1   ankyrin repeat, family A (RFXANK-like), 2 (Ankra2), mRNA 1,05 5,85 0,0007 0,1015 
NM_017040.1   protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb), mRNA 1,05 5,66 0,0008 0,1015 
NM_001012118.1   odd-skipped related 2 (Drosophila) (Osr2), mRNA 1,04 5,47 0,0010 0,1069 
NM_001106063.1   hypothetical gene supported by AF152002 (LOC290595), mRNA 1,04 6,65 0,0003 0,0873 
NM_001107586.1   cleavage stimulation factor, 3' pre-RNA subunit 2, tau (Cstf2t), mRNA 1,03 5,49 0,0010 0,1060 
NM_139105.1   ribonuclease/angiogenin inhibitor 1 (Rnh1), mRNA 1,02 8,05 0,0001 0,0736 
NM_001009622.1   SAR1 homolog B (S. cerevisiae) (Sar1b), mRNA 1,02 6,11 0,0005 0,0962 
NM_001107111.1   interleukin 10 receptor, beta (Il10rb), mRNA 1,02 6,00 0,0006 0,0996 
NM_001008298.1   STARD3 N-terminal like (Stard3nl), mRNA 1,02 7,78 0,0001 0,0736 
NM_001006981.2 
  dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), 
mRNA 1,02 6,72 0,0003 0,0867 
NM_001012359.1   angiogenin, ribonuclease, RNase A family, 5 (Ang), mRNA 1,02 5,78 0,0007 0,1015 
NM_133583.1   N-myc downstream regulated gene 2 (Ndrg2), mRNA 1,02 5,80 0,0007 0,1015 
NM_001004220.1   electron-transfer-flavoprotein, beta polypeptide (Etfb), mRNA 1,01 5,85 0,0007 0,1015 
NM_031682.1   hydroxysteroid (17-beta) dehydrogenase 10 (Hsd17b10), mRNA 1,00 6,41 0,0004 0,0900 
NM_057196.1   BAI1-associated protein 2 (Baiap2), mRNA 
-
1,11 -6,85 0,0003 0,0859 
NM_001014011.1   GRAM domain containing 3 (Gramd3), mRNA 
-
1,11 -7,84 0,0001 0,0736 
NM_001047877.1   arylsulfatase G (Arsg), mRNA 
-
1,14 -7,60 0,0001 0,0736 
NM_001108125.1   sestrin 3 (Sesn3), mRNA 
-
1,15 -7,04 0,0002 0,0859 
NM_001033075.1   defensin alpha 7 (Defa7), mRNA 
-
1,17 -5,86 0,0007 0,1015 
NM_013085.3   plasminogen activator, urokinase (Plau), mRNA 
-
1,26 -5,66 0,0008 0,1015 
NM_133598.2   glycine cleavage system protein H (aminomethyl carrier) (Gcsh), mRNA 
-
1,29 -7,02 0,0002 0,0859 
 
Table2: summary of the results of the linear model, after performing the hypothesis tests and adjusting the p-values for 
multiple testing. Results include (log) fold changes, t-statistics, and p-values. The basic statistics used for significance 
analysis is the moderated t-statistic, which is computed for each probe and for each contrast.95 Selected  differentially 
expressed genes in mono-associated rats (LMD9) in comparison with Germ Free rats. ID represent the accession 
number in gene bank, (log)FC represent a level of expression en logarithmic function, adj.p.val represent the p value 
adjusted. 
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II-2) ANALYSIS OF THE HOST RESPONSE TO THE PRESENCE OF STREPTOCOCCUS 
THERMOPHILUS 
Basic analyses computed with gene ontology using the “Biomart” 
(http://www.ensembl.org/biomart/martview) function available at Ensembl public database  allowed to 
divide differentially expressed genes  into different functional categories based on the biological 
process efficiently stimulated the gene expression involved in the cellular metabolism and proteins  
processing, Cell growth and development, signal transduction, ion homeostasis,  transport activity, 
and unknown function were presented by “other” (Figure7). 
Analysis computed by Ingenuity Pathway Analysis software(IPA; http://www.ingenuity.com), a   
Functional Analysis that identifies the biological functions, canonical pathway, and networks that 
are most significant to the data set, we have shown that IPA mapped and annotated 95 genes , 
among which 45 could be associated to 9 networks. Six of these are main networks interconnected 
by at least one common gene. The remaining 3 networks are deemed to be independent. Six of these 
are main networks interconnected by at least one common gene (Figure8). The remaining 3 
networks are deemed to be independent. The composition of each network is given in Table 4, 
which are classified into major and minor networks according to their score and to the number of 
genes identified and linked to these networks. The first six networks were identified as major 
networks fairly high scores ranging from 35 for the best of them to 19 for the 6th. The other 
networks are comprised of few gene products and cannot be directly associated to major networks, 
which means  that only 3 out of the total gene list products were not associated to major networks.. 
In Figure 9, we present in more detail, the most likely network (6 networks). 
Network 1 contains 2 under-expressed gene, which  are colored in green, and 18 over-expressed 
genes, which  are colored in red. This principal network is interconnected on 3 most important 
complexes: NFκ-B which is known to play a central role in survival cell pathway, 38pMAPK which 
plays an important role in cell differentiation process , Akt which is important in the embryonic 
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development, cell growth and cell survival. NFκ-B in this network up-regulates the TGFRB2, gene 
involved in the development process of colonic epithelium by governing a cell differentiation and 
migration and down-regulates PLAU gene involved in the cell cycle arrest. Network 1 showed also 
that JNK complex, which is a member of the mitogen-activated protein kinase group of signaling 
proteins and that plays a key role in the differentiation of ES cells (Ping Xu et al, 2009), upregulates 
PTK2B and KRT8. PTK2B has a direct interaction with SLC2A1 and ANXA11. KRT8 has a direct 
interaction with KRT19. 38pMAPK complex upregulates PTK2B by a direct interaction.  
Network 2 contain one gene down-regulated (green)and 16 genes upregulated (red). This second 
principal network is centered on TGFRB1 which is known to play a central role in developmental 
processes. We noticed that TGFB1 in this network interacts and upregulates target genes as 
TGFBR. TGFRB1 indirectly upregulates MUC5 that indirectly interacts and upregulates SLC2A1. 
Network 3 contains 13 upregulated genes (red)and one downregulated gene (green). This network 
shows that HNF4A complex orchestrates the interconnection of most genes. In particularly,  this 
gene complex  interacts directly and upregulates DLST and CSTF2T.  
Network 4 contain 12  upregulated genes (red) This network is orchestrated by APP complex that 
has a direct interaction with HSD17B10 and indirectly with CA1. 
The two last Networks 5 and 6 contain 11 upregulated genes (red) each. The network 5 presents 
important interactions between products of target genes and has one gene downregulated relatively 
to network 6. It’s also formed by two sub-clusters: the up cluster and the bottom cluster (Figure 
5)The bottom cluster is constructed by 6 target genes NDUFB2, NDUFA10, NDUFB7, NADH2 
deshydrogenase (ubiquitinone), NADH2 dehydrogenase and NADH dehydrogenase  which are 
involved in the oxidative phosphorylation pathway. The network 6 is centered on TNF, a tumor 
necrosis factor  which plays an important role in cell signaling and inflammatory response. The 
cellular response (e.g., proliferation versus apoptosis) to TNF is determined by the balance between 
the apoptotic signaling pathway and NF-κB survival pathway stimulated by TNF. 
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The minor networks, which were at first considered to be less pertinent, were emerged of the 
networks considered principals. The result revealed interconnection between network 3 and 9 
(figure 10), and the interconnection is presented by a direct interaction between MIR 124 and 
STOM. In contrast network 8 was remained single. 
II-3) GENES AND MOLECULAR PATHWAYS AFFECTED BY STREPTOCOCCUS 
THERMOPHILUS STIMULATION. 
Among the 95 mono-associated LMD9 genes undergoing knowledge expression variation upon 
Streptococcus thermophilus stimulation, the pathway analysis knowledge database has revealed that 
45 gene products could be defined as “Top Bio Functions”. Most relevant functions were associated 
with: 
- Molecular and Cellular Functions that included, Small Molecule Biochemistry ( 15 gene; p 
value :9,57E-04 - 4,09E-02) , Cellular Assembly and Organization (10 gene; p value: 2,22E-
03 - 4,96E-02), Molecular Transport (10 gene; p value: 2,56E-03 - 4,09E-02), Energy 
Production (5 gene; p value: 2,56E-03 - 1,11E-02), and Lipid Metabolism (5 gene; p value: 
9,57E-04 - 3,52E-02).  
- Physiological System Development and Function associated with Embryonic Development 
(5 gene; pvalue:1,04E-04 - 1,19E-02), Tissue Morphology (11 gene; pvalue: 1,04E-04 - 
4,67E-02),  Reproductive System Development and Function (2 gene; pvalue: 3,46E-04 - 
3,46E-04), and Organ Morphology (5 gene; pvalue: 4,24E-04 - 3,52E-02).  
- Diseases and Disorders composed by Genetic Disorder ( gene; pvalue: 3,50E-05 - 4,67E-
02), Metabolic Disease(8 gene; pvalue: 3,50E-05 - 2,94E-02), Gastrointestinal Disease(19 
gene products; pvalue: 1,93E-04 - 4,24E-02), and Hematological Disease (12 gene; pvalue: 
1,18E-03 - 4,67E-02). 
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- Canonical pathway analysis of  targets gene list showed metabolic pathway including 
oxidative phosphorylation associated with 5 of gene targets such as NADH deshydrogenase, 
NADH dehydrogenase (ubiquinone), hydroxysteroid (17-beta) dehydrogenase. Wntβ-
catenin signaling pathway including 3 of gene targets such as TGFBR, PP2A and ub. And 
PI3KAkt signaling including 3 of gene targets such as 14-3-3 γ, 14-3-3ε and PP2A. 
V) DISCUSSION 
The primary role of the colon has been known for years to maintain water and electrolyte balance 
and to excrete undigested food materials. Currently, the colon is appreciated as a metabolically 
active organ and, therefore, colonic health is closely linked with overall health of humans and 
animals (O’Keefe SJ , 2008). Until recently, however, the physiology of the colon has received little 
attention in biological studies as compared to other body organs. Dietary composition may be the 
most important factor affecting colonic health because of its direct effects on microbial 
fermentation, morphology, and metabolism. Microbial populations, and their fermentation play a 
key role in colonic health and physiology, previous study reported by cherbuy et al have shown that 
microbiota have an impotant role in maturation of colonic epithelium (cherbuy et al, 2010). Gut 
bacteria play a critical role in the maintenance of colonic health, but the molecular mechanisms 
involved in the process are not well understood. A considerable focus has been given to the Lactic 
acid bacteria that have demonstrated in the last 10 years a most important benefice on the colonic 
health (Turpin et al, 2010). 
In recent years, micro-array studies have been increasingly used to analyze tissue or cell response to 
a given stimuli (Childs RA. Et al, 2009; Febbo PG. et al, 2006; Mayburd AL. et al, 2009), and 
provide a lot of data for analysis. However, improved integration of this huge mass of data is 
needed to better understand the biological processes for which slight modifications in gene 
expression can have consequences. To this end, in the present study, we carried out pathway and 
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functional analysis on the Streptococcus thermophilus induced genes in colonic epithelium cells 
using Ingenuity Pathway Analysis tool. 
In the present study we have investigated the gene expression profile of mono-associated rats with 
Streptococcus thermophilus bacteria  to understand the behaviour of host colonic epithelium in the 
presence of lactic acid bacteria (S.thermophilus LMD9), here we presented in vivo  the resulting 
host response after 30 days of inoculation. Implantation of S. thermophilus strain LMD9  in GF rats 
occurred progressively in accordance with study presented by Rull et al (Rul et al, 2010 submetted). 
Analysis of gene expression profil has shown that this adaptive response of S.thermophilus  
(LMD9) was accompanied by significant physiological and functional changes in the host colonic 
epithelium. 
The gene expression analysis of the host colonic epithelium have revealed a up-regulation of most 
important genes involved in the cellular development and maintenance; cellular Growth and 
Proliferation; cell Cycle; energy Production, molecular transport, and metabolism process among 
the functional categories examined by Ingenuity Pathway Analysis. 
Molecular transport:  
Genes for the transport category in particularly genes coding of solutes carriers SLC2A1, SLC1A4, 
SLC9A2, SLC26A3. Transporters were identified as being more highly expressed in the colon than 
in the small intestine (Barrett KE, et al 2001). Many of these transporters have been described as 
highly expressed in the colon and involved in the bi-directional transport of electrolytes and fluids, 
which is the principal role of the colon (Geibel JP et al, 2004). However, the majority of known 
drug and nutrient transporters or carriers of bioactive compounds (Steffansen B et al, 2004) are not 
differently expressed between the small intestine and the colon.  Recent study computed by Gail et 
al at 2009, on colonic gene expression in conventional and Germ Free mice has provided that 
expression of SLC26A3 is reduced  in the Germ Free mice, but the level return to normal upon 
bacterial colonization (Gail A. et al, 2009). other  study reported by Ingrid et al has shown down-
regulation of SLC2A1, SLC1A4, and CA1 during DSS treatment  in comparison to normal 
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conditions (Ingrid B. et al, 2002).The SLC2A1, SLC1A4, and CAI are the specifics products 
expressed by enterocytes and that are involved in colonic CO2 excretion, intracellular pH 
regulation, NA+ and Cl- absorption and, indirectly, in water transport (Charney AN et al, 1994). 
Combined our results of all observations that were listed in this contest suggest strongly that 
Streptococcus thermophilus has a positive impact on stimulation and maintenance of colonic 
absorption function by stimulation of membrane permeability.  
Regulation of Cell cycle (proliferation and differentiation):  
This study have showed also an up-regulation of genes involved in the regulation of cell cycle such 
as, transforming growth factor that is a gene that provides instructions for producing protein called 
transforming growth factor beta. The TGFβ-1 protein helps control the growth and division 
(proliferation) of cells, the process by which cells mature to carry out specific functions 
(differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). The TGFβ-
1 protein is found throughout the body and plays a role in development before birth the formation of 
blood vessels, the regulation of muscle tissue and body fat development, wound healing, and 
immune system function. TGFβ-1 is particularly abundant in tissues that make up the skeleton, 
where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between 
cells (the extracellular matrix) (Gijs R. Van Den Brink,2003). Within cells, this protein is turned off 
(inactive) until it receives a chemical signal to become active. However, TGFB2 is involved  in the 
development process of colonic epithelium by governing a cell differentiation and migration, their  
inactivation lead to a pathogenic role in the formation of human colon cancer (Muñoz NM et al, 
2006 ). previous findings in colon cancers showed inactivation of TGF-β signaling (Biswas S. et 
al,2004; Biasi F. et  al, 2008). In the present study we have found that this gene was regulated by 
NF-κB-complex. The NF-κB  a complex pathway involved in the cell survival, growth and 
differentiation (valeriu B et al, 2009). Our results  were Reinforced by direct Interaction  with target 
genes KRT8 and K19. KRT8 is one of the major intermediate filament proteins expressed in single-
layered epithelia of the gastrointestinal tract (Matthias T. et al, 2006), the function of KRT8  as a 
  
158
regulator of cell division and cell differentiation suggest that altered KRT8 might contribute to 
tumor development (Matthias T. et al, 2006), loss of this gene in transgeneic mice lead to increased 
cell proliferation (Casanova ML. et al, 1999). KRT9 that is found expressed in the ducts of the 
human pancreas ( Schussler MH et al, 1992), is responsible for the structural integrity of epithelial 
cells. Expression of KRT19 is often accompagned with expression of KRT8 differentiate cells of 
epithelial origin(Jeffrey Allard W. et al, 2004). In this study we have also shown an indirect 
interaction between genes target and p38Mitogen-activated Protein Kinase complex. Several recent 
finding have demonstrated that p38MAPK is involved in various vertebrate cell differentiation 
process, namely adipocytic ( Engelman JA. et al, 1998 ) and myogenic differentiation (Wu Z. et al, 
2000). Analysis computed by Mathieu H et al (Mathieu H. et al, 2001) have demonstrated that 
p38MAPK was found to be activated rapidly in intestinal cells induced to differentiate. Additionally 
specific inhibition of p38 significantly reduced the expression of several differentiation markers 
(Matheiu et al, 2001). In the seam context , this study has shown a direct interconnection between 
JNK complex, that was involved in the differentiation of ES cells (Ping Xu et al, 2009), and PTK2B 
gene, that is a cytosolic tyrosine kinases that are known to be important for processes such as cell 
proliferation, differentiation, and motility (Annemiek Beverdam et al, 2010), lead some evidence of 
the role of S.thermophilus to promote cell differentiation process. 
All of these data  were reinforced by down-regulation of Sesn3 named sestrin-3 involved in the 
arrest of cell cycle, and were in concordance with expression of Kruppel like factor 4 and 14-3-3σ, 
genes resulted differentially expressed using Supressive subtractive hybridization technology 
(chapter III), that were involved in the arrest of cell cycle and start of cell differentiation process.  
These observations suggest that  Streptococcus thermophilus has an anti proliferative impact on 
colonic epithelium cells and a positive effect on the cell differentiation. 
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Metabolism and energy production: 
On the other hand, we identified multiple genes associated with metabolism and energy production  
processes, such as mitochondrial genes ( NADH2 dehydrogenase, NADH2 dehydrogenasa 
ubiquinone, NDUFB). Genes that were distributed on the surface epithelial cells of the normal small 
intestine and colon ( Andrew JS. Macpherson et al, 1992). Induction of the mitochondrial genes is 
commonly observed during disturbed ATP homeostatsis caused by increased energy demand or 
decreased mitochondrial energy suplly ( Montalto M. et al, 2004; Schulzke JD. Et al, 2006). 
However, up-regulation of these genes lead to suggest that these genes were important to produce 
energy necessary to enhance intestinal permeability ( Somasundaram S. et al, 1997) consequently, 
facilitate electrolytes and indirect water transport. This result was also in concordance with 
production of lactose by Streptococcus thermophilus (Rull et al, 2010 submetted). 
Immune response: 
Down-regulation of the Defaα7, Mammalian -defensins constitute a family of cysteine-rich, 
cationic antimicrobial peptides produced by phagocytes and intestinal Paneth cells, playing an 
important role in innate host defense (Ganz T et al, 2002), and Plau, a urokinase gene that her over-
expression was due to the mucosal inflammation(Blassi F. et al 1988; Elliott R. et al, 1987), 
indicated that Streptococcus thermophilus did not caused damage of the colonic epithelium of 
mono-associated rats. 
In conclusion, the current experiment used microarray technology to identify global changes in 
colonic gene expression induced by Streptococcus thermophilus . In particular, mono-associated 
colonic epithelium had an up-regulation of genes associated with cell differentiation, metabolic and 
transport functions a down-regulation of genes associated with proliferation and immune response, 
highlighting potential genes and pathways that may be responsible for the signaling pathway. Up-
regulation of genes related to transport activity in the mono-associated colonic epithelium may 
indicate an elevated absorption rate in the colonic epithelium in the presence of Streptococcus 
thermophilus. This report give another evidences for utility of microbita and use of probiotic.   
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Figure 7: Functional categories of selected induced genes by streptococcus thermophilus in rat colonic epithelium. 
Analysis based on gene ontology using ensemble public database. The  percentual represent a percentual of genes 
relative of total genes.  
 
 
Network  Score 
Focus 
Molecules Top Functions 
 1  35  18 
 Embryonic Development, Tissue Morphology, Reproductive System Development and 
Function 
 2  31  16  Cellular Movement, Genetic Disorder, Immunological Disease 
 3  24  13  Cellular Development, Cellular Function and Maintenance, Cell Death 
 4  20  12  Energy Production, Molecular Transport, Nucleic Acid Metabolism 
 5  19  11  Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry 
 6  19  11  Antigen Presentation, Antimicrobial Response, Humoral Immune Response 
 8  2  1  Cancer, Reproductive System Disease, Carbohydrate Metabolism 
 9  2  1  Cellular Function and Maintenance, Small Molecule Biochemistry, Cellular Development 
Table 3: the networks  generated by  genes differentially expressed in the assay using IPA. The score indicates the 
likelihood that the assembly of a set of focus genes in a network could be explained by random chance alone . the data 
base attributed general general functions of each network which are determined by interrogating the ingenuity pathway 
knowledge base for relationships between the genes in the network and the cellular functions they impact.  
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Figure 8: Interconnections between networks. From our 45 differentially expressed genes, the data base has identified 9 
networks. The first  six are heavily interconnected as shown by solid lines between the networks.  Networks from 7 to 9 
do not share common genes. 
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Network6 
 
Figure 9: Close up of network (Network 1-6). A maximum autorized number of 35 genes were used to generate a 
network. Direct interactions between each gene within a network were represented. Genes highlighted in green were 
down-regulated whereas genes highlighted in red were up-regulated. Genes in white, which were not found in the assay, 
were added by the data base as they are relevant to the network. Solid lines represents a direct interaction whereas a 
dashed line represents  an indirect interaction. 
  
168
Network 3-9 
 
Figure 10: Connection of network 3 with minor network 9. Network s are built as previously described in figure 4. 
Genes that are in green were down regulated whereas genes in red were up- regulated. Genes in white, which were not 
found in the assay, were added by the data base as they are relevant to the network. Solid lines represent direct 
interaction between gene products whereas dashed lines represents indirect  interactions. Orange line display 
interconnection between minor network (network9) and major network 3. 
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ID 
 
Molecules in Network 
 
Score 
 
Focus Molecules Top Functions 
 
1 
Akt, ALDH3A2, ANKRA2, ANXA11, CASP1, Collagen(s), Creb, CTSS, 
DYNC1LI2, Focal adhesion kinase, FSH, IL12 (complex), Insulin, Jnk, KRT8, 
KRT19, LDL, Mapk, NDRG2, NFkB (complex), P38 MAPK, PDGF BB, 
peptidase, PITPNA, Pkc(s), PLAU, PTK2B, SESN3, SLC2A1, Tgf beta, 
TGFBR2, TNFRSF9, TNIP1, TXNRD1, Vegf 
 
35 18 
Embryonic 
Development, Tissue 
Morphology, 
Reproductive System 
Development and 
Function 
2 
ANG, ANXA8, C5ORF13, CIITA, CNIH, CTSS, FGF10, GDF15, GLI1, 
GRAMD3, KLF4, KRT8, KRT19, MAPK1, MIR302A (includes EG:407028), 
MUC5AC, NIPAL2, OSR2, Pdgfr, Pki, PKIG, PPP2R2A, RFX5, RHOB, RNH1, 
S100A4, SAR1B, SLC26A3, SLC2A1, sodium, TAX1BP3, TGFB1, TGFBR, 
TGIF1, TMEM54 
 
31 16 
Cellular Movement, 
Genetic Disorder, 
Immunological Disease 
3 
AKR1A1, ALDH16A1, ATP5E, ATP6AP1, BHMT, CKS2, CSTF2T, DLST, 
FNTA, GCSH, HBP1, HNF4A, HSD17B11, Insulin, KIF1B, KITLG, KRT19, 
LSR, MAEA, NMI, NR3C1, OGDH, PGLS, PTP4A2, RABGGTB, retinoic acid, 
RNF10, RPS16, RPS4X, STOM, THRAP3, TNFAIP8, UBQLN1, UMPS, ZG16 
 
24 13 
Cellular Development, 
Cellular Function and 
Maintenance, Cell 
Death 
4 
2-mercaptoethanol, 3-alpha,17-beta-androstanediol, ALDH3A2, APP, ATP5D, 
ATP5F1, CA1 (includes EG:759), CRYL1, CTNNB1, EDF1, EIF3J, ESR1, 
ETFB, GADD45G, HSD17B10, HTT, IDO1, Integrin alpha 6 beta 1, KLK2, L-
triiodothyronine, MNAT1, PHB2, PRDX2, PTMA, RARA, RPS4X, RXRA, 
SLC1A3, SNW1, testosterone, TPD52L1, TRAM1, TSPAN8, TTR, UBE2K 
 
20 12 
Energy Production, 
Molecular Transport, 
Nucleic Acid 
Metabolism 
5 
Ap2a2-Cltc-Hd, CBY1, CLTC, COX5B, DAK, DENND4A, EEF1A1, EF-1 
alpha, EZH2, HERC1, Histone h3, Hsp70, IFNB1, KIF1B, KIF1C, MAGED2, 
NADH dehydrogenase, NADH2 dehydrogenase, NADH2 dehydrogenase 
(ubiquinone), NDUFA10 (includes EG:4705), NDUFB2, NDUFB7, PDC, 
PI4KB, RAE1, REM1, RSRC1, SELT, SH3BP4, SYNPO2, YWHAA, YWHAD, 
YWHAE, YWHAG, ZBTB7A 
 
19 11 
Carbohydrate 
Metabolism, Lipid 
Metabolism, Small 
Molecule Biochemistry 
6 
ANKS1A, ARCN1, ARSG, CCL18, CHP2, CLCA1 (includes EG:1179), 
CRADD, DEFB103A, FGFR1OP (includes EG:11116), Gd3+, I kappa b kinase, 
IL10, IL10R, IL10RB, IL22R1-IL10R2, MAPK3, MEFV, MIR298 (includes 
EG:723832), NLR, p85 (pik3r), PPP2CB, PPP2R1B, PPP2R5B, PPP2R5E, 
RELA, SCIN, SFI1, SLC9A2, TLR5, TMEM9B, TNF, TNFAIP8, TNFSF13B, 
UBD, UCN3 
19 11 
Antigen Presentation, 
Antimicrobial 
Response, Humoral 
Immune Response 
7 DHRS11, MIR198 2 1 - 
8 galactokinase, GALK2 2 1 
Cancer, Reproductive 
System Disease, 
Carbohydrate 
Metabolism 
9 MIR124, TTC7A 2 1 
Cellular Function and 
Maintenance, Small 
Molecule Biochemistry, 
Cellular Development 
 
Table 4: the genes found to be differentially regulated in our experiments and the number of such genes displayed in 
the “focus molecules” . the score is generated using a pvalue calculation and is displayed as the negative log p-value. 
This score indicates the likelihood that the assembly of a set of focus genes in a network could be explained by random 
chance alone. A score of 2 indicates that there is a 1 in 100 chance that the focus genes are toghether in a network due 
to random chance. Therefore, network s with scores of 2 or higher have at least a 99% confidence of not being 
generated by random chance alone. The database attributed general cellular functions to each network which are 
determined by interrogating the Ingenuity Pathway Knowledge base for relationships between the genes in the network 
and the cellular functions they impact. 
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GENERAL CONCLUSION 
Vertebrates are essentially born germ-free but normally acquire a complex intestinal microbiota 
soon after birth. Most of these organisms are non-pathogenic to immunocompetent hosts; in fact, 
many are beneficial, supplying vitamins for host nutrition and filling the available microbiological 
niche to limit access and consequent pathology when pathogens are encountered. Thus, colonic 
epithelium health depends on interplay between host and microbiota. This is evident in 
inflammatory conditions such as inflammatory bowel disease, where aberrant responses to 
microbiota can result in host pathology. Studies with axenic (germ-free) or deliberately colonised 
animals have revealed that commensal organisms are required for the development of a fully 
functional immune system and affect many physiological processes within the host.  
The prospects of this  work are to understand the molecular mechanisms by which the microbiota 
influence the homeostasis of the intestinal epithelium. For this aim, we have colonized gnotobiotic 
rats with lactic acid bacteria such as Streptococcus thermophilus.  
S.thermophilus has been used in this study for a number  of reasons.  It’s among the first to colonize 
the intestinal tract in the birth (>108 /g faeces) (Moreau et al, 1986) (Palmer et al, 2007) and its 
presence in the faces and in breast milk has been recently described ( Perez et al, 2007). Therefore, 
S.thermophilus can have an impact on the maturation and homeostasis of intestinal epithelium after 
birth. This bacterium  is important since it is used as probiotics in the manufacturing of some 
industrial products, particularly yoghurt and milk fermentation. Moreover, recent data indicate that  
the S.thermophilus LMD-9  strain used in this study is among the 57 bacteria species found in 90% 
of 124 European human individuals (Qin J. et al, 2010).  
The research discussed in this thesis was  carried out in three  steps. The first one, was the 
generation of  mono-associated rats with Streptococcus thermophilus by oral administration and the 
integrative study of the crosstalk established between the bacterium and the host. The results have 
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demonstrated that S. thermophilus is able to adapt its global metabolism to gut environment by 
emphasizing its carbohydrate metabolism in the digestive tract. This is in accord with the beneficial 
role of fermented milk consumption in improving lactose intolerance. Moreover S.thermophilus is 
able to induce the host colonic epithelium p27kip1 protein which is involved in the cell cycle arrest, 
leading to a differentiation of colonic epithelium cells..   
In the second step we have used the suppressive subtractive hybridization (SSH) technology to 
identify differentially expressed genes. The subtraction library was prepared by subtracting mRNA 
between epithelial cells isolated from colonic mono-associated rats (inoculated with LMD9 strain of 
S. thermophilus) and germ-free rats (without bacteria). Eighty transcripts  were sequenced after 
SSH and among these, 32 corresponded to genes whose expression in colonic epithelial cells is 
potentially activated in the presence of S.thermophilus. Candidate genes can be grouped into four 
essential functional groups: genes that play a role in cell-cycle arrest and induction of 
differentiation, genes involved in the pathway of cell-communication, genes involved in binding 
and genes involved in regulation of biological processes.  
The two most important candidate genes, Kruppel like factor4 and 14-3-3 σ, were tested by 
conventional RT-PCR, quantitative RT-PCR, and Western blot analysis in mono-associated animals 
versus  germ-free animals. The results confirmed that selected candidate genes increase their 
expression in the presence of S. thermophilus, suggesting   that the bacerium has an antiproliferative 
impact on colonic epithelium cells reinforced by a promotion of the differentiation of these cells. 
These results partly confirmed the role of S. thermophilus in the modulation of  the expression of 
genes involved in essential intestinal functions such as the maturation of cells. 
Finally, in the third step, we have used gene array technology  to comparatively characterize 
differences in gene transcription in the colon of mono-associated (LMD) and germ-free (GF) rats 
evoked by oral administration of Streptococcus thermophilus LMD9 strains used in fermented dairy 
products .  
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We showed  that Streptococcus thermophilus  caused important changes on the transcriptional 
profile of the host. This bacteria, also considered a probiotic, evoked a complex response in the gut, 
reflected by differential regulation of a number of genes involved in essential biological functions 
such as metabolic activity, transport activity, development and cell growth, which are essential of a 
healthy colonic functionality.  
Differential expression of an array of genes described in this report evokes novel hypothesis of 
possible interactions between the Streptococcus thermophilus  bacteria and the host organism and 
warrants further studies to evaluate the functional significance of these transcriptional changes on 
the functionality of the host. 
In summary, these results proved that the normal  colonic host function of many  biological 
functions  is dependent on  bacterial colonization as commensal  or  probiotic. The critical tools of 
strain combination experiments, axenic /gnotobiotic , and omics technologies will allow us to 
understand the mechanisms that underlie host-bacteria in health and improve the therapies of the 
defects that occur in the colonic diseases.  
